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Abstract
COPII coated vesicles transport secretory proteins from the endoplasmic
reticulum (ER) to the Golgi apparatus. Six proteins are required for COPII vesicle
formation and are part of the COPII coat. Five of these proteins - two
heteromeric complexes, Sec23p/Sec24p and Secl 3p/Sec31 p, and a small
GTPase, Sari p - are present in the cytosol. The sixth protein, Secl 6p, is tightly
associated with the ER membrane.
The function of Secl 6p was explored by investigating the role of proteins
that interact with Secl 6p. Two cytosolic COPII coat components, Sec23p and
Sec24p, bind independently to distinct regions of Secl 6p. Sec23p binds to the
C-terminal domain of Secl6p, while Sec24p binds to the central domain of
Secl 6p These interactions suggest that Secl 6p may act as a scaffold for the
assembly of soluble coat proteins.
An integral ER membrane protein, Sed4p, was identified in a screen for
dosage-dependent suppressors of temperature-sensitive secl6 mutants. The
cytosolic domain of Sed4p binds to the C-terminal domain of Secl6p. Sed4p is
likely to interact with Secl 6p before vesicle budding is complete, since Sed4p is
present in the ER membrane, but not on vesicles. Deletion of SED4 decreases
the rate of ER to Golgi transport and exacerbates mutants defective in vesicle
formation, suggesting that Sed4p is important, but not necessary for vesicle
formation at the ER. Extensive genetic interactions between SED4, SAR1 and
SEC16 show close functional links between these proteins and imply that they
might function together as a multi-subunit complex on the ER membrane.
Secl2p, a close homolog of Sed4p, also acts early in the assembly of
transport vesicles. However, SEC12 performs a different function from SED4
because Secl2p does not bind Secl6p, and genetic tests show that SEC12 and
SED4 are not functionally interchangeable.
Issi p, a close homolog of Sec24p, was identified in a two-hybrid screen
for proteins that bind to the central domain of Secl 6p. Deletion of iss 1 and a
temperature-sensitive sec24 mutant exacerbate mutants defective in vesicle
docking, suggesting that Issi p and Sec24p function to facilitate docking of ER-
derived vesicles.
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Chapter 1
Coat-Mediated Vesicle Formation
PREFACE
Part of this chapter has been submitted for publication in "The Molecular
and Cellular Biology of the Yeast Saccharomyces". Vol. 3. Broach, J. R., Pringle,
J., and E. Jones Eds. Cold Spring Harbor Laboratory Press, as:
Chris A. Kaiser, Ruth E. Gimeno and David A. Shaywitz. Protein Secretion,
Membrane Biogenesis and Endocytosis.
OVERVIEW
The secretory pathway of eukaryotic cells consists of a series of intracellular,
membrane-bounded compartments. Transport between the compartments of the
secretory pathway occurs by vesicles that form by budding from one
compartment and are consumed by fusion with the next (Palade, 1975). In each
compartment, proteins to be secreted have to be sorted from resident proteins,
and secreted proteins have to be targeted to the correct acceptor compartment.
An important goal in understanding the secretory pathway is to understand how
vesicles are formed at different steps in this pathway and how this process
achieves sorting of cargo molecules. Since docking molecules that recognize the
acceptor membrane are components of the vesicle, vesicle formation is also
likely to affect targeting to the acceptor membrane.
In the most well studied cases, vesicle formation is associated with the
formation of a coat of peripheral membrane proteins around the budding vesicle.
Three distinct coats -- the clathrin coat, the coatomer coat and the COPII coat --
have been identified. Although the subunit composition of each coat is different,
the three coats are similar in the use of a small GTP-binding protein to regulate
the association of cytosolic coat components with the membrane. Furthermore,
in all three coats vesicle formation is coupled to the sorting of cargo molecules.
Weak sequence homology between components of the coatomer and the clathrin
coat suggests that these two coats are distantly related (Cosson et al., 1996).
Formation of clathrin and coatomer coated vesicles has been analyzed
extensively in vitro; these studies suggest that coat-mediated vesicle formation
involves at least three biochemically distinct steps. First, cytosolic coat
components assemble onto the membrane. In both clathrin and coatomer coats,
this process is coupled to the sorting of cargo proteins. Second, the membrane
has to curve to form a vesicle bud of defined diameter. Finally, the curved
membrane has to pinch off to form a coated vesicle. For each coat it will be
important to understand how these steps occur and how they are regulated.
Since both the clathrin and the coatomer coat have been used as a
paradigm for vesicle formation mediated by the COPII coat, I will review briefly
the literature concerning these two coats before discussing in detail what is
known about the COPII coat.
CLATHRIN COATED VESICLES
The clathrin coat consists of two heteromeric protein complexes, a
complex containing clathrin light and heavy chain ("clathrin"), and a tetrameric
complex, termed adaptor protein complex (AP complex). Clathrin coated
vesicles mediate transport from the trans Golgi compartment to the lysosome and
endocytic uptake at the plasma membrane; two distinct, though homologous, AP
complexes, AP-1 (trans Golgi) and AP-2 (plasma membrane), are used for these
two processes. Both AP-1 and AP-2 complexes bind to the cytosolic domain of
integral membrane cargo proteins through a conserved motif characterized by
aromatic amino acid residues (Robinson, 1994).
The first step in clathrin coated vesicle formation is the recruitment of AP
complexes to the membrane. This assembly reaction is mediated by at least two
classes of proteins, the small GTPase ARF and cargo proteins. ARF was first
described as a component of coatomer coated vesicles and has been studied
primarily in this context; the properties of ARF will be discussed in detail in the
coatomer section (see below). A role for ARF in AP-1 recruitment was suggested
by the observation that conditions that remove ARF from membranes inhibit AP-1
association with Golgi membranes in vivo (Robinson and Kreis, 1992). In vitro
assays that measure binding of AP-1 complexes to purified Golgi membranes or
to permeabilized cells demonstrated unequivocally that ARF is required for high
affinity binding to Golgi membranes (Traub et al., 1993; Stamnes and Rothman,
1993; Le Borgne et al., 1996). However, ARF is not sufficient for high affinity
AP-1 binding: conditions that increase the amount of ARF bound to Golgi
membranes in vitro do not increase the number of high affinity AP-1 binding sites
(Le Borgne et al., 1996). Thus, ARF may be one component of a multi-subunit
AP-1 receptor or it could act by activating downstream elements for AP-binding
(see coatomer section below).
The second class of proteins implicated in AP recruitment are integral
membrane cargo proteins. A recent study by Le Borgne et al. (1996) shows that
the number of high affinity AP-1 binding sites on Golgi membranes correlates
with the amount of cargo proteins present, strongly suggesting that cargo
proteins are part of the AP-1 binding site. However, cargo molecules are not
sufficient for AP-1 recruitment to membranes, as demonstrated by the inability of
membranes to recruit AP-1 in the absence of ARF.
Once AP complexes are bound, clathrin has to be recruited to AP-
containing membranes. Since clathrin and purified AP complexes bind to each
other in vitro, clathrin may bind to AP complexes directly (Pearse and Robinson,
1984; Smythe et al., 1992; Zaremba and Keen, 1993).
An interesting paradox is presented by the observation that both clathrin
and adaptor complexes are present in the cytosol at concentrations that are high
enough to allow binding to each other in vitro, but the two complexes do not
appear to associate in the cytosol in vivo (Smythe et al., 1992; Zaremba and
Keen, 1993). It has been suggested that cytosolic clathrin is bound to inhibitors,
such as valosin-containing protein and Hsc70, that block association with
adaptins (Robinson, 1994); presumably, adaptins bound to cargo containing
membranes are able to remove these inhibitors from clathrin. Alternatively,
additional molecules on the membrane may act together with adaptor complexes
to recruit clathrin from the cytosol.
Clathrin associated with membranes forms two distinct structures: flat
sheets and curved lattices (Heuser, 1980; Maupin and Pollard, 1983; Miller et al.,
1991). Experiments using cells depleted of potassium suggest that clathrin
lattices first form as planar sheets and then proceed to form curved lattices
(Larkin et al., 1986). When the number of cargo proteins for clathrin coated
vesicles on the plasma membrane is increased, the amount of flat clathrin sheets
increases accordingly, demonstrating that formation of flat clathrin lattices is
mediated by cargo proteins (Miller et al., 1991). Since the amount of clathrin
coated pits does not increase with the number of cargo proteins, it has been
suggested that the transition from flat to curved clathrin lattices is regulated and
requires factors in addition to cargo proteins (Miller et al., 1991). At present the
biochemical mechanism(s) for the transition from flat to curved clathrin lattices
are unknown.
After formation of a clathrin coated bud, the bud becomes constricted, and
then pinches off the membrane. A biochemical assay has been developed that
detects formation of a constricted bud by measuring the accessibility of plasma
membrane proteins to either antibodies or small molecules (Schmid and Smythe,
1991). Experiments using this assay demonstrate that bud formation,
constriction and pinching off are distinct reactions (Schmid and Smythe, 1991;
Carter et al., 1993). In particular, formation of constricted coated pits requires
GTP, but not GTP hydrolysis, while pinching off requires GTP-hydrolysis (Carter
et al., 1993).
A 100 kD GTP-binding protein, dynamin, has been implicated in
constricting the bud and then allowing scission to occur. Mutants in dynamin
block budding of clathrin coated vesicles, but allow the formation of coated pits
(Kosaka and Ikeda, 1983; Damke et al., 1994). Interestingly, in GTPyS treated
nerve terminals, tubular invaginations accumulate that are similar to the ones
seen in dynamin mutants; the stalks of these invaginations are surrounded by
rings containing dynamin, and the invaginations are often capped by a clathrin
coated bud (Takel et al., 1995). This study demonstrates that dynamin can
localize to the neck of clathrin coated buds, a position that would be expected for
a protein that mediates constriction and scission. Since dynamin self-assembles
into rings and stacks of interconnected rings in vitro, it has been suggested that
dynamin assembly is directly responsible for constricting the neck of clathrin
coated vesicles (Hinshaw and Schmid, 1995). In a model for bud constriction
and scission, GDP to GTP exchange on dynamin allows assembly of dynamin
rings around the neck of clathrin coated buds, thus constricting them at the neck.
GTP hydrolysis on dynamin is then thought to induce a conformational change
that closes the rings, resulting in a budded vesicle (Hinshaw and Schmid, 1995).
COATOMER COATED VESICLES
Coatomer is a seven subunit protein complex that is present in the cytosol
and forms a coat on Golgi-derived vesicles (Waters et al., 1991; Serafini et al.,
1991; Rothman, 1994). Coatomer-coated vesicles mediate retrograde transport
from the Golgi apparatus to the ER (Letourneur et al., 1994), and have also been
suggested to participate in transport from the ER to the Golgi apparatus
(Bednarek et al., 1995; Aridor et al., 1995) and in transport between Golgi
cisternae (Orci et al., 1986; Rothman, 1994). The role of coatomer in the last two
process, however, is disputed (see Pelham, 1994 for review).
Coatomer recruitment to the membrane probably involves two classes of
proteins: the small GTP-binding protein ARF and cargo molecules. ARF is a 21
kD myristoylated protein that is absolutely required for coatomer binding to Golgi
membranes from chinese hamster ovary cells. Vesicles made from these
membranes in vitro contain stoichiometric amounts of ARF and coatomer,
suggesting that ARF is a component of the coatomer coat (Orci et al., 1993;
Ostermann et al., 1993). ARF binding to membranes precedes and modulates
coatomer binding suggesting that ARF recruits coatomer to the membrane
(Donaldson et al., 1992a; Palmer et al., 1993; Ostermann et al., 1993).
The mechanism by which ARF associates specifically with Golgi
membranes has been the subject of considerable interest. Membrane binding of
ARF is regulated by its GTPase cycle: ARF in its GTP bound form is stably
bound to membranes, while ARF-GDP is present in the cytosol (Walker et al.,
1992; Palmer et al., 1993; Donaldson and Klausner, 1994). Since ARF-GTP can
bind to phospholipids and phospholipid vesicles (Kahn, 1991; Walker et al.,
1992), it has been suggested that the association of ARF-GTP with membranes
is due to the intrinsic affinity of ARF-GTP for lipids. Nucleotide exchange
factor(s) for ARF in the Golgi membrane (Donaldson et al., 1992b; Helms and
Rothman, 1992) may direct the specific association of ARF with these
membranes in vivo. In addition to non-specific binding, a specific ARF receptor
on Golgi membranes has been postulated, based on the observation that ARF is
bound to membranes in two distinct pools: a liposome extractable, non-saturable
pool and a non-extractable, saturable pool. It has been suggested that ARF-GTP
is first non-specifically bound to the membrane and then recruited to its receptor
where it forms a stable interaction (Helms et al., 1993).
The role of ARF in coatomer recruitment has recently been reexamined,
after it was found that ARF activates phospholipase D (PLD; Brown et al., 1993;
Cockcroft et al., 1994). Recent data suggest that the effects of ARF on coatomer
assembly could be mediated by its ability to stimulate phospholipase D (PLD),
implying that ARF is not an obligatory component of the coatomer coat (Ktistakis
et al., 1995; Ktistakis et al., 1996). Thus, Golgi membranes from cell lines with
high intrinsic PLD activity do not require ARF for budding of coatomer coated
vesicles and the vesicles that form do not contain stoichiometric amounts of ARF
(Ktistakis et al., 1995; Ktistakis et al., 1996). Furthermore, membranes from
chinese hamster ovary cells that have been preincubated with ARF and
reisolated are capable of forming coatomer coated vesicles in the apparent
absence of ARF (Ktistakis et al., 1995). Phosphatidic acid, a reaction product of
PLD, stimulates coatomer binding to liposomes and has been suggested to
mediate the effects of ARF on coatomer binding (Ktistakis et al., 1996).
Purified coatomer binds to the cytosolic domain of cargo proteins in vitro;
the ER recycling motif KKXX appears to be a critical component of the coatomer
binding site (Cosson and Letourneur, 1994). This observation suggests that the
cytosolic coatomer complex could be recruited to the membrane by cargo
proteins in a manner similar to what has been suggested for clathrin coat
components. Thus far, however, the role of cargo proteins in coatomer
recruitment has not been examined directly.
Little is known about events that lead to budding after recruitment of the
coatomer coat. For instance, it is unclear whether the coatomer complex can
assemble into distinct flat and curved state similar to clathrin lattices.
Furthermore, it is unknown how the coatomer coated bud is constricted and how
it pinches off. Since coatomer coated buds formed in vitro with purified
components are unable to proceed to form vesicles (Orci et al, 1983; Ostermann
et al., 1993), distinct requirements for vesicle budding must exist. In vitro, these
requirements can be met by addition of fatty acyl-coenzyme A (Ostermann et al.,
1993); however, it is unclear, whether fatty acyl-coenzyme A participates in
vesicle budding in vivo.
COPII COATED VESICLES
COPII coated vesicles are the primary vehicle for transporting secretory
proteins from the ER to the Golgi apparatus in both the yeast Saccharomyces
cerevisiae and, probably, in mammalian cells.
Protein Transport from the Endoplasmic Reticulum to the Golgi Apparatus
in Saccharomyces cerevisiae
The dissection of ER to Golgi transport in yeast has been facilitated by two
events: the discovery of conditional mutants that are defective in either vesicle
formation or vesicle fusion, and in vitro reconstitution studies which have helped
to define the essential components of the assembly and fusion machinery.
The first genetic screen for secretory (sec) mutants identified twenty-three
complementation groups; analysis of the maturation of a marker protein revealed
that a subset of the sec mutants were defective in ER to Golgi transport (Novick
et al., 1981; Fig. 1). Careful morphological analysis further divided the ER to
Golgi mutants into two classes: mutants required for the formation of vesicles and
mutants required for the consumption of vesicles. Vesicle consumption mutants
(including secl7, sec18, and sec22) accumulated 50nm transport vesicles, while
vesicle formation mutants (including sec12, sec13, sec16, and sec23) did not
(Kaiser and Schekman, 1990). Epistasis analysis confirmed that vesicle
formation mutants function at an earlier stage than vesicle consumption mutants
(Kaiser and Schekman, 1990).
The second approach to dissection of ER to Golgi transport is based on
the in vitro reconstitution of this transport step (Baker et al., 1988; Ruohola et al.,
1988). In its simplest form, in vitro ER to Golgi transport assays measure
addition of Golgi-specific carbohydrate modifications to radiolabeled c-factor that
has been posttranslationally translocated into the ER. Gently-lysed cells or
partially purified ER membranes can serve as a donor compartment, while the
acceptor compartment is generally supplied by a membrane fraction enriched in
Golgi membrane by differential centrifugation. In the presence of exogenously
added cytosolic proteins and ATP, typically 25 to 50% of the input a(-factor is
modified in this system.
The basic in vitro assay has been modified to allow vesicle formation to be
evaluated independently of vesicle fusion. The assay for vesicle budding begins
with (x-factor within rapidly sedimenting ER membranes, and follows its
conversion to a slowly sedimenting fraction that corresponds to free vesicles
(Groesch et al., 1990; Rexach et al., 1991; Rexach et al., 1994; Barlowe et al.,
1994; Oka and Nakano, 1994). In this assay, mutants required for vesicle
formation in vivo (such as sec12 and sec23) were also found to be defective for
vesicle budding in vitro. Similarly, the vesicle accumulating mutant sec18 was
shown to be defective for vesicle fusion in vitro (Rexach et al., 1991; Rexach et
al., 1994; Oka and Nakano, 1994). Importantly, these studies of mutants
establish a faithful correspondence between the in vitro transport assay and the
events that occur in vivo.
Attempts to purify ER to Golgi transport vesicles from whole cells have
failed probably because of the low abundance of these organelles. Pure ER to
Golgi transport vesicles can be produced in quantity by in vitro budding reactions
under conditions where vesicle fusion with an acceptor compartment is inhibited
by either mutation or antibody (Groesch et al., 1990; Rexach et al., 1994;
Barlowe et al., 1994; Oka and Nakano, 1994). Purified ER-derived vesicles thus
produced are functional transport intermediates since they are competent to fuse
with Golgi membranes (Groesch et al., 1990; Rexach et al., 1994; Barlowe et al.,
1994; Oka and Nakano, 1994). ER-derived vesicles produced in vitro have
uniform morphology (-60 nm diameter), and when formed under the appropriate
conditions are encapsulated in a protein coat that can be visualized by electron
microscopy after fixation and staining with tannic acid. This coat consists of a
subset of the proteins required for vesicle formation in vivo and in vitro, and has
been termed COPII (Barlowe et al., 1994). Vesicle production in vitro appears to
reproduce the normal selectivity in segregation of vesicle proteins from ER
proteins that occurs before or during vesicle formation, since the vesicles that
bud in vitro contain known vesicle docking factors, such as Sec22p, and Bosl p,
but do not contain resident ER proteins (Barlowe et al., 1994; Rexach et al.,
1994). In addition, these vesicles have a characteristic set of twelve membrane
proteins, termed ERV (ER-vesicle associated) proteins (Rexach et al., 1994).
Components of COPII Coated Vesicles in Saccharomyces cerevisiae
Vesicle formation from the ER in vitro requires both ER membranes and
concentrated cytosolic protein. Five polypeptides - two heteromeric protein
complexes, the Sec23p/Sec24p complex and the Secl 3p/Sec31 p complex, and
a small GTP-binding protein, Sarl p - in pure form will satisfy this requirement for
cytosolic protein in vesicle budding (Salama et al., 1993; Barlowe et al., 1994).
These five proteins are present on completed vesicles and are abundant
components of the COPII coat (Barlowe et al., 1994). In addition to these
cytosolic factors, three other proteins -- Secl6p, Secl2p, and Sed4p -- are also
involved in COPII vesicle formation. Secl6p is a protein that is tightly associated
with the ER membrane and is also present on ER-derived vesicles produced in
vitro (Espenshade et al., 1995). Two integral ER membrane proteins, Secl2p
and Sed4p, regulate COPII vesicle formation, but are not incorporated into
completed vesicles (Barlowe et al., 1994; Gimeno et al., 1995).
It is important to note that the distinction between cytosolic and
membrane-associated COPII coat components is defined by the behavior of the
in vitro assay as carried out on ER membranes that have been extracted with
urea to remove peripheral proteins, and may not accurately reflect the distribution
of these proteins in living cells. For example, Sec23p and Sarilp have been
defined as cytosolic COPII coat components in the context of the in vitro assay,
yet these proteins appear to be principally associated with membranes in crude
cell extracts (Hicke and Schekman, 1989; Nishikawa and Nakano, 1991).
It is also notewothy that the in vitro budding assay has been most useful
for study of essential factors that can be depleted from the starting ER
membranes and then be added back in soluble form. Additional peripheral
membrane proteins like Secl6p that are not easily extracted from ER
membranes may have escaped detection by the budding assay in its current
form.
Sec23p and Sec24p: Cytosolic Vesicle Coat Proteins
SEC23 was initially isolated as an ER to Golgi mutant in the original sec
screen, and was subsequently determined to participate in vesicle formation in
vivo (Novick et al., 1981; Kaiser and Schekman, 1990). The conservation of the
temperature sensitive phenotype under in vitro conditions facilitated the
biochemical isolation of Sec23p activity from wild-type cytosol (Baker et al., 1988;
Hicke et al., 1989). Functional Sec23p was purified as a 300-400 kD complex
that contains both the 85 kD Sec23p and a 105 kD protein designated Sec24p
(Hicke et al., 1992; Barlowe et al., 1994); the precise stoichiometry of these two
protein partners has not yet been established. Sec24p, like Sec23p, is required
for vesicle formation at the ER in vitro, as demonstrated by antibody block
experiments (Hicke and Schekman, 1992). Chapter 4 of this thesis describes a
temperature-sensitive sec24 mutant; analysis of this mutant demonstrates that
Sec24p is required for ER to Golgi transport in vivo. The Sec23p/Sec24p
complex represents one of the major components of the COPII vesicle coat, and
is required for its formation (Barlowe et al., 1994; Bednarek et al., 1995).
Not only do Sec23p and Sec24p interact with each other, both
biochemically and genetically, but they also each exhibit genetic interactions with
the genes encoding the other COPII components -- SEC13, SEC31, SEC16, and
SAR1 (Kaiser and Schekman, 1990; Oka and Nakano, 1994; Chapter 4; Fig. 2).
Work presented in Chapter 2 of this thesis shows that Secl6p binds directly to
both Sec23p and Sec24p; the two protein partners bind to different sites on
Secl6p, and the binding of one subunit can occur in the absence of the other.
Sec23p has also been shown to function as a GTPase-activating protein (GAP)
for Sarl p, stimulating its GTPase activity by a factor of ten; Sec24p does not
appear to affect the GAP activity of Sec23p (Yoshihisa et al., 1993). While the
GAP activity of Sec23p has also stimulated the generation of several different
hypotheses regarding Sec23p function (Oka and Nakano, 1994; Schekman and
Orci, 1996), the exact role of the Sec23p/Sec24p complex in the formation of
COPII vesicles remains to be established.
Sec 13p and Sec3 l1p: Cytosolic Vesicle Coat Proteins
SEC13, like SEC23, was isolated in the original sec mutant screen, and,
like SEC23, was shown to be required for the vesicle formation step of ER to
Golgi transport (Novick et al., 1981; Kaiser and Schekman, 1990).
Immunodepletion experiments revealed a requirement for Secl 3p in the in vitro
transport assay (Pryer et al., 1993; Salama et al, 1993). Purification of Secl3p
activity from wild-type cytosol revealed that Sec1 3p exists as a 700 kD complex
with the 150 kD Sec31p protein (Pryer et al., 1993; Salama et al, 1993); the exact
stoichiometry of Secl 3p and Sec31 p in this complex has not yet been
established. Both SEC13 and SEC31 are essential genes, required for vesicle
transport in vivo and in vitro (Kaiser and Schekman, 1990; Salama et al., 1993;
Barlowe et al, 1994; Wuestehube et al., 1996). The Secl3p/Sec31p complex,
like the Sec23p/Sec24p complex, represents a major component of the COPII
coat and is required for its formation (Barlowe et al., 1994; Bednarek et al, 1995).
Both SEC13 and SEC31 exhibit genetic interactions with the other COPII
genes (SEC23, SEC24, SAR1, SEC16) (Kaiser and Schekman, 1990; Gimeno et
al, 1995; A. Frand and C. Kaiser, unpublished observations; Fig. 2). Structurally,
Secl 3p appears to consist almost entirely of WD-40 repeats, a motif first
described in the 3-subunit of trimeric G-proteins, and subsequently shown to
specify a 1-propeller structure (Wall et al., 1995; Neer and Smith, 1996). Secl3p
appears to interact with a WD-40-containing domain of Sec31 p, raising the
possiblility of a homotypic interaction (Shaywitz et al., in preparation). A different
region of Sec31 p has recently been shown to bind Secl 6p, consistent with the
proposed role of Secl6p as COP!I scaffold (Shaywitz et al., in preparation).
The function of the Secl3p/Sec31p complex in the formation of COPII
vesicles remains incompletely understood, a conclusion emphasized by recent
data which suggests that Secl3p may not always be required for ER to Golgi
transport. In particular, loss of function mutations in at least three genes (BST1,
BST2/EMP24, and BST3) have been isolated that bypass the requirement for
Secl 3p in ER to Golgi transport (Elrod-Erickson and Kaiser, 1996). These
mutants have only subtle phenotypes on their own: mutations in bstl-3 slow
transport of a subset of secreted proteins from the ER to the Golgi apparatus and
increase the rate at which ER-resident proteins, such as Kar2p, reach the Golgi
apparatus (Schimmbller et al., 1995; Stamnes et al., 1995; Elrod-Erickson and
Kaiser, 1996). This phenotype is consistent with a decrease in the fidelity of
cargo sorting at the ER that could be explained if BST1-3 encode components of
a checkpoint that monitors fidelity of cargo sorting and prevents the budding of
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immature or improperly coated vesicles (Elrod-Erickson and Kaiser, 1996).
Alternatively, since Bst2p/Emp24p is a major integral membrane component of
ER-derived transport vesicles, it has been suggested that Emp24p/Bst2p is a
sorting receptor for a subset of cargo molecules (Schimmbller et al., 1995; see
below).
Sec 16p: An ER-associated Vesicle Coat Protein
SEC16 encodes an essential, multi-domain 240 kD hydrophilic protein
required for ER to Golgi transport in vivo (Novick et al., 1981; Espenshade et al.,
1995). Secl6p is tightly associated with the periphery of the ER, and is also
found on ER-derived transport vesicles, suggesting that Secl 6p is a component
of the COPII coat (Espenshade et al., 1995). In contrast to the other COPII
components, Secl6p cannot be extracted from membranes by urea, explaining
why it does not needed to be added as a cytosolic factor to the in vitro transport
assay (Espenshade et al., 1995). Work presented in Chapter 2 of this thesis
shows that Secl 6p binds directly to the COPII subunits Sec23p and Sec24p.
More recent data suggest that Secl6p also binds to the COPII coat component
Sec31p (Shaywitz et al., in preparation). Based on these protein interactions we
suggested that Secl 6p on the ER membrane serves as a scaffold that organizes
the recruitment and assembly of COPII coat components from the cytosol (see
Appendix II and Chapter 2). SEC16 exhibits genetic interactions with the five
other COPII genes, underlining the importance of Secl6p in COPII vesicle
formation (Nakano and Muramatsu, 1989; Kaiser and Schekman, 1990; Chapter
3; Fig. 2). Furthermore, multiple genetic interactions between SEC16 and SAR1
suggest that Sarl p could regulate the assembly of cytosolic coat components
onto Secl 6p (Chapter 3).
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Sarip: a GTPase Coupled to Vesicle Assembly
SARi, an essential gene required for ER to Golgi transport, encodes a
small GTP-binding protein most closely related to ARF, a GTP-binding protein
that regulates assembly of the coatomer (COPI) coat (Oka et al., 1991; Barlowe
et al., 1993). Sarlp is a component of the COPII vesicle coat, and is required for
its formation (Barlowe et al., 1994; Bednarek et al., 1995).
SAR1 exhibits genetic interactions with the five other COPII coat
components (Fig. 2). In addition, the activity of Sarl p has been shown to be
modified by the COPII subunit Sec23p, which functions as a Sarl p-GAP, and by
Secl2p, which functions as an exchange factor for Sarlp. Sarlp has an intrinsic
guanine-nucleotide off-rate (0.07 min - 1) and GTPase activity (0.0011 min-1)
similar to those of other small GTP-binding proteins (Barlowe et al., 1993).
Secl 2p and Sec23p increase these rates (respectively) by about an order of
magnitude and Secl2p and Sec23p together increase the rate of GTP hydrolysis
by approximately 50-fold (Barlowe and Schekman, 1993; Yoshihisa et al., 1993).
Like Arflp, Sarlp requires the presence of detergents or phospholipids for GTP
binding (Barlowe et al., 1993), however, unlike other small GTP-binding proteins,
including ARF, Sarl p does not appear to require lipid modifications for its
function (Oka et al., 1991; Barlowe et al., 1993).
In vitro studies suggest that vesicle budding requires Sarl p in its GTP-
bound form (Rexach and Schekman, 1991; Oka et al., 1991; Barlowe et al. 1993;
Barlowe et al., 1994; Oka and Nakano, 1994). GTP-hydrolysis is not required for
vesicle formation since budding still occurs when non-hydrolyzable analogs of
GTP, are used, although under these conditions greater quantities of
Sec23p/Sec24p and Secl 3p/Sec31 p are needed (Barlowe et al., 1994). GTP-
hydrolysis by Sarilp is required for the overall transport process as the vesicle
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fusion step appears is sensitive to nonhydrolyzable GTP analogs (Barlowe et al.,
1994; Oka and Nakano, 1994).
Sarl p is thought to function by regulating assembly and disassembly of
the cytosolic COPII coat components. A simple model is that Sarilp in its GTP-
bound state promotes assembly of the COPII coat, while GTP-hydrolysis by
Sarlp promotes disassembly of the COPII coat (Barlowe et al., 1994). This
hypothesis is supported by in vitro data demonstrating that the COPII vesicle coat
produced in the presence of GTP is unstable, and readily dissociates from
budded vesicles, but when non-hydrolyzable analogs of GTP are substituted in
the budding reaction, the resulting COPII coat is stabilized (Barlowe et al., 1994).
These in vitro studies also indicate that COPII coat disassembly occurs in two
distinct steps: first, Sarl p rapidly hydrolyzes GTP and dissociates from the
vesicle, leaving a coat of Sec23p/Sec24p, Secl 3p/Sec31 p and possibly Secl 6p
(Barlowe et al., 1994). Second, Sec23p/Sec24p and Secl 3p/Sec31 p dissociate
from the vesicle (Barlowe et al., 1994); it has not been established whether the
dissociation of Secl 6p from the vesicle membrane ever occurs.
Secl2p and Sed4p: ER Proteins that Regulate COPII Coat Formation
Secl2p and Sed4p are integral membrane proteins that influence vesicle
budding at the ER, but are not themselves incorporated into vesicles. SEC12, an
essential gene required for the formation of ER-derived vesicles, encodes a type
II transmembrane protein that localizes to the ER, but is absent from vesicles
produced in vitro (Nakano et al., 1988; Nishikawa and Nakano, 1993; Barlowe et
al., 1994). The cytosolic domain of Secl2p is essential and stimulates guanine-
nucleotide exchange by Sarilp, whereas the luminal domain appears to be less
important since truncation of this domain does not greatly interfere with SEC12
function (d'Enfert et al., 1991a; Barlowe and Schekman, 1993). The cytosolic
25
domain of Sec12p may also function to recruit Sarlp to the ER membrane since
overexpression of Secl2p depletes Sarip from the cytosol and increases the
membrane-associated pool of Sarlp (d'Enfert et al., 1991b; Barlowe et al., 1993).
Recruitment does not appear to involve direct binding between Secl2p and
Sarl p since a stable association between these proteins has not been observed.
However, if Sarl p in its GTP-bound state has a high affinity for membranes,
Secl2p may effect recruitment simply by stimulating guanine nucleotide
exchange on Sarlp; this mechanism of membrane association would be similar
to what has been suggested for ARF (see above). It appears that for Sarl p to be
properly activated, the exchange activity of Secl2p must be in proximity to the
ER membrane since truncations of Secl2p that liberate a soluble exchange
activity inhibits vesicle budding from the ER. This inhibition can be overcome by
the addition of increased amounts of Sarl p (Barlowe et al., 1993).
SED4 encodes a type II transmembrane protein that is 45% identical to
Secl2p in its cytosolic and transmembrane domains, but has a divergent luminal
domain (Hardwick et al., 1992); however, Sed4p does not appear to stimulate the
nucleotide exchange activity of Sarlp (C. Barlowe, personal communication).
The cytosolic domain of Sed4p binds to the C-terminal domain of Secl 6p
(Chapter 3). Since Sed4p is present on the ER, but is not incorporated into
vesicles, the interaction between Secl6p and Sed4p is likely to occur before
vesicle formation is complete (Chapter 3). Although the deletion of SED4 causes
only minor growth and secretion defects in wild-type cells, a strain carrying an
otherwise silent sarl-5 mutation is rendered temperature-sensitive for growth and
secretion when SED4 is deleted (Chapter 3). SED4 exhibits genetic interactions
with both SAR1 and SEC16, and Sed4p has also been shown to bind to Secl6p;
we therefore suggested that Sed4p together with Secl 6p and Sarl p may act to
initiate vesicle formation at the ER (Chapter 3).
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COPII Vesicles in Mammalian Cells
Mammalian homologs of several COPII proteins have now been identified.
Mammalian Sarlp, Secl3p, and Sec23p all localize to the transitional region of
the ER, consistent with a role in vesicle formation at the ER (Kuge et al., 1994;
Shaywitz et al., 1995; Orci et al., 1991). Furthermore, in mammalian cells, the
transport of the marker protein VSV-G from the ER to the Golgi is inhibited both
in vivo (by a dominant negative mutant of hamster Sarilp) and in vitro (by anti-
Sarlp antibodies), suggesting that the function of Sarlp in ER to Golgi transport
has been evolutionarily conserved (Kuge et al., 1994). The demonstration that
reciprocal human/yeast chimeras of Secl 3p both complement the secretion
defect of a temperature-sensitive sec13 mutant provides further support for the
conservation of COPII component function (Shaywitz et al., 1995).
Cargo Sorting during COPII Vesicle Formation
Considerable evidence has accumulated indicating that the entry of cargo
molecules into ER-derived secretory vesicles reflects an important sorting
decision made by the cell. For example, although discrete retention signals
(which allow resident ER proteins to be retrieved from the Golgi) have been
characterized, resident ER proteins lacking these signals still exit the ER at a rate
much slower than that of actual secreted proteins (Munro and Pelham, 1987;
Hardwick et al., 1990). Furthermore, careful immuno-electron microscopy (EM)
studies suggest that at least some secretory proteins are concentrated in both
mammalian cells and yeast (Mizuno and Singer, 1993; Balch et al., 1994;
Bednarek et al., 1995). Finally, COPII vesicles formed in vitro from either
microsomes or from nuclear envelope preparations are enriched for proteins
known to enter the secretory pathway, and seem to lack resident ER proteins
(such as Kar2p, Secl2p, and Sec61p) (Barlowe et al., 1994; Bednarek et al.,
1995). These data suggest that a distinction between resident and transported
protein is made in the ER, at the level of packaging into transport vesicles.
If important sorting decisions occur during the formation of COPII vesicles,
it is likely that the COPII proteins themselves participate in the selection process,
and communicate critical information about the selection of cargo to the budding
vesicles, possibly through interactions with transmembrane proteins. Coat-
mediated sorting is well documented during the formation of clathrin and COPI-
coated vesicles in mammalian cells (Schekman and Orci, 1996). In these coats,
sorting is mediated by binding of integral membrane cargo proteins or sorting
receptors to subunits of the clathrin or the COPI coat (Ohno et al., 1995; Cosson
and Letourneur, 1994). Thus far, no binding between a COPII subunit and a
cargo protein has been demonstrated, although it has been suggested that
Sec23p may sample cargo proteins at the ER during the initial steps of vesicle
formation (Schekman and Orci, 1996).
The analysis of sorting during vesicle formation at the ER is complicated
by the absence of a defined sorting signal or sorting receptor. No common signal
required for exit from the ER has been defined and mutants blocked in ER to
Golgi transport did not reveal a candidate sorting receptor. One attractive
hypothesis is that the sorting of integral membrane proteins is mediated by the
interaction of these proteins with the COPII coat. In this scheme, the coat
complex would collectively function as a "receptor surface," with many potential
sites available for interaction with cargo membrane proteins. The sorting of
soluble cargo molecules requires additional assumptions; one possibility is that
soluble cargo binds to integral plasma membrane proteins, and follows them
through the secretory pathway. Alternatively, there may be a family of integral
membrane proteins that function as "sorting receptors," binding on the one hand
to COPII proteins, and on the other, to soluble cargo molecules. Emp24p/Bst2p
has been suggested to be such a receptor. Emp24p is an integral ER membrane
protein that was cloned because it is also a prominent component of ER-derived
vesicles (Schimmbller et al., 1995). A chromosomal deletion of EMP24 is viable,
but causes a kinetic defect in ER to Golgi transport of a subset of cargo proteins,
suggesting a role in segregating particular cargo molecules into the vesicles.
However, direct binding of Emp24p to cargo proteins has not been observed.
Emp24p/Bst2p and a second ER membrane protein, Bstl p, were also
identified because their deletion allows cells to grow in the absence of Secl3p
(Elrod-Erickson and Kaiser, 1996; see above). Strains deleted for Bstl p or
Emp24p/Bst2p have a decreased fidelity of cargo protein sorting, evidenced by a
kinetic defect in the export of a secreted protein (invertase) from the ER, and
missorting of the normally ER-retained proteins Kar2p, Pdilp, and an invertase
mutant defective in signal sequence cleavage (Elrod-Erickson and Kaiser, 1996).
Since bstl and bst2 mutants affect both protein sorting and the requirement for a
COPII coat component, Bstl p and Emp24p/Bst2p may constitute part of a
checkpoint that monitors both protein sorting and COPII coat assembly, before
allowing vesicle formation to proceed (Elrod-Erickson and Kaiser, 1996).
Towards a Model for COPII Vesicle Formation
Biochemical and molecular analysis of the proteins required for vesicle
formation suggest an outline for the pathway of COPII coat assembly. Analogous
to the known mechanism of coat recruitment in clathrin and coatomer coated
vesicles, the first step in vesicle formation at the ER is thought to be guanine-
nucleotide-exchange by Sari p and recruitment of Sari p to the ER membrane.
Since Secl2p, a nucleotide exchange factor for Sarip, increases the amount of
Sari p bound to the membrane, it is thought that Sari p in its GTP-bound form
binds to membranes either directly or through a membrane-bound receptor.
Thus far, no Sarlp receptor has been identified; in particular, no direct binding of
Sarlp to either Secl 2p or Sed4p has been demonstrated. However, since both
Secl 6p and the Secl 6p-binding protein Sed4p show strong genetic interactions
with Sarl p, Sed4p, possibly together with Secl 6p, may serve as a receptor for
Sarl p (Chapter 3).
Sarilp in its GTP-bound, membrane-associated form is thought to then
recruit the cytosolic coat components Sec23p/Sec24p and Secl 3p/Sec31 p to the
membrane. Work presented in chapter 2 of this thesis and recent results by D.
Shaywitz (see above) suggest that Secl6p, a protein tightly bound to the ER
membrane, acts as the receptor for these cytosolic coat components. Since the
C-terminal domain of Secl6p interacts with Sed4p, a protein that is not
incorporated into vesicles, but has strong genetic interactions with Sarl p, we
proposed that the Sec23p/Sec24p complex binds to Secl 6p first, followed by
binding of Secl3p/Sec31p (Chapter 2). The proposal that Secl6p is a receptor
for cytosolic coat components implies that binding of cytosolic coat components
to Secl6p is regulated by Sarlp. Sarlp could affect the affinity of Secl6p for
coat components directly; alternatively, proteins such as Sed4p and Secl2p
could mediate this effect of Sarl p.
At present, it is unclear how cargo molecules are loaded into COPII coated
vesicles. Analogous to cargo loading into clathrin and coatomer coated vesicles
it might be expected that a component of the COPII coat directly binds to cargo
proteins. So far, however, no binding between COPII coat components and
cargo protein has been described. Secl 6p would be an ideal candidate for a
cargo binding protein, since it is localized at the interface between the ER
membrane and cytosolic coat components; binding of cargo proteins to Secl6p
could modulate its affinity for cytosolic coat components.
Little is known about the requirements for constricting COPII coated buds
and pinching off vesicles. In vitro, formation of COPII coated vesicles requires
only cytosolic COPII coat components and ER membranes (Barlowe et al.,
1994), suggesting that no additional cytosolic factors are involved in budding.
Possibly, budding factors have so far escaped detection because they are tightly
associated with the ER membrane, similar to Secl6p. Alternatively, the large
amounts of coat components used in the in vitro assay or the special composition
of the ER membrane may allow vesicle budding to occur even in the absence of
special budding factors.
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Figure 1. Genes required for ER to Golgi transport in Saccharomyces cerevisiae.
Genes required for vesicle formation are indicated on the left, genes required for
vesicle docking or fusion are indicated on the right (vesicle docking genes above
the arrow, vesicle fusion genes below the arrow).
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Figure 2. Interactions between ER vesicle formation genes/proteins. A.
Synthetic lethal interactions. The following alleles were tested: sarl-5, sec24-1,
sec23-1, secl6-2, sed4-Al1, secl2-4, sec31-1, secl3-1. No synthetic lethal
interactions were observed between sarl-5 and secl2-4, and between sec23-1
and secl2-4. The following combinations were not tested: sarl-5/sec24-1, sarl-
5/sec31-1, sed4-A 1/sec24-1, sed4-A 1/sec31-1, sec24-1/sec31-1. B. Multi-copy
suppression. Suppression of the following alleles was tested: sec23-1, secl6-2,
sed4-Al1, secl2-4, secl3-1. SAR1, SED4 and SEC12were expressed on a high
copy (2g) plasmid, SEC23 and SEC16 were expressed on a low-copy (CEN)
plasmid. The effect of SEC13 overexpression has not been examined
systematically. C. Protein-protein interactions. The interactions shown have
been detected in both two-hybrid and coprecipitation experiments. No binding
was detected between Sarl p and Secl 6p, Sarl p and Secl 2p, Sarl p and Sed4p,
and between Secl 2p and Secl 6p. Sarilp interacted with Sec23p in the two-
hybrid assay, but did not coprecipitate with Sec23p.
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Chapter 2
COPII Coat Subunit Interactions: Sec24p and Sec23p Bind to
Adjacent Regions of Secl6p
PREFACE
This chapter represents a collaboration between myself and Peter Espenshade.
Peter Espenshade purified bacterially expressed Sec23p and Sec24p and
performed the in vitro binding experiments.
This chapter has been submitted in its entirety to Molecular Biology of the Cell
as:
Ruth E. Gimeno, Peter Espenshade, and Chris A. Kaiser. COPII Coat Subunit
Interactions: Sec24p and Sec23p Bind to Adjacent Regions of Secl6p.
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ABSTRACT
Formation of COPII coated vesicles at the endoplasmic reticulum (ER)
requires assembly onto the membrane of five cytosolic coat proteins, Sec23p,
Sec24p, Secl 3p, Sec31 p and Sarl p. A sixth vesicle-coat component, Secl 6p, is
tightly associated with the ER membrane, and has been proposed to act as a
scaffold for membrane association of the soluble coat proteins. We previously
showed that Sec23p binds to the C-terminal region of Secl6p. Here we use two-
hybrid and coprecipitation assays to demonstrate that the essential COPII protein
Sec24p binds to the central region of Secl6p. In vitro reconstitution of binding
with purified recombinant proteins demonstrates that the interaction of Sec24p
with the central domain of Secl 6p does not depend on the presence of Sec23p.
However, Sec23p facilitates binding of Sec24p to Secl6p and the three proteins
can form a ternary complex in vitro. Truncations of Sec24p demonstrate that the
N-terminal and C-terminal regions of Sec24p display different binding
specificities. The C-terminus binds to the central domain of Secl 6p while the N-
terminus of Sec24p binds to both the central domain of Secl 6p and to Sec23p.
These findings define binding to Secl 6p as a new function for Sec24p and
support the idea that Secl 6p is a scaffold molecule.
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INTRODUCTION
Transport of proteins between compartments of the secretory pathway is
mediated by cytoplasmic vesicles that form by budding from the membrane of the
donor compartment. In the best studied cases, vesicle formation is driven by the
assembly of vesicle coats that are composed of particular sets of peripheral
membrane proteins (reviewed by Schekman and Orci, 1996). COPII coated
vesicles mediate transport from the endoplasmic reticulum (ER) to the Golgi
apparatus in both yeast and mammalian cells (Barlowe et al., 1994; Schekman
and Orci, 1996). Genetic and biochemical studies in yeast have identified six
proteins that are components of the COPII coat and that are required for vesicle
formation in vivo and in vitro (Nakano and Muramatsu, 1989; Kaiser and
Schekman, 1990; Hicke et al., 1989; Hicke et al., 1992; Salama et al., 1993;
Barlowe et al., 1994). Five of these proteins - two heteromeric protein
complexes, Secl3p/Sec31p and Sec23p/Sec24p, and a small GTP-binding
protein, Sarl p - are found in the cytosol and in association with membranes.
Vesicle formation can be reconstituted by adding these five proteins in soluble
form to ER membranes that have been extracted of peripheral proteins with urea
(Barlowe et al., 1994). The sixth essential COPII protein, Secl6p, is a 240 kD
peripheral membrane protein that is found on membranes but not in soluble form
and resists extraction by urea. In an in vitro budding reaction, Secl6p is
incorporated into the vesicle coat starting as a peripheral ER protein not as a
soluble protein (Espenshade et al., 1995).
Clearly, an important aspect in COPII vesicle formation is the recruitment
of cytosolic coat components to the membrane. Drawing an analogy to the role
of the small GTP-binding protein ARF in recruitment of the coatomer (COPI) coat
to Golgi vesicles (Donaldson et al., 1992), the small GTP-binding protein Sarlp
has been proposed to regulate recruitment of Sec23p/Sec24p and
Secl3p/Sec31p to the ER membrane (Schekman and Orci, 1996). Membrane-
associated receptors for small GTP-binding proteins and coat components have
been suggested to participate in the recruitment of clathrin coats and COPI coats
to the Golgi membrane (Helms et al., 1993; Stamnes et al., 1993; Traub et al.,
1993). For COPII coats, Secl6p appears to have the properties of a membrane
receptor for coat formation since Secl6p is tightly bound to the membrane and
associates with the soluble COPII coat component Sec23p (Espenshade et al.,
1995). Moreover, genetic interactions between SEC16 and SAR1 suggest that
assembly of Secl 6p with soluble coat proteins may be regulated by Sarl p
(Gimeno et al., 1995).
We became interested in a possible interaction between Sec24p and
Secl 6p, when we identified a Sec24p homolog in a two-hybrid screen for
proteins that bind to the central domain of Secl6p (R. E. Gimeno and C. Kaiser,
unpublished). Sec24p is a 105 kD protein that is required for vesicle budding in
vitro (Hicke et al., 1992), but its precise role in vesicle formation has not been
established. Sec24p copurifies with Sec23p as part of a 300-400 kD complex
(Hicke et al., 1992). Sec23p stimulates the GTPase activity of Sarip in vitro, but
Sec24p does not appear to contribute to this activity (Yoshihisa et al., 1993).
In this paper, we show that Sec24p binds to the central region of Secl6p,
a portion of Secl 6p molecule that is separable from the region at the C-terminus
of Secl6p that is required for binding to Sec23p. The identification of a second
COPII coat component as a Secl6p binding protein reinforces the proposal that
Secl6p is a scaffold that organizes the COPII coat.
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MATERIALS AND METHODS
General Techniques. Yeast transformations were performed using standard
methods (Kaiser et al., 1994). DNA manipulations were carried out as described
(Sambrook et al., 1989). For PCR, Vent polymerase was used (New England
Biolabs, Beverly, MA). Western blotting was performed as described (Gimeno et
al., 1995) using the following antibodies: anti-invertase (1/1,000), anti-Sec23p
(1/500; kindly provided by L. Hicke), anti-Sec24p (1/1,000; kindly provided by T.
Yoshihisa), anti-GST (1/1,000; Santa Cruz Biotechnology, Santa Cruz, CA), and
HRP-coupled sheep anti rabbit Ig (1/10,000; Amersham Corp., Arlington Heights,
IL). Unless otherwise noted, protein concentrations were determined by the
Biorad Protein Assay (Biorad Laboratories, Hercules, CA) using BSA (Boehringer
Mannheim, Indianapolis, IN) as a standard.
Isolation of sec24-1 and Cloning of SEC24: A temperature-sensitive allele of
SEC24 was isolated by screening a collection of 1800 random temperature-
sensitive mutants for accumulation of the ER forms of carboxypeptidase Y and
invertase by Western blotting (E. Chitouras, A. Frand, and C. A. Kaiser,
unpublished). One of these mutants, EH382, displayed a strong, temperature-
dependent accumulation of the ER-forms of CPY and invertase. This secretion
defect segregated 2:2 in crosses and cosegregated with the temperature-
sensitive growth defect, indicating that both growth and secretion defects were
caused by a single mutation. The gene responsible for the defects was cloned
by complementation of the temperature-sensitive growth defect of EH382 using a
library of yeast genomic DNA in pCT3 (Thompson et al., 1993). One
complementing clone, pAF70, contained a 4.3 kb insert. Comparison of the
restriction map and DNA sequence of pAF70 with the sequence of SEC24
(generously supplied by T. Yoshihisa and R. Schekman) showed that pAF70
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contained the entire SEC24 open reading frame flanked by 0.8 kb at the 5'- and
3'- end each. To demonstrate that the mutation in EH382 was indeed a mutation
in SEC24, the chromosomal SEC24-locus of a wild-type strain was marked with
URA3 by directing integration of the plasmid pRH285, containing a 3 kb BamHI
fragment with the C-terminal 896 amino acids of SEC24, to the homologous
chromosomal locus by cleaving pRH285 in the insert sequences with BgAl before
transformation. The marked strain was then crossed to EH382. Tetrad analysis
showed complete linkage of the plasmid sequences to the Ts growth phenotype.
The SEC24 allele in EH382 was designated sec24-1.
Two-Hybrid Protein-Protein Interaction Assay. Protein-protein interactions
were tested in the two-hybrid system as described (Gyuris et al., 1993; Bartel and
Fields, 1995). Interactions were tested between proteins fused to the lexA DNA-
binding domain that were expressed from either the constitutive ADH promoter or
the inducible GAL 1 promoter and proteins fused to either the acidic activation
domain of GAL4 expressed from the ADH promoter or to an acidic bacterial
sequence expressed from the GAL1 promoter. All interactions were tested by
measuring the expression of O-galactosidase from the reporter construct pSH18-
34 in EGY40 (Golemis and Brent, 1992).
Plasmids were constructed as follows: A SEC24 fusion to lexA lacking the
N-terminal 33 amino acids (pRH286) was constructed by inserting the 3 kb
BamHI fragment of pAF70 into pEG202. To create a full-length SEC24 fusion to
lexA (pRH287), the N-terminus of SEC24 was amplified by PCR and ligated into
pEG202, creating pRH284. The C-terminus of SEC24 was then inserted by
ligating the 3 kb BamHI fragment of pAF70 into pRH284. The N-terminal SEC24
lexA fusion (pRH321) contains the 2 kb EcoRI fragment of pRH287 ligated into
pEG202. The fusion of the C-terminal region ofSEC24 to lexA (pRH347) was
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made by first inserting the 0.6 kb EcoRI fragment of pRH287 into pEG202-AAT, a
derivative of pEG202, and then inserting the 1.1 kb Apal-Xhol fragment of
pRH286 into the resulting construct. To make a GAL 1 promoted SEC23 fusion to
lexA (pDS79), the EcoRI-Xhol fragment of pPE82 (Espenshade et al., 1995) was
inserted into pGILDA, a GAL 1 promoted derivative of pEG202 (kindly provided by
D. Shaywitz). The central domain of Secl6p (aa 565-1235) was fused to the
GAL4 acidic activation domain by inserting the BamHI fragment of pPE53
(Espenshade et al., 1995) into pGAD GH (Hannon et al.,1993) to make pPE167.
A lexA-fusion containing aa 447-1235 of Secl6p (pPE62) was made by inserting
the Ncol-Pvull fragment of pPE4 (Espenshade et al., 1995) into pEG202.
Indicator cells were grown to exponential phase in selective medium
containing 2% glucose. To measure interactions of proteins expressed from the
GAL 1 promoter, cells were grown to exponential phase in selective medium
containing 2% raffinose, then galactose was added to 2% and growth was
continued for an additional 5 h. P-galactosidase activity assays were performed
on glass-bead extracts as described (Kaiser et al., 1994). Units of 3-
galactosidase are expressed as: [OD420 x vol. of assay] / [0.0045 x protein
concentration in extract x vol. of extract assayed x time].
Coprecipitation of GST-fusion Proteins from Yeast Extracts. Glutathione-S-
transferase (GST) fusions for coprecipitation experiments were constructed as
follows. SEC24 (aa 34-926; pRH305) was fused to the GST gene expressed
from the GAL1 promoter by inserting a 3 kb BamHI fragment of pAF70 into
pPE127, a derivative of pRD56 (Espenshade et al., 1995). To construct a GST
fusion to the N-terminus of SEC24 (pRH348; aa 34-666), a 2 kb BamHI-EcoRl
fragment of pRH321 was inserted into pPE127. A GST-fusion to the C-terminus
of SEC24 (pRH360; aa 666-926) was created by first inserting the 0.6 kb EcoRI
fragment of pRH286 into pPE127, then cutting the resulting plasmid with BgMl
and Xhol and ligating it with the 1 kb BgAI-Xhol fragment of pRH305. To produce
a soluble and detectable central domain of Secl6p (pRH317), invertase was
fused to amino acids 565-1235 of Secl6p, and the fusion protein was expressed
from the GALl promoter. pRH317 is identical to pPE53 (Espenshade et al.,
1995), with the exception that the vector backbone is marked with LEU2. To
facilitate detection of Sec23p, SEC23 was expressed from the GAL 1 promoter
(pPE123).
Coprecipitation experiments were performed in CKY473 (Mata, ura3-52,
leu2-3,112, Gal+). Cells were grown to exponential phase in selective medium
containing 2% raffinose, galactose was added to 2%, and extracts were prepared
3 to 4 h later. 10-16 x 107 cells (5-8 0D600 units) were suspended in 30 p[ ColP
buffer (20 mM HEPES, pH 6.8, 80 mM potassium acetate, 0.2 M NaCI, 5 mM
magnesium acetate, 0.02 % Triton X-100, 5 mM DTT), containing a protease
inhibitor cocktail (2.5 x 10-4 U/ml a2-macroglobulin, 1 mM PMSF, 0.5 gg/ml
leupeptin, 0.7 gg/ml pepstatin, and 2 lgg/ml aprotinin; all Boehringer Mannheim).
Cells were lysed by vigorous agitation with glass beads 4 x 20 sec with 1 min
intervals on ice. Extracts were diluted with 200 l ColP buffer as above, and the
lysate was cleared by centrifugation at 13,000 x g for 10 min followed by
centrifugation at 100,000 x g for 30 min. The supernatant was diluted to 700 p1
with ColP buffer (supplemented as above), glutathione Sepharose 4B beads
(Pharmacia, Piscataway, NJ) were added, and samples were incubated for 1 h at
250C. The beads were washed 4 times with ColP buffer and bound proteins
were released by boiling in 30 p1 ESB (60 mM Tris HCI, pH 6.8, 100 mM DTT, 2%
SDS, 10% glycerol, 0.001% bromphenol blue).
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Preparation of Recombinant Sec23p and Sec24p. Sec23p and Sec24p were
expressed as GST-fusion proteins in E. coil strains AP401 (Ion::ATn 10, Pakula,
1988) and CKB175 (ompT, Ion::ATn 10; kindly provided by T. Opperman, M.I.T.),
respectively. To construct the Sec23p expression vector (pPE124), the BamHI-
Xhol (filled in) fragment of pPE119 (Espenshade et al., 1995) was ligated into
pGEX-2T (Pharmacia). A fusion of SEC24 to GST (pPE166) was made by
inserting the Sinal fragment of pRH325 into the Sinai site of pGEX-2T. pRH325
contains the entire SEC24 reading frame with the N-terminal 1.2 kb derived from
pRH287 and the C-terminal 1.6 kb derived from pRH305.
Fusion proteins were induced and purified as described (Smith, 1993) with
the following modifications. Cultures were grown to exponential phase at 301C
for GST-Sec23p and at 250C for GST-Sec24p and fusion proteins were induced
by addition of 0.5 mM IPTG and growth was continued for 2-3 h. Cells were
lysed by sonication in phosphate-buffered saline (PBS) containing 0.5 mM EDTA
and the same protease inhibitor cocktail used for the coprecipitation experiments.
After addition of 1% Triton X-100, cell debris was removed by centrifugation at
16,000 x gfor 10 min at 40C. Fusion proteins were isolated by batch purification
using glutathione Sepharose 4B beads (Pharmacia). Sec23p and Sec24p were
liberated from the GST moieties by cleavage of the bound fusion proteins with
thrombin (Sigma, St. Louis, MO) in cleavage buffer (50 mM Tris-HCI pH 7.5, 150
mM NaCI, 2.5 mM CaCI2). Cleavage was stopped by addition of 1 mM PMSF.
Recombinant proteins were stored in 10% glycerol at -800C. Protein
concentration was determined by comparison of purified protein to dilutions of
bovine serum albumin, Fraction V (Boehringer Mannheim) after resolution by
SDS-PAGE and staining with Coomassie brilliant blue (BRL Life Technologies,
Gaithersburg, MD).
Binding of recombinant Sec24p to recombinant Sec23p was assayed as
follows. 250 p1 bacterial lysate containing GST-Sec23p (in PBS, 0.02% Triton X-
100, total protein: 0.5 mg) was incubated with 30 p•l packed glutathione beads for
1 h at 40C. Beads were collected by centrifugation and washed two times with 1
ml of PBS, 0.02% Triton X-100 and once with 1 ml of binding buffer (25 mM
Hepes-KOH pH 6.8, 0.1% Triton X-100, 1 mM MgCl2, 0.5 mM DTT, 0.25 mg/mI
BSA). Washed beads contained ~-11 pmol GST-Sec23p, as judged by Western
blotting using GST as a standard. Beads were resuspended in 35 p1 binding
buffer, and 6 pmol Sec24p in 15 Il cleavage buffer was added. As a control,
Sec24p was added to 30 p1l packed glutathione beads not preincubated with
GST-Sec23p. Reactions were incubated at 220C for 1 h, the beads were
collected by centrifugation, and the supernatant containing unbound Sec24p was
mixed with an equal volume of 2 x ESB. Beads were washed two times with 1 ml
of binding buffer and solubilized by addition of 100 p1 of 1 x ESB. Equal volumes
of protein samples were separated by SDS-PAGE and visualized by staining with
Coomassie brilliant blue (BRL).
Preparation of Yeast GST-Secl6 Fusion Proteins and In Vitro Binding
Assays. The central and C-terminal domain of Secl6p (amino acids 565-1235
and 1645-2194, respectively) were expressed in yeast as GST-fusion proteins
from the GAL1 promoter (pRH323 and pPE122, respectively). pRH323 is the 2
kb BamHI fragment of pPE53 (Espenshade et al., 1995) in pPE127. pPE122 has
been described (Gimeno et al., 1995). As a control, GST (no fusion) was
expressed from the GAL 1 promoter (pRD56; Espenshade et al.,1995).
GST-fusion proteins were expressed in CKY474 (MATa leu2-3,112 ura3-
52 pep4::LEU2 Gal+). Cells were grown to exponential phase in selective
medium containing 2% raffinose, galactose was then added to 2%, and cells
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were grown for an additional 4 hours at 300C. Cells were spheroplasted as
described (Espenshade et al.,1995) and gently lysed with glass beads in lysis
buffer (20 mM Hepes-KOH, pH 6.8, 80 mM KOAc, 5 mM MgOAc, 0.02% Triton
X-100, 0.6 M NaCI), containing the protease inhibitor cocktail as above. Cell
debris was removed by centrifugation of the lysate at 17,500 x g for 15 min at
40C. The supernatant was frozen in liquid nitrogen and stored at -800C.
For binding experiments, aliquots of the frozen supernatants were mixed
with 30 .tl of packed glutathione sepharose beads (Pharmacia) in a total volume
of 500 gI lysis buffer. Beads were incubated for 1 h at 40C and then collected by
centrifugation. The supernatant was discarded and the beads were washed two
times with 1 ml lysis buffer, once with lysis buffer lacking NaCI (20 mM Hepes-
KOH, pH 6.8, 80 mM KOAc, 5 mM MgOAc, 0.02% Triton X-100) and once with
binding buffer (25 mM Hepes-KOH pH 6.8, 0.1% Triton X-100, 1 mM MgCl2, 0.5
mM DTT, 0.25 mg/ml BSA). Beads were resuspended in 35 p.1 of binding buffer
to which the indicated amount of recombinant Sec23p or Sec24p in 15 p.1 of
cleavage buffer was added. Unless otherwise indicated, the final concentration
of NaCI in the reaction was 45 mM. Reactions were incubated for 1 h at 220C,
beads were then collected by centrifugation and unbound recombinant Sec24p or
Sec23p was sampled by mixing 20 pl of supernatant with an equal volume of 2 x
ESB. Beads were washed two times with 1 ml of binding buffer and bound
proteins were solubilized by addition of 100 p.1 of 1 x ESB (GST and GST-Secl6p
central domain). Samples that contained GST fused to the C-terminal domain of
Secl 6p were first treated with 0.1 gg thrombin in 50 p.1 cleavage buffer for 1 h
and then solubilized by adding an equal volume of 2 x ESB. Thrombin digestion
was necessary to distinguish Sec24p from GST-Secl6p (aa 1638-2194), since
these two proteins migrated similarly on gels and the anti-Sec24p antibody
crossreacted with the GST-fusion protein. Equal volumes of bound and unbound
proteins were resolved by SDS-PAGE and analyzed by Western blotting.
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RESULTS
Sec24p Binds to the Central Domain of Secl6p in the Two-Hybrid System.
Binding of Sec24p to Secl 6p was first examined using the yeast two-
hybrid system (Fields and Song, 1989; Gyuris et al., 1993). Interaction between
two proteins, one fused to the lexA DNA-binding domain and the other fused to
an acidic transcription activation domain, was detected by the level of 13-
galactosidase expression in yeast from a lacZ reporter gene carrying lexA
operator sites in the promoter. Sec24p (amino acids 34-926) interacted strongly
with the central domain of Secl6p (amino acids 565-1235, Fig. 1 A). Sec24p
also interacted strongly with Sec23p, as expected from the known association of
these proteins in cell extracts (Fig. 1 A). No interaction was observed between
Sec24p and the activation domain alone or between the central domain of
Secl 6p and Sec23p, indicating that the observed interactions are specific.
To define the region of Sec24p that interacts with Secl 6p, we constructed
fusions corresponding to the N-terminal and C-terminal portions of Sec24p (Fig.
1). Both the N-terminal and the C-terminal fusion showed a significant interaction
with the central domain of Secl 6p, but only the N-terminal domain interacted with
Sec23p (Fig. 1 A). These tests for interaction place the Sec23p binding site in
the N-terminal region of Sec24p, and suggests that both the N-terminal and the
C-terminal regions of Sec24p have sites that can bind to Secl 6p.
We also used the two-hybrid system to identify the part of Secl 6p that
interacts with the C-terminal domain of Sec24p. The C-terminus of Sec24p
(amino acids 666-926) fused to an acidic activation domain was tested for
interaction with three Secl6p fragments fused to the lexA DNA-binding domain
(Fig. 1 B). The C-terminal domain of Sec24p interacted only with the central
domain of Secl6p (Fig. 1 B). Sec23p, in contrast, interacted only with the C-
terminal domain of Secl6p but not the central domain (Fig. 1 B). These results
show that Sec23p and the C-terminal domain of Sec24p bind to different regions
of Secl 6p.
Sec24p Binds to the Central Domain of Secl6p in Yeast Extracts.
To confirm the interactions detected by two-hybrid assay, we tested for the
relevant protein-protein interactions in yeast extracts. Sec24p (amino acids 34-
926), the N-terminal domain, and the C-terminal domain of Sec24p were fused to
glutathione-S-transferase (GST) and expressed in yeast from the GAL 1
promoter. To allow detection of the central domain of Secl6p (amino acids 565-
1235), this domain was fused to invertase and similarly expressed from the GAL1
promoter. GST-fusion and associated proteins were purified by affinity to
glutathione beads from extracts prepared from yeast strains coexpressing one of
the GST-fusion proteins and the Secl6p-invertase fusion. Binding to Secl6p
was detected for GST fused to Sec24p, the Sec24p N-terminus or the Sec24p C-
terminus (Fig. 2 top panel, lanes 1-6) whereas no binding was detected for the
control that used GST only (Fig. 2 top panel, lanes 7 and 8). Association
between Secl 6p and the two truncated Sec24p fusion proteins was reproducibly
stronger than the association of the Secl 6p and the Sec24p fusion that
contained both the N-terminal and C-terminal regions. The relatively strong
binding of truncated fusion proteins could be because truncation of the protein
gives better access to Secl6p binding sites.
The GST-Sec24p fusion proteins were also tested for their ability to bind to
Sec23p expressed from the GAL 1-promoter. Fusions to Sec24p or the Sec24p
N-terminus, but not fusions to the Sec24p C-terminus or to GST alone,
coprecipitated Sec23p (Fig. 2 bottom panel). These results are in complete
agreement with the data obtained from the two-hybrid assays, and demonstrate
that binding of Sec24p to Sec23p only requires the N-terminus of Sec24p, while
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binding to the central domain of Secl6p is mediated by both the N-terminus and
the C-terminus of Sec24p.
Purification of Recombinant Sec23p and Sec24p from E. coli.
In order to reconstitute the binding of Sec24p and Sec23p to Secl 6p in
vitro we required a source of pure Sec23p and Sec24p. Sec23p and Sec24p
were expressed as GST-fusion proteins in E coil, purified by their affinity to
glutathione beads, and then released from the beads by cleavage with thrombin
(see Materials and Methods). Sec23p purified in this manner was >90% pure as
judged by Coomassie-stained SDS-PAGE (Fig. 3 A, lane 1). Optimal expression
of Sec24p required induction at low temperature in a multiple protease deficient
strain (Ion- ompT-) to prevent proteolytic degradation. After purification, the
Sec24p preparation contained two major contaminating proteins (Fig. 3 A, lane
2); these proteins are probably bacterial proteins that bind non-specifically to
glutathione beads, since they were also present - at much lower levels - in the
Sec23p preparations, and did not react with anti-Sec24p antibodies. We used
this partially purified preparation of Sec24p for all the experiments described
below.
Bacterially expressed Sec24p and Sec23p were tested for their ability to
bind to each other in vitro (Fig. 3 B). Beads containing purified GST-Sec23p
coprecipitated all of the Sec24p added (Fig. 3 B, lanes 3 and 4), while no binding
of Sec24p was detected to glutathione-beads alone (Fig. 3 B, lanes 5 and 6).
Using the ability to bind to Sec23p as a criteria for function, all of the recombinant
Sec24p appeared to be active. The ability of recombinant Sec23p to bind to
recombinant Sec24p in solution confirmed previous suggestions that no
additional yeast proteins were required for association of Sec23p with Sec24p
(Hicke et al., 1992).
59
Binding of Sec23p and Sec24p to Secl 6p In Vitro.
To test binding of Sec23p and Sec24p to Secl 6p in vitro, we purified the
central and the C-terminal domain of Secl6p as GST-fusion proteins from yeast
(see Materials and Methods). All purification steps were performed in the
presence of 0.6 M NaCI to extract Secl6p fusion proteins from membranes.
Under these extraction conditions, endogenous Sec23p and Sec24p did not
copurify with Secl 6p (note the absence of Sec23p and Sec24p in Fig. 4 A and B,
lanes 3, 6, 9). No major contaminating proteins were present in the Secl6p
preparations, as determined by Coomassie-stained SDS-PAGE; however, each
of the Secl 6p preparations contained a different set of proteins with faster
mobility than the full length fusion proteins (Fig. 4 E). Some of these minor
contaminants are likely degradation products of the Secl6p fusions, since a
similar spectrum of bands was also detected upon long exposure of Western
blots probed with anti-GST antibody (Fig. 4 A and B, and our unpublished data).
To test binding, Sec23p or Sec24p (2 pmol each) were added to the
purified GST-Secl 6p fusion proteins (11-13 pmol) bound to glutathione beads
under conditions of low salt (45 mM NaCI). After incubation, the beads were
collected and washed by centrifugation and bound proteins ("B" in Fig. 4 A and B)
were compared to unbound proteins present in the supernatant ("S" in Fig. 4 A
and B). A large fraction of Sec24p bound to the central domain of Secl6p (Fig. 4
A, lane 1) and a smaller, but still significant amount bound to the C-terminal
domain of Secl6p (Fig. 4 A, lane 4). In the control, Sec24p did not bind to GST
alone (Fig. 4 A, lane 7).
As expected, Sec23p behaved differently from Sec24p in this assay.
Sec23p bound efficiently to the C-terminus of Secl6p (Fig. 4 B, lane 4), but no
Sec23p bound to the central domain of Secl6p or to GST alone (Fig. 4 B, lanes 1
and 7). These data are consistent with the results of the two-hybrid and
coprecipitation experiments and clearly demonstrate that the COPII coat
components Sec23p and Sec24p bind to two distinct regions of Secl6p.
Sec23p and Sec24p copurify as a 300-400 kD complex from yeast cytosol
(Hicke et al., 1992). To test whether Sec23p and Sec24p can form a complex
when bound to Secl 6p, we added both Sec23p and Sec24p to GST fused to the
central domain of Secl6p. If Sec24p can bind simultaneously to the central
domain of Secl6p and to Sec23p, Sec24p should recruit Sec23p to the GST-
Secl6p fusion protein. Importantly, these experiments employed a Secl6p
fusion to which Sec23p alone would not bind. In the presence of Sec24p, a
significant portion of Sec23p bound to the central domain of Secl6p (Fig. 4 C,
lanes 3 and 4, compare to Fig. 4 B, lanes 1 and 2). Furthermore, the presence of
Sec23p significantly increased the amount of Sec24p bound to the central
domain of Secl6p (Fig. 4 C, compare lanes 1 and 2 and lanes 3 and 4). Optimal
binding of Sec24p to the central domain of Secl6p required stoichiometric
amounts of Sec23p (Fig. 4 D). These data argue that Sec24p has distinct
binding sites for the central domain of Secl6p and for Sec23p, and show that
Sec23p and Sec24p can bind to Secl 6p as a complex.
To evaluate the relative strengths of these protein-protein interactions, we
examined the stability of binding at different concentrations of NaCI (Fig. 5).
Binding of Sec24p to the central domain of Secl6p was disrupted by 150 mM
NaCI (Fig. 5 A), while binding of Sec23p to the C-terminal of Secl6p was stable
up to 300 mM NaCI (Fig. 5 C). The presence of Sec23p did not affect the salt
sensitivity of the interaction between Sec24p and the central domain of Secl 6p
(Fig. 5 B). These data suggest that Sec23p binds more tightly to Secl6p than
Sec24p, and argue that the stability of the interaction between Sec24p and the
central domain of Secl6p is unchanged by Sec23p.
DISCUSSION
Previous studies have shown that Sec23p, Sec24p and Secl 6p are
constituents of the protein coat of vesicles that bud from the ER (Barlowe et al.,
1994 and Espenshade et al., 1995). Sec23p binds to Sec24p in a complex of
300-400 kD that can be isolated from the cytosol (Hicke et al., 1992), and Sec23p
binds to the C-terminal region of Secl6p (Espenshade et al., 1995). In this paper
we show that Sec24p also binds to Secl 6p. In tests of truncated Secl 6p
molecules for binding, Sec24p was found to bind to a central region of Secl6p
and, more weakly, to the C-terminal region of Secl6p, whereas Sec23p only
bound to the C-terminal region of Secl6p. These binding interactions were
reconstituted in vitro using recombinant Sec23p and Sec24p expressed in E. coil
and GST-Secl6p fusion proteins purified from yeast. Importantly, in vitro
binding of Sec24p to Secl 6p did not require the presence of Sec23p, and binding
of Sec23p to Secl6p did not require Sec24p.
Since Sec24p bound to the central domain of Secl6p could also recruit
Sec23p to bind to this region of Secl 6p, we suggest that Sec23p and Sec24p
can bind to Secl6p in a ternary complex. It is possible that Sec23p and Sec24p
are always in a complex and that the proteins bind to Secl6p as a unit.
Alternatively, Sec23p and Sec24p may bind to Secl6p in sequential steps of coat
assembly to build a Sec23p/Sec24p/Sec1 6p complex. Interestingly, Sec23p
appears to positively regulate the interaction between Sec24p and Seci 6p since
the presence of Sec23p increases the amount of Sec24p that will bind to Secl 6p
in vitro. This increased binding could simply reflect the stoichiometry of Sec24p
binding to Seci 6p. For example, if the Sec23p/Sec24p complex contains two
copies of Sec24p, formation of a Sec23p/Sec24p complex should double the
number Sec24p molecules that can bind to each molecule of Secl6p.
Alternatively, increased binding could result from a conformational change in
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Sec24p induced by Sec23p that increases the affinity of Sec24p for Secl 6p. The
Sec23p/Sec24p/Secl 6p complex showed similar sensitivity to 150 mM salt as
the Sec24p/Secl16p complex suggesting that Sec23p does not greatly increase
the strength of the interaction between Sec24p and Secl 6p.
Because Secl6p, Sec23p and Sec24p are all components of the COPII
vesicle coat, the protein-protein interactions that we have detected are likely to
reflect subunit contacts that form during coat assembly on the ER membrane and
that exist in the completed vesicle coat. By testing subdomains of Secl 6p and
Sec24p for interactions we have succeeded in identifying the region in these two
molecules that are responsible for particular protein-protein interactions. From
these interactions a view of the relative arrangement of Secl6p, Sec23p and
Sec24p proteins has begun to emerge (Fig. 6). Sec23p and Sec24p appear to lie
next to each other along the Secl6p molecule: Sec23p binds to the C-terminal
region of Secl6p and Sec24p binds to both the central domain of Secl6p and to
the C-terminal domain of Secl6p. Given that the C-terminal region of Sec24p
contacts the central region of Secl 6p and that the N-terminal region of Sec24p
contacts Sec23p the most likely arrangement of Sec24p is with its N-terminus
oriented towards the C-terminus of Secl6p. The complex that we propose -
which includes Sec23p, Sec24p and Secl 6p - has not been isolated intact from
yeast cells presumably because the high salt extraction conditions that are
required to liberate Secl6p from the membrane also disrupt binding of Sec23p
and Sec24p to Secl6p.
The ability of Sec23p and now Sec24p to bind to Secl 6p reinforces the
proposal that Secl 6p acts as a membrane receptor to recruit soluble coat
proteins to the membrane. The arrangement of cytosolic coat components along
Secl 6p suggests a pathway for how COPII coat assembly on Secl 6p takes
place. Sarl p is currently the best candidate for the regulatory molecule that
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controls the initiation of vesicle coat assembly. Two proteins that we have
identified to bind to the C-terminus of Secl6p are Sec23p and Sed4p
(Espenshade et al., 1995; Gimeno et al., 1995). Sed4p genetically interacts with
Sarip (Gimeno et al., 1995), and Sec23p is a GTPase activating protein for
Sarl p (Yoshihisa et al., 1993). An attractive possibility is that Sarilp initiates the
coat assembly process by regulating assembly events that occur at the C-
terminus of Secl 6p. One of the early assembly steps - possibly mediated by
Sarilp in its GTP-bound form - could be the recruitment of Sec23p to bind to the
C-terminus of Secl6p. Binding of Sec23p to Secl6p could, in turn, recruit
Sec24p to bind to the central domain of Secl 6p. An attractive feature of this
model is that it explains how an initiating event at the C-terminus of Secl6p could
lead to the regulated sequential assembly of a large multisubunit complex on the
membrane. The availability of pure proteins, both coat components and the
template onto which they assemble, will allow us to test this hypothesis.
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Figure 1. Two-hybrid interactions between Secl 6p, Sec24p and Sec23p. The
extent of each of the gene fragments of SEC24 and SEC16 are indicated by
gene diagrams and by the amino acids numbers included in each construct given
in brackets. Each interaction was evaluated by P3-galactosidase assays of two to
four independent transformants for which the mean activity is given (the standard
deviation was always less than 20%).
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Figure 2. Affinity isolation of complexes between Sec24p, Secl6p and Sec23p
from yeast extracts. The indicated fragments of Sec24p fused to GST (lanes 1-6)
or GST only (lanes 7 and 8) were coexpressed with either the central domain of
Secl6p fused to invertase (pRH317, upper panel) or Sec23p (pPE123, lower
panel). GST-fusion and associated proteins were purified by affinity to
glutathione-agarose. Proteins were detected by Western blotting after SDS-
PAGE on a 6% gel. T = total, B = bound. Lanes 1, 3, 5, 7:100,000 x g
supernatant from 0.044 OD600 U of cells. Lanes 2, 4, 6, 8: material bound to
beads from 0.73 OD600 U of cells.
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Figure 3. Sec23p and Sec24p expressed in E coil bind to each other. (A)
Purified E. coli recombinant Sec23p (7 pmol, lane 1) and Sec24p (8 pmol, lane 2)
were resolved by SDS-PAGE on a 6% gel and stained by Coomassie brilliant
blue. (B) Immobilized E. coil recombinant GST-Sec23p (11 pmol; lanes 1-4) or
glutathione beads only (lanes 5-6) were incubated with 6 pmol of E. coli
recombinant Sec24p or buffer for 1 h at 220C. Bound (B) and soluble (S)
proteins were separated by SDS-PAGE on a 6% gel and stained with Coomassie
brilliant blue.
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Figure 4. Sec24p binds to the central domain of Secl6p in vitro. The binding
reactions in parts (A) and (B) contain one of the following GST-fusion proteins
immobilized on glutathione agarose: lanes 1-3, 11 pmol of GST-Secl6p(565-1235);
lanes 4-6, 13 pmol of GST-Secl6p(1638-2194); lanes 7-9, 11 pmol of GST only.
To test binding, the immobilized proteins were incubated with 2 pmol of
recombinant Sec24p (A), 2 pmol of recombinant Sec23p (B), or buffer for 1 h at
220C. Bound (B) and soluble (S) fractions were resolved by SDS-PAGE on 10%
gels and proteins were detected by Western blotting. (C) GST-Secl6p(565-1235)
(11 pmol) was incubated with 2 pmol of recombinant Sec24p (lanes 1-4) and
either 3 pmol recombinant Sec23p (lanes 3 and 4) or buffer (lanes 1 and 2) for 1
h at 220C. Bound (B) and soluble (S) fractions were recovered as above.
Proteins were detected by Western blotting after SDS-PAGE on a 10% gel. (D)
GST-Secl6p(565-1235) (11 pmol) was incubated with 2 pmol of recombinant
Sec24p (lanes 1-4) and the indicated amounts of recombinant Sec23p for 1 h at
220C. Bound (B) and soluble (S) fractions were recovered as above. Sec24p
was detected by Western blotting after SDS-PAGE on a 8% gel. Blots were
quantitated by densitometry and the average from two independent experiments
is shown. % Bound = B / B + S. (E) The GST-fusion proteins affinity-purified
from yeast that were used in the binding reactions were separated by SDS-PAGE
on a 10% gel and stained with Coomassie brilliant blue: lane 1, 17 pmol of GST-
Secl6p(565-1235); lane 2, 20 pmol of GST-Secl6p(1638-2194); lane 3, 17 pmol of
GST.
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Figure 5. Salt sensitivity of the interactions between Sec23p or Sec24p and
Secl 6p. Binding was performed in the presence of the indicated amounts of
NaCI as described in Figure 4. Proteins were detected by Western blotting after
SDS-PAGE on a 8% gel and quantitated by densitometry. The average of two
independent experiments is shown. % Bound = B / B + S. (A) Binding of
Sec24p to the central domain of Secl6p( 565-1235). (B) Binding of Sec24p to the
central domain of Secl6p(565-1235) in the presence of 2 pmol Sec23p. (C)
Binding of Sec23p to the C-terminal domain of Secl6p(1638-2194).
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Figure 6. Proposed interactions between cytosolic COPII coat components and
Sec 16p.
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Table I. Plasmids
Source or Reference
pRS315
pRS316
pCT3
pAF70
pEG202
pGILDA
pJG4-5
pGAD-GH
pSH18-34
pRH286
pRH321
pRH347
pDS79
pPE58
pPE59
pPE62
pPE81
pPE167
pRH346
pRD56
pRH305
pRH348
pRH360
pRH317
pPE123
pRH323
pPE122
pGEX-2T
pPE124
pPE166
centromere vector marked with LEU2
centromere vector marked with URA3
centromere vector marked with URA3
SEC24 in pCT3
lexA DNA binding domain in a 2g vector marked with HIS3
lexA DNA binding domain in a 2g vector marked with HIS3
acidic activation domain in a 2g vector marked with TRP1
GAL4 activation domain in a CENvector marked with LEU2
lacz gene under control of 8 lexA DNA binding sites in a
2g vector marked with URA3
SEC24 (34-926) in pEG202
SEC24 (1-666) in pEG202
SEC24 (666-926) in pEG202
SEC23in pGILDA
SEC16 (1645-2194) in pEG202
SEC16 (1-824) in pEG202
SEC16 (447-1235) in pEG202
SEC23in pJG4-5
SEC16 (565-1235) in pGAD-GH
SEC24 (666-926) in pJG4-5
GAL 1 promoted GSTin pRS316
GALl promoted GST-SEC24 (34-926) in pRS316
GALl promoted GST-SEC24 (1-666) in pRS316
GALl promoted GST-SEC24 (666-926) in pRS316
GAL 1 promoted SEC16 (565-1235)-SUC2 in pRS315
GAL 1 promoted SEC23in pRS315
GALl promoted GST-SEC16 (565-1235) in pRS316
GALl promoted GST-SEC16 (1638-2194) in pRS316
bacterial GSTexpression vector
SEC23 in pGEX-2T
SEC24 (1-926) in pGEX-2T
Note: The numbers in parenthesis indicate the amino acid numbers of the preceding gene's product
Plasmid Description
Sikorski and Hieter, 1989
Sikorski and Hieter, 1989
Thompson et al., 1993
This study
Gyuris et al., 1993
Shaywitz and Kaiser, unpublished
Gyuris et al., 1993
Hannon et al., 1993
Gyuris et al., 1993
This study
This study
This study
This study
Espenshade et al., 1995
Espenshade et al., 1995
This study
Espenshade et al., 1995
This study
This study
Espenshade et al., 1995
This study
This study
This study
This study
This study
This study
Gimeno et al., 1995
Smith, 1993
This study
This study
Plasmid
Chapter 3
SED4 Encodes a Yeast ER Protein that Binds Secl6p and
Participates in Vesicle Formation.
PREFACE
This chapter represents primarily my own work. Peter Espenshade contributed
plasmids for Table II and Figure 7, and helped in the analysis of vesicles
produced in vitro by gel filtration chromatography.
This chapter has been published in its entirety in the Journal of Cell Biology as:
Ruth E. Gimeno, Peter Espenshade, and Chris A. Kaiser. (1995). SED4 Encodes
a Yeast ER Protein that Binds Secl6p and Participates in Vesicle Formation. J.
Cell Biol. 131:325-338.
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ABSTRACT
SEC 16 is required for transport vesicle budding from the ER in
Saccharomyces cerevisiae, and encodes a large hydrophilic protein found on the
ER membrane and as part of the coat of transport vesicles. In a screen to find
functionally related genes, we isolated SED4 as a dosage-dependent suppressor
of temperature-sensitive SEC16 mutations. Sed4p is an integral ER membrane
protein whose cytosolic domain binds to the C-terminal domain of Secl6p as
shown by two-hybrid assay and coprecipitation. The interaction between Sed4p
and Secl 6p probably occurs before budding is complete, because Sed4p is not
found in budded vesicles. Deletion of SED4 decreases the rate of ER to Golgi
transport, and exacerbates mutations defective in vesicle formation, but not those
that affect later steps in the secretory pathway. Thus, Sed4p is important, but not
necessary, for vesicle formation at the ER.
Secl2p, a close homolog of Sed4p, also acts early in the assembly of
transport vesicles. However, SEC12 performs a different function than SED4
since Sec1 2p does not bind Sec1 6p, and genetic tests show that SEC12 and
SED4 are not functionally interchangeable.
The importance of Sed4p for vesicle formation is underlined by the
isolation of a phenotypically silent mutation, sarl-5, that produces a strong ER to
Golgi transport defect when combined with sed4 mutations. Extensive genetic
interactions between SAR1, SED4 and SEC16 show close functional links
between these proteins and imply that they might function together as a
multisubunit complex on the ER membrane.
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INTRODUCTION
The transport of proteins between successive organelles of the secretory
pathway is mediated by vesicle carriers that bud from the membrane of the donor
compartment and then fuse with the membrane of the acceptor compartment
(Palade, 1975). A general feature of vesicle formation is the recruitment of
proteins from the cytoplasm to the membrane for assembly of a coat on the
budding vesicle (Pearse and Robinson, 1990; Rothman and Orci, 1992). In
Saccharomyces cerevisiae, seven proteins have been identified by genetic and
biochemical methods that are required for vesicle budding from the ER (Novick et
al., 1980; Nakano and Muramatsu, 1989; Kaiser and Schekman, 1990; Hicke et
al., 1992; Salama et al., 1993). Five of these proteins (Secl3p, Sec31p, Sec23p,
Sec24p and Sarlp) when added in soluble form to ER membranes will drive
vesicle budding (Salama et al., 1993; Barlowe et al., 1994). Under the
appropriate conditions, the vesicles that form have a coat that contains all five
proteins (Barlowe et al., 1994). We recently found that a sixth protein, Secl 6p, is
also a vesicle coat protein (Espenshade et al., 1995). However, Secl6p is
unlikely to be recruited to the vesicle from the cytoplasm since there is no soluble
cytoplasmic pool of Secl6p. Instead, Secl6p adheres tightly to the ER
membrane and may form a peripheral membrane scaffold onto which cytosolic
coat proteins assemble (Espenshade et al., 1995).
An important mechanistic problem is how coat assembly on the ER
membrane is regulated so that vesicle formation occurs at the proper time and
place. Secl2p is a potential early regulator of vesicle assembly because Secl2p
resides in the ER membrane and is required for vesicle formation, but is not
incorporated into the finished vesicle structure (Nakano et al., 1988; Rexach and
Schekman, 1991; Barlowe et al., 1994). The cytosolic, N-terminal domain of
Secl2p catalyzes exchange of GTP for GDP on the 21 kD GTPase Sarlp
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(Barlowe and Schekman, 1993). Overexpression of Secl2p increases the
amount of Sarl p that can be bound to ER membranes in vitro, suggesting that
Secl2p can recruit Sarlp to the ER membrane (d'Enfert et al., 1991b). Sarlp-
GTP at the ER membrane is thought to then initiate assembly of coat proteins on
the forming vesicle (Barlowe et al., 1994; Oka and Nakano, 1994).
S. cerevisiae has a second gene, SED4, that is closely related to SEC12.
The N-terminal, cytosolic domain of Secl2p shares 45% amino acid identity with
Sed4p but the luminal domains of these proteins appear unrelated (Hardwick et
al., 1992). This similarity in sequence implies that SED4 is involved in vesicular
transport although the step in the secretory pathway where SED4 functions has
been difficult to establish. Deletion of SED4 does not cause a pronounced
growth or secretion defect and although SED4 was isolated as a multicopy
suppressor of a deletion of ERD2, the gene encoding the HDEL receptor in
yeast, the mechanism of this suppression is not understood (Hardwick et al.,
11992).
We became interested in the action of SED4 in vesicular transport when
we isolated SED4 as a multicopy suppressor of secl6 mutations. In this report,
we show that SED4 is involved in ER to Golgi transport and probably functions in
conjunction with Secl6p and Sarlp in an early step in vesicle formation.
Furthermore, we found that, although Sed4p and Secl2p are similar in structure
and location, these proteins appear to engage in functionally distinct processes.
MATERIALS AND METHODS
Strains, Media and Microbiological Techniques. Saccharomyces cerevisiae
strains are listed in Table I. Yeast media [rich medium (YPD), minimal medium
(SD) and synthetic complete medium (SC)] were prepared and yeast genetic and
molecular biological techniques were performed using standard methods (Kaiser
et al., 1994). Yeast transformations were carried out using the lithium acetate
method (Gietz and Schiestl, 1991). Transformants were selected on SC medium
lacking the appropriate auxotrophic supplement. All experiments on plasmid-
bearing strains were performed on at least two independent transformants. To
assay loss of URA3 marked plasmids, 105 cells were plated on SC medium
containing 0.1% 5-fluoroorotic acid (Boeke et al., 1984).
Molecular Biological Techniques. DNA manipulations, subcloning and
Southern blotting were carried out using standard methods (Sambrook et al.,
1989). DNA hybridizations were performed using the ECL Nucleic Acids
detection system (Amersham, Arlington Heights, IL). DNA sequencing was
performed using the Sequenase kit (USB, Cleveland, OH). Site-directed
mutagenesis was performed using the protocol of Kunkel (Kunkel et al., 1987).
PCR was carried out using Taq polymerase (Perkin Elmer Cetus, Norwalk, CT).
Isolation and Analysis of Multicopy Suppressors of secl6. The YEp24
library (Carlson and Botstein, 1982) contains genomic inserts in a vector carrying
the S. cerevisiae URA3 gene and the 2g origin of replication. Two temperature-
sensitive sec 16 strains, CKY50 and CKY52, were transformed with YEp24 library
DNA. A total of 35,000 (CKY50) and 13,000 (CKY52) transformants at a density
of 1.5 x 103 to 1 x 104 colonies per plate were replica-plated and incubated at
restrictive temperatures of 300, 330 and 36 0C (CKY50) or 330 and 36 0C (CKY52).
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Plasmids isolated from temperature-resistant colonies were tested for the ability
to confer the temperature-resistant phenotype. A group of overlapping plasmids
conferred growth up to 330C (CKY50) and 360C (CKY52) and represented the
strongest suppressor locus. The corresponding gene was mapped to the right
arm of chromosome III near the SED4 open reading frame by hybridizing an
internal restriction fragment to a Southern blot of S. cerevisiae chromosomes
(Clontech, Palo Alto, CA) and to a set of ordered yeast genomic clones (Riles et
al., 1993). The suppressing gene was shown to be SED4 by subcloning
fragments into pRS306-2p and testing for their ability to confer temperature-
resistance to CKY50.
Plasmid Constructions. Plasmids are summarized in Table II. p5007 is a
YEp24 library plasmid containing SED4. pRH26 is the 7.4 kb Apal-SaA fragment
of p5007 in pRS306-2t. pRH46 is the 5.2 kb Sacl-Sa/l fragment of pRH26 in
pRS306-2t. pRH107, pRH67 and pPE87 are the 5.2 kb Sacl-SaA fragment of
pRH46 in pRS316, pRS306 and pRS305-2p, respectively. pRH121 and pRH120
are the 5.2 kb Sacl-Sa/l fragment of pRH117 (see below) in pRS316 and
pRS306-2t, respectively.
Plasmids carrying truncations of SED4 were obtained as follows: pRH26
was cut with Spel and the 11.6 kb fragment was self-ligated to make pRH47.
pRH46 was cut with ApaLI, the 5' overhang was filled in, a 3.5 kb fragment was
purified and cut with Sacl-Apal to produce a 1.8 kb fragment that was ligated into
SacI-Smal cut pRS316-2t to make pRH54. pRH77 contains the 1.2 kb Xhol-
Sspl fragment of pRH46 ligated into Xhol-Smal cut pRS306-2#. pRH78 contains
the 1.2 kb Xhol-Spel fragment of pRH77 ligated into Xhol-Spel cut pRH26.
pRH46 was cut with HindIll and the 11 kb fragment was self-ligated to make
pRH128. pRH62 was constructed using two PCR steps (Horton et al., 1989; Yon
and Fried, 1989). PCR primers used were 5'-TTG TAA ATA AAG CCG TGC
ACA TTG TGC TTA TAG GAG AAC TGT AA-3' (nt 1124-1101, SED4, and nt
1125-1104, SEC12, underlined), 5'-GGG ATT ACT TCT ATG GAT G-3' (nt 802-
820, SEC12) and 5'-GAT GAA GAT GAA GAC GGC-3' (nt 1932-1949, SED4),
templates used were pSEC1230 (Nakano et al., 1988) and pRH46. The PCR
product was cut with SaA-EcoRI and inserted into SaA-EcoRI cut pRH50 (see
below) to make pRH56. pRH62 is the 2.5 kb EcoRI fragment of pRH46 ligated
into EcoRI cut pRH56. pRH141 is the 2.6 kb EcoRI fragment of pRH117 (see
below) ligated into EcoRI cut pRH62. pRH148 is the 5.2 kb Xhol-Sacl fragment
of pRH141 in pRS316.
pRH50 and pRH213 are the 3.5 kb Xhol-Hindlll fragment of pSEC1230 in
pRS306-2g and pRS316, respectively.
Epitope-tagging SED4 and SEC12. SED4 was tagged with the haemagglutinin
(HA) epitope (Kolodziej and Young, 1991) as follows: A single copy of the HA
epitope was inserted before the C-terminal HDEL sequence of SED4 using site-
directed mutagenesis, resulting in SED4-HA1. The mutagenic oligomer
consisted of 27 nt encoding the HA epitope (underlined) flanked by 20 and 27 nt
complementary to the SED4 sequence on the 5' and 3' end respectively (5'-CCG
TAA ACT ACG CTG GCC TTT ACC CAT ACG ACG TCQ CAG ACT ACG CTC
ATG ACG AAT TGT GAA TAA CGA AAT AA-3'). Tandem repeats of the HA
epitope were inserted by introducing a Notl site between the last nucleotide of the
HA tag and the C-terminal HDEL sequence by site-directed mutagenesis. The
mutagenic oligomer consisted of a Notl site (underlined) flanked by sequences
complementary to SED4-HA 1 (5'-GAC GTC CCA GAC TAC GCT AQGC GGC
CGC CAT GAC GAA TTG TGA ATA ACG-3'). A cassette containing 3 HA
epitopes (Tyers et al., 1993) was then inserted into the newly created Notl site,
creating pRH117. By DNA sequencing, pRH117 encodes SED4 containing 7
tandem repeats of the HA epitope (SED4-HA).
The N-terminal domain of SED4 was placed under control of the GAL 10
promoter and tagged at its 3' end with a c-myc epitope (myc) (Munro and
Pelham, 1987) as follows: pCD43 is pRS316 with a 0.6 kb EcoRI-BamHI
fragment containing the GAL 1/GAL 10 promoter region inserted into the
polylinker. A 1 kb fragment encoding aa 1-346 of SED4 plus a Notl site was
amplified by PCR using pRH46 as a template and the following primers: 5'-AGT
GAA TTC ATA ATG AGT GGC AAC TCT GC-3' (nt -3 to +17, SED4) and 5'-ATG
GGT ACC GTC GAC CTA GCG GCC GCT TTT CCA AAT ATT TCG TAA AAT
TGA TG-3' (nt 1214-1239, SED4). The amplified fragment was cut with EcoRI-
Kpnl and ligated into pCD43, producing pRH183. A cassette encoding three
copies of the myc epitope flanked by Notl sites was constructed using
overlapping oligonucleotides (kindly provided by B. Futcher, Cold Spring Harbor
Laboratories, Cold Spring Harbor, NY). The oligonucleotides were annealed,
filled in and ligated into Noti-cut Bluescript vector (pKS+) to make pRH177/23.
The nucleotide sequence of the 3 x myc cassette in pRH177/23 is 5'-GCG GCC
GCT CTG AGC AAA AGC TCA TTT CTG AAG AGG ACT TGA ATG GAG AAC
AGA AAT TGA TCA GTG AGG AAG ACC TCA ACG GTG AGC AGA AGT TAA
TAT CCG AGG AGG ATC TTA ATA GTG CGG CCG C-3'. The 3 x myc cassette
of pRH177/23 was ligated into Notl cut pRH183, the resulting product was cut
with Pvul and inserted into Pvul cut pRS313, creating pRH260. By DNA
sequencing, pRH260 encodes a protein with 3 tandem repeats of the myc
epitope plus 14 additional amino acids at the C-terminus. The N-terminal domain
of SEC12 was similarly placed under control of the GAL 10 promoter and tagged
with the myc epitope. A 1 kb fragment encoding aa 1-354 of SEC12 plus a Notl
site was amplified by PCR using pSEC1230 as a template and the following
primers: 5'-AGT GAA TTC ACT ATG AAG TTC GTG ACA G-3' (nt -3 to +16,
SEC12) and 5'-TGC GCT CGA GCT AGC GGC CGC TTT TAG AGA TTT TTT
GTT TCA TTG AGG-3' (nt 1037-1062, SEC12). The amplified fragment was cut
with EcoRI-Kpnl and ligated into pCD43, producing pRH186. The 3 x myc
cassette was ligated into Notl cut pRH186, the resulting product was cut with
Pvul and inserted into Pvul cut pRS313, creating pRH261. By DNA sequencing,
pRH261 encodes a protein with 3 tandem repeats of the myc epitope plus 14
additional amino acids at the C-terminus.
Construction of a SED4 Deletion Allele. A deletion of the entire SED4 open
reading frame (sed4-A 1) was constructed by site-directed mutagenesis. The
mutagenic oligomer (5'-CTT TTA AAC TTA GAA AAA CTA GCA TAA TAA TGG
ATC CAA GCT TGA ATA ACG AAA TAA TAT ATA TTA ATG TTA AAT ATG-3')
consisted of 32 nucleotides complementary to the 3' untranslated region of
SED4, 10 nucleotides creating a Hindill and a BamHI site (underlined), and 36
nucleotides complementary to the 5' untranslated region of SED4. Mutagenesis
of pRH67 deleted the entire SED4 reading frame as shown by restriction
mapping. A 5 kb marker cassette (hisG-URA3-Kanr-hisG) (modification of Alani
et al., 1987; kindly provided by S. Elledge, Baylor College of Medicine, Houston,
TX) was inserted into the newly created BamHI site to make pRH73 (sed4-
A 1::URA3).
A diploid (CKY8 x CKY10) was transformed with a 6.9 kb, purified Sacl-
SaA fragment of pRH73. Tetrad analysis of Ura+ transformants gave 2:2
segregation of URA3. By Southern blot analysis, the genomic SED4 locus was
deleted in four Ura+ spores examined. Loss of the URA3 marker by
recombination of the hisG repeats was selected on SC medium containing 0.1%
5-fluoroorotic acid to produce sed4-A 1.
93
Protein Extracts, Western Blotting and Cell Fractionation. Yeast protein
extracts were prepared from 2-6 x 107 exponentially growing cells as described
(Rothblatt and Schekman, 1989). Cells were lysed in 30 p•l ESB (60 mM Tris HCI
(pH 6.8), 100 mM DTT, 2% SDS, 10% glycerol, 0.001% Bromphenol Blue) by
vigorous agitation with 0.5 mm glass beads (Sigma, St. Louis, MO). Extracts
were diluted with 70 i1 of ESB and 10-20 p•l were resolved by SDS-PAGE
(Laemmli, 1970). Western blotting was performed using standard methods
(Harlow and Lane, 1988). The following antibodies were used: anti-HA antibody
(12CA5 ascitic fluid; BABCO, Richmond, CA) at 1/1,000 dilution, anti-myc
antibody (9E10 ascitic fluid; K. Morrison, Harvard University, Boston, MA) at
1/1,000 dilution, rabbit anti-CPY antibody (gift of R. Schekman) at 1/5,000
dilution, HRP-coupled sheep anti-rabbit Ig (Amersham) at 1/10,000 dilution and
HRP-coupled sheep anti-mouse Ig (both Amersham) at 1/10,000 dilution. Blots
were developed using the ECL system (Amersham). Cell fractionation was
performed as described (Espenshade et al., 1995) using CKY295.
Radiolabeling and Immunoprecipitations. Cells were grown in selective SC
medium supplemented with 2% glucose and then shifted to the indicated
temperatures 2 h before labeling. Tunicamycin treatment and temperature-shift
experiments of the dpm 1-6 mutant were performed as described (Orlean et al.,
1991). 2-6 x 107 exponentially growing cells (1-3 OD600 units) were
radiolabeled in supplemented SD medium by incubating with 30 gCi [35S]-
methionine per OD600 unit (Express protein labeling mix (NEN, Boston, MA),
spec. activity 1200 Ci /mmol). Samples were chased by the addition of 1/100
volume of a solution containing 0.1 M ammonium sulfate, 0.3% cysteine, 0.4%
methionine. Labeled samples of 1 OD600 units of cells were collected into
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chilled tubes containing an equal volume of 40 mM sodium azide. Protein
extracts were prepared in 30 [l ESB by vigorous agitation with glass beads.
Extracts were diluted with 1 ml IP buffer (50 mM Tris HCI (pH 7.4), 150 mM NaCI,
1% Triton X-100, 0.2% SDS), absorbed for 20 min with 50 gI 10% S. aureus cells
(Sigma) and cleared by centrifugation at 12,000 x g for 5 min. 0.5 g1 anti-CPY or
anti-HA antibody was added and extracts were rotated for 1 h at 250C. Immune
complexes were collected by adding 30 p1 50% Protein A Sepharose (Pharmacia,
Piscataway, NJ) per sample and incubating for 1 h at 250C. Protein A Sepharose
beads were washed twice with IP buffer and once with detergent-free IP buffer
(50 mM Tris HCI (pH 7.4), 150 mM NaCI). Protein was released into 30 pl ESB
by heating to 1000C for 2 min. 10 •l of the supernatant was separated by SDS-
PAGE and visualized by fluorography (Harlow and Lane, 1988).
Two-Hybrid Protein-Protein Interaction Assay. Sed4p and Secl2p were
tested for binding to Secl6p in vivo as described by Gyuris et al., 1993. The N-
terminal domain of Sed4p or Secl2p was fused to the acidic activation domain in
pJG4-5 as follows. A fragment encoding aa 1-347 of SED4 was amplified by
PCR using pRH46 as a template and the following primers: 5'-AGT GAA TTC
ATA ATG AGT GGC AAC TCT GC-3' (nt -3 to +17, SED4) and 5'-CTA GTC GAC
CTA TTT CCA AAT ATT TCG TAA AAT TGA TG-3' (nt 1038-1016, SED4). The
corresponding fragment encoding aa 1-354 of SEC12 was amplified similarly
using pSEC1230 as a template and the following primers: 5'-AGT GAA TTC
ATG AAG TTC GTG ACA GCT AG-3' (nt 1-20, SEC12) and 5'-TGC GCT CGA
GCT ATT TAG AGA TTT TTT GTT TCA TTG AGG-3' (nt 1062-1037, SEC12).
Fragments were cut with EcoRI-Sail (SED4) or EcoRI-Xhol (SEC12) and ligated
into EcoRI-Xhol cut pJG4-5 to make pRH154 and pRH155, respectively. pPE58,
59 and 74 are plasmids encoding aa 1645-2194, aa 1-824 and aa 447-1737 of
SEC16 fused to the lexA DNA binding domain in pEG202 (Espenshade et al.,
1995).
Two-hybrid interactions were tested in EGY40 (Golemis and Brent, 1992)
transformed with the appropriate plasmids. LacZ expression was tested by
patching 4 to 8 transformants on SC medium (pH 7.0) lacking the appropriate
amino acids and supplemented with 2% galactose and 40 mg/I X-gal. For 0-
galactosidase assay, cells were grown to exponential phase in selective medium
containing 2% raffinose, then galactose was added to 2% and growth was
continued for 10 h. Extracts were prepared and assayed as described (Kaiser et
al., 1994). Protein concentrations in the extracts were determined using the
Bradford Assay (Biorad, Melville, NY). Units of P-galactosidase are expressed
as: [OD420 x vol. of assay] / [0.0045 x protein concentration in extract x vol. of
extract assayed x time].
Binding to GST-fusions. The C-terminus of Secl6p (aa 1688-2194) was fused
to the glutathione-S-transferase gene (GST) expressed from the GAL1 promoter
(pRD56, a kind gift of Dr. Ray Deshaies) to create pPE122. The N-terminal
domains of Sed4p and Secl2p were expressed from the GAL 10 promoter and
tagged with the myc epitope as described above (pRH260 and pRH261).
pPE122 and either pRH260 or pRH261 were transformed into CKY289. For
controls, CKY289 carrying pRD56 and either pRH260 or pRH261 were used.
Cells were grown to exponential phase in selective medium containing 2%
raffinose, galactose was added to 2%, and extracts were prepared 4 h later. 4 x
107 cells were suspended in 40 p•l ColP buffer (20 mM HEPES (pH 6.8), 80 mM
potassium acetate, 5 mM magnesium acetate, 0.1% Triton X-100) containing 2.5
x 10-4 U/mi a2-macroglobulin, 1 mM PMSF, 0.5 ng/ml leupeptin, 10 ng/ml E64
and 0.4 ng/ml aprotinin (all Boehringer, Indianapolis, IN) and were lysed by
vigorous agitation with 0.5 mm glass beads 4 x 20 sec with 1 min intervals on ice.
Extracts were diluted to 1 ml with ColP buffer with protease inhibitors, and the
lysate was cleared by centrifugation at 13,000 x g for 5 min. Glutathione
Sepharose 4B beads (Pharmacia, Piscataway, NJ) were added and samples
were incubated for 1 h at 250C. The beads were washed 3 times with ColP
buffer and once with detergent-free ColP buffer. Proteins were released from the
beads by boiling in 30 pl ESB. Total protein extracts were prepared from 2 x 107
cells lysed in ESB by agitation with glass beads.
Immunofluorescence. Indirect immunofluorescence was performed essentially
as described by Pringle et al., 1991. Cells were fixed by adding formaldehyde
(final concentration of 3.7%) to the medium and incubating for 2 h at 250C. Fixed
cells suspended in 0.1 M potassium phosphate (pH 7.2) were spheroplasted with
50 U lyticase for 30 min at 370C. Incubations in primary or secondary antibody
were for 1 h and were performed in a humid chamber at 250C. The antibodies
and concentrations used were: 12CA5 at a 1/5,000 dilution, anti-BiP polyclonal
antiserum (kind gift of M. Rose, Princeton University, NJ) at 1/1,000 dilution,
FITC-coupled goat anti-rabbit IgG and rhodamine-coupled goat anti-mouse IgG
(both Boehringer) at 1/300 dilution. Cells were mounted in medium containing
DAPI and p-phenylenediamine. Images were recorded on a Zeiss axioscope
using Kodak T-Max 400 film developed according to the manufacturer's
specifications.
Electron Microscopy. Electron microscopy was performed as described in
Kaiser and Schekman, 1990. Wild type (CKY291), sed4-A 1 sarl-5 (CKY293)
and sec17-1 (CKY54) cells were grown to exponential phase in YPD at 240C and
shifted to 380C for 2 h prior to fixation. Cells were fixed for electron microscopy
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with potassium permanganate. To count vesicles, random well-stained sections
were selected, photographed at a magnification of 13,000x, and vesicles seen on
the negative were counted. Vesicle counts were normalized to cell volume by
measuring the area of the cell section and assuming a section thickness of 90
nm. 29 and 33 cell sections were counted for the sed4-A 1 sarl-5 and the secl 7-
1 strain, respectively. Data are expressed as mean ± standard error of the mean.
In Vitro Vesicle Synthesis. Membranes and cytosol used in the vesicle
synthesis reaction were prepared as previously described (Wuestehube and
Schekman, 1992) using CKY295 as a source of membranes and CKY93 as a
source of cytosol. Standard vesicle synthesis reactions of 500 il contained 100
[ig of membranes, 1.2 mg of cytosol prepared in the absence of added guanine
nucleotide, 1mM GDP-mannose, 0.1 mM guanine nucleotide, and an ATP
regeneration system in reaction buffer (20 mM Hepes-KOH (pH 6.8), 150 mM
KOAc, 5mM MgOAc, 250 mM sorbitol) with protease inhibitors (1 mM PMSF, 0.5
ng/p•l leupeptin, 1 gM pepstatin). The reaction with apyrase added contained 10
U/ml of apyrase in the place of the ATP regeneration system. Reactions were
incubated at 200C for 2 h. Donor membranes were removed by centrifugation at
32,000 rpm for 10 min at 40C in a Beckman TLA100.3 rotor. Vesicles were
pelleted from this medium speed supernatant by centrifugation at 60,000 rpm for
30 min at 40C in a Beckman TLA100.3 rotor. Vesicle pellets were solubilized in
30 91 ESB and proteins were analyzed by Western blotting.
Vesicles formed in vitro were fractionated by gel filtration on a 14 ml (1 x
18 cm) Sephacryl S-1000 column equilibrated in reaction buffer as described
(Barlowe et al., 1994). A 0.7 ml sample of medium speed supernatant from two
0.5 ml reactions was applied to the column, eluted in reaction buffer, and 0.75 ml
fractions were collected. Vesicles in each fraction were concentrated by
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centrifugation at 60,000 rpm for 30 min at 40C in a Beckman TLA100.3 rotor.
Proteins solubilized in 30 la1 ESB were analyzed by Western blotting.
Cloning and Sequence Determination of sarl-5. sarl-5 was cloned by gap
repair as follows: pRH259 contains the SAR1 gene on a 1.3 kb Hindll-Sal
fragment of pSEC1210 (Nakano and Muramatsu, 1989) inserted into pRS316
with a deletion from the EcoRI to the Notl sites of the polylinker. A sarl-5 sed4-
Al double mutant was transformed with plasmid pRH259 cut with EcoRI and
BamHI to produce a gap covering the SAR1 coding sequence. Gap-repaired
plasmids carrying the mutation (pRH262) were identified by their inability to
suppress the temperature-sensitivity of secl6-2 and sec23-1 strains. The
mutational change in a plasmid carrying sarl-5 was identified by sequencing with
synthetic oligonucleotide primers. SARi and sarl-5were placed on a 2[t plasmid
by inserting the 1 kb EcoRI-Hindlll fragment of pRH259 and pRH262 into
pRS306-2g, creating pRH280 and pRH279.
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RESULTS
SED4 is a Multicopy Suppressor of secl6 Mutations. secl6-2 mutants fail to
grow at temperatures above 300C (Fig. 1, column 1). To identify genes that
interact with SEC16, we screened a S. cerevisiae genomic DNA library in a
multicopy (2g) vector for plasmids that permit temperature-sensitive (Ts) secl6
mutants to grow at restrictive temperatures. One set of overlapping plasmids
was recovered that suppressed the growth defect of secl6-2 cells up to 360C
(Fig. 1, column 2). Subcloning and sequencing identified the suppressing locus
as SED4.
SED4 overexpression partially suppressed the Ts growth defect of all four
secl6 alleles (not shown). However, SED4 overexpression could not bypass a
sec16 null allele (sedl6-A1::TRP1) as demonstrated in the following plasmid
shuffling experiment. CKY234 carries a chromosomal sed16-A1::TRP1 allele
and a URA3 marked plasmid containing SEC16. CKY234 transformed with
SED4 on a 2g, LEU2 marked plasmid (pPE87) could not grow without the URA3
marked SEC16 plasmid, whereas CKY234 transformed with SEC16 on a LEU2
marked plasmid (pPE8) could grow without the URA3 marked plasmid.
We examined the ability of SED4 overexpression to suppress Ts
mutations in other secretion genes. The sec and bet mutants listed in Table I
were transformed with either SED4 on a multicopy plasmid (pRH46) or the 2[t
vector alone, and tested for growth at 300, 330, 360 and 380C. Overexpression of
SED4 partially suppressed the growth defect of sec2-41 at 330C, but had no
effect on the growth defect of any of the other mutants tested. Importantly,
overexpression of SED4 did not suppress the growth defect of a strain carrying a
Ts mutation in SEC12, the gene most like SED4.
The ability of SED4 overexpression to suppress the secretion defect of
secl6-2 was examined by following the maturation of the vacuolar enzyme
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carboxypeptidase Y (CPY). Covalent modifications of CPY in the ER, the Golgi,
and the vacuole mark the early events in the secretory pathway (Stevens et al.,
1982). Strains were grown at 320C for 2 h, labeled for 5 min, and then chased.
In a secl6-2 strain, none of the ER-form (pl) of CPY was converted into the
mature, vacuolar form (m) even after 30 min (Fig. 2, lanes 1-5), whereas the
same strain containing SED4 on a 2y plasmid allowed maturation of CPY (Fig. 2,
lanes 6-10). Thus, the suppression of the secretion defect of sec 16-2 by SED4
parallels the suppression of the growth defect.
The Conserved N-terminal and Transmembrane Domains of Sed4p Confer
Suppression of the Growth Defect of sec16-2 Strains. To identify the portion
of SED4 required for suppression of sec16, truncations of SED4 were tested. By
comparison to SEC12, SED4 is comprised of an N-terminal cytosolic domain, a
transmembrane domain, and a C-terminal luminal domain. SED4 alleles with
either a partial (sed4-T1) or a complete (sed4-T2) deletion of the C-terminal
domain suppressed secl6-2 almost as well as wild type SED4 demonstrating
that this domain is not necessary for suppression (Fig. 3). The N-terminal and
transmembrane domains of Sed4p were required for suppression, since deletion
of a 39 amino acid segment of the N-terminal domain (sed4-T4) or deletion of the
transmembrane domain (sed4-T3) completely abolished the ability to suppress
sec16-2 (Fig. 3). To demonstrate that sed4-T4 is expressed at levels similar to
SED4, we constructed an epitope-tagged allele, sed4-T4-HA, that contains the
HA epitope at the same position as SED4-HA (see below). By Western blotting,
the levels of Sed4-T4-HAp were identical to Sed4-HAp (not shown).
The function of the C-terminal luminal domain of Sed4p was further
examined by fusing it to the N-terminal and transmembrane domains of Secl2p
and testing this chimera for suppression of either secl6-2 or secl2-4. The
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chimera behaved like wild type SEC12: SEC12-SED4 on either a low or a high
copy plasmid did not suppress secl6-2, but complemented both secl2-4 and a
chromosomal deletion of secl2 (Fig. 3 and data not shown). These results
demonstrate that the function of SED4 is specified by its conserved N-terminal
and transmembrane domains.
Sed4p is an O-glycosylated ER Membrane Protein. Sed4p was epitope-
tagged by inserting seven copies of the haemagglutinin (HA) epitope before the
C-terminal HDEL sequence (see Materials and Methods). Epitope-tagged SED4
appeared to be functional since SED4-HA suppressed secl 16-2 to the same
extent as untagged SED4 (not shown). Immunoblots probed with anti-HA
antibodies detected a protein that migrated more slowly than a 190 kD molecular
weight standard (Fig. 4A, lane 1). As expected for Sed4p-HA, this band was
more abundant in a strain overexpressing Sed4p-HA (Fig. 4A, lane 2) and was
not present in a strain expressing untagged SED4 (Fig. 4A, lane 5).
An epitope-tagged Secl2-Sed4p fusion protein (Fig. 3) was useful for
estimating the abundance of Secl2p relative to Sed4p. Since both Sed4p-HA
and the chimera were tagged at the same position and migrated similarly on
SDS-PAGE, they were likely to be detected with equal efficiency by Western
blotting. Sed4p-HA expressed from either a high or a low copy vector was 5 to
10 times more abundant than Sec12-Sed4p-HA, expressed from the same vector
(Fig. 4A, compare lanes 1 and 3 and lanes 2 and 4).
The difference between the observed molecular weight of Sed4p-HA
(>190 kD) and the molecular weight predicted from the amino acid sequence
(117kD) prompted us to examine possible modifications of Sed4p. The C-
terminal, luminal domain of Sed4p contains three potential N-linked glycosylation
sites and is rich in serine and threonine residues that could accept O-linked
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glycosylation. Unglycosylated Sed4p-HA was produced in PRY303, a strain that
carries a Ts mutation in dolichol phospho mannose synthase, an enzyme
required for both N- and O-linked glycosylation (Orlean, 1990). Sed4p-HA,
immunoprecipitated from PRY303 cells labeled at the restrictive temperature,
migrated more rapidly than Sed4p-HA expressed in wild type cells (Fig. 4B, lane
4), indicating that Sed4p-HA is a glycoprotein. Treatment of cells with
tunicamycin, an inhibitor of N-linked glycosylation, or treatment of extracts with
EndoH to remove N-linked carbohydrate chains had no effect on the
electrophoretic mobility of Sed4p-HA (Fig. 4B, lane 5 and data not shown),
indicating that Sed4p-HA is modified primarily by O-glycosylation. The
discrepancy between the migration of Sed4p-HA without carbohydrate
modifications (190 kD) with that predicted from the amino acid sequence (117
kD) is probably due to anomalous migration on SDS-PAGE since Sed4p-HA
expressed in bacterial cells also migrated at 190 kD (not shown).
Sed4p-HA behaved as an ER-membrane protein on cell fractionation. A
large fraction of Sed4p-HA in a cell lysate pelleted at 500 x g and the remainder
pelleted at 10,000 x g (not shown). As expected for an integral membrane
protein, Sed4p-HA was partially solubilized from the 10,000 x g pellet by
treatment with 1% Triton-X 100, but was not released by treatment with 2.5 M
urea, 0.5 M NaCI, or sodium carbonate (pH 11) (not shown).
The intracellular location of Sed4p-HA was further examined by indirect
imnmunofluorescence. Figure 5 (top panel) shows diploid cells expressing SED4-
/HA from a high copy plasmid stained with anti-HA antibody. The staining was
chiefly at the nuclear periphery with extensions into the cytoplasm and around
the periphery of the cell body. This pattern is typical for proteins located in the
ER (Rose et al., 1989). The anti-HA staining pattern was identical to the anti-BiP
staining observed in a double labeling experiment (Fig. 5, bottom panel),
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indicating that Sed4p-HA is distributed throughout the ER. A similar, though
weaker, staining was seen for Sed4p-HA expressed from a low copy plasmid,
while no staining was apparent in a control strain transformed with untagged
SED4 (not shown).
Sed4p is Excluded from ER Vesicles Produced In Vitro. To investigate
whether Sed4p is present on vesicles that have budded from the ER, we followed
the fate of Sed4p-HA in a cell-free ER budding reaction (Wuestehube and
Schekman, 1992). ER membranes were isolated from a sed4 deletion strain
expressing Sed4p-HA from a low copy plasmid. Vesicles were produced by
incubating these membranes with a guanine nucleotide and cytosol. Vesicles
that had formed in vitro were isolated by first removing the donor membranes by
centrifugation at medium speed and then pelleting the vesicles at high speed.
Sec22p was used as a vesicle marker protein and about 10% of Sec22p was
recovered in the high speed pellet (HSP) after incubation of donor membranes at
200C with GTP and cytosol (Fig. 6). Incubation at 40C, in the presence of
apyrase, or in the absence of cytosol decreased the amount of Sec22p in the
HSP by 10-fold, while incubation in the presence of GMP-PNP, a non-
hydrolyzable GTP-analog, reduced vesicle formation by about two-fold. The
conditions that promote vesicle formation in these reactions, and the efficiency of
vesicle formation are consistent with those found previously (Rexach et al, 1994).
Sed4p-HA was detectable in both ER membrane and vesicle fractions, but only
0.1-0.5% of membrane-bound Sed4p-HA was released into the vesicle fraction at
200C as compared to 10% of the input Sec22p. Even less (0.01%) was released
on incubation at 40C, without GTP or with GMP-PNP. To determine whether the
small amount of Sed4p-HA released in a GMP-PNP reaction was present on ER
to Golgi transport vesicles or was associated with another type of membrane, the
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vesicle fraction from a GMP-PNP reaction was fractionated further by gel-filtration
chromatography (Barlowe et al., 1994). Most Sed4p-HA eluted before Sec22p
on a Sephacryl S-1000 column (data not shown). Thus, the small amount of
Sed4p that is released from the ER is not in transport vesicles and Sed4p, like
Secl2p, appears to be largely excluded from budded vesicles.
The N-terminal domain of Sed4p binds to the C-terminal domain of Secl6p.
The genetic interaction between SED4 and SEC16 suggested that their products
might physically associate. As an initial test of this possibility we used the two-
hybrid system (Fields and Song, 1989; Gyuris et al., 1993). The N-terminal
domain of SED4 was fused to an acidic transcription activation domain and
tested for interaction with each of three overlapping parts of SEC16 fused to the
lexA DNA binding domain. Interaction was scored by the ability of the lexA DNA
binding domain and the acidic activation domain to be brought together to drive
transcription of a lacZ reporter gene. A strong interaction was detected for the
combination of the N-terminal domain of SED4 and the C-terminal domain of
SEC16 (Table Ill). This interaction was specific for SED4 since a parallel test of
the N-terminal domain of SEC12 gave no interaction (Table III). The possibility
that SEC12 failed to interact because of poor expression was tested by
evaluating protein levels by Western blotting with antibodies against the HA-tag
present in the acidic activation domain. Both Secl2p and the Sed4p fusion
proteins were present at comparable levels, indicating that the results of the two-
hybrid test do reflect the inability of Secl2p to interact with Secl6p.
Sed4p and Secl 6p were also tested for binding in cell extracts. Since
Secl 6p (Espenshade et al., 1995) and Sed4p are both insoluble, we tested
association of only the putative interacting regions expressed in soluble form.
The N-terminal domains of Sed4p and Secl2p were tagged with the myc epitope
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and expressed from the GAL 10 promoter (SEC12N-MYC and SED4N-MYC).
These epitope-tagged constructs were first tested for functionality as follows. We
found that overexpression of either the Secl2p N-terminal domain or the Sed4p
N-terminal domain has a dominant negative effect and exacerbates the
temperature-sensitivity of secl2-4 and other mutants defective in vesicle
formation (d'Enfert et al., 1991a; Gimeno and Kaiser, unpublished observations).
SEC12N-MYC and SED4N-MYC both inhibited the growth of secl2-4 to the
same extent as untagged controls, indicating that addition of the epitope did not
interfere with function. These tagged domains were tested for binding to the C-
terminal domain of Secl6p fused to glutathione-S-transferase (GST) and
expressed from the GAL1 promoter (GST-SEC16C). GST-Secl6Cp and
associated proteins were isolated by affinity to glutathione beads from extracts
prepared from yeast cells expressing GST-SEC16C and either SED4N-MYC or
SEC12N-MYC. Sed4Np-Myc, but not Secl2Np-Myc, associated with GST-
Secl 6Cp bound to glutathione beads as detected by Western blotting using the
anti-myc antibody (Fig. 7, lanes 1 and 2). The binding of Sed4Np-Myc was
dependent on the presence of Secl 6Cp since none associated with GST alone
(Fig. 7, lanes 3 and 4). Thus, the binding experiments gave the same result as
the two-hybrid tests; Sed4p can bind to the C-terminal domain Secl6p and a
parallel interaction is not seen for Secl2p.
Deletion of SED4 Slows Transport of CPY from the ER to the Golgi. The
genetic and physical interactions between Sed4p and Secl 6p prompted us to
examine more carefully the phenotypes of a chromosomal deletion of SED4
(sed4-A 1). Previously, no growth or secretion defect was found in a SED4
disruption strain (Hardwick et al., 1992). Consistent with these data, sed4-A 1
cells grew as well as isogenic wild type cells at a range of different temperatures
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(150, 250, 380 or 400C) and showed no accumulation of the ER form of CPY by
Western blotting (not shown). However, sed4-A 1 strains did not grow at 41OC,
although wild type strains grew slowly at this temperature. This growth defect of
sed4-A 1 strains was complemented by SED4 and could be suppressed by SAR1,
SEC16 or SEC23 on a low copy vector, but not by SEC13 or SEC12 (not shown).
Complementation of sed4-A 1 at 41 oC provided another test of SED4 function and
was also used to establish the importance of the N-terminal domain (Fig. 3).
We examined the kinetics of secretion of CPY in sed4-A1 cells at 380C
(Fig. 8). In wild type, 50% of the ER (pl) form of CPY was converted to the Golgi
(p2) form after 4 min of chase, and CPY was completely converted to the mature
vacuolar (m) form after 8 to 10 min of chase (Fig. 8A, lanes 7-12). In sed4-A 1, pl
CPY persisted beyond 10 min of chase indicating slowed transport from the ER
(Fig. 8A, lanes 1-6). Quantitation of the rate of conversion of pl CPY to mature
form (Fig. 8B) gave a half-life of pl CPY of 7.1 min in a sed4-A1 strain compared
to 4.4 min in wild type. This transport defect in sed4-A 1, although subtle, was
highly reproducible, and a 1.6- to 2-fold lower transport rate from the ER to the
Golgi of sed4-A 1 cells was found in four independent experiments.
Deletion of SED4 Exacerbates Vesicle Formation Mutations. Synthetic lethal
interactions between genes that affect the secretory pathway have been found
among genes required for protein translocation across the ER membrane
(Rothblatt et al., 1989), genes required for vesicle formation at the ER (Kaiser
and Schekman, 1990), genes required for vesicle fusion with the Golgi (Kaiser
and Schekman, 1990; Newman et al., 1987), and genes required for fusion of
secretory vesicles with the plasma membrane (Salminen and Novick, 1987).
Because such interactions have only been detected between genes that affect
the same step of the pathway, systematic tests for synthetic lethality can often
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define the step where a gene product acts. To test the interactions of sed4-A 1, a
URA3-marked sed4-A 1 strain was crossed to a panel of Ts secretion mutants.
The temperature-sensitivity of mutations in each of four genes required for
vesicle formation at the ER (secl2-4, sec 13-1, sec 16-2, sec23-1) was
significantly increased, when combined with sed4-A1::URA3 (Table IV).
Importantly, these effects were specific for vesicle formation functions since
sed4-A 1 did not increase the temperature-sensitivity of the mutants required for
vesicle fusion (secl 17-1, sec18-1, sec22-3, Table IV and not shown) or any other
secretion mutations (sec20-1, sec21-1, sec2-41, sec4-8, sec7-1, sec8-9, not
shown). This pattern of synthetic lethal interactions shows that only defects in
vesicle formation were made more severe by the absence of Sed4p and
therefore points to a role for SED4 in vesicle formation at the ER.
Isolation of sed4 as an Early Secretory Pathway Mutant. Perhaps the most
convincing demonstration that SED4 is important for ER to Golgi transport came
from the isolation of a sed4 mutant in a general screen for new secretion
mutants. We examined a collection of 1,800 random Ts mutants for
accumulation of the ER forms of CPY and invertase by Western blotting (E.
Holzmacher and C. Kaiser, unpublished). After backcrossing and
complementation testing, Ts mutations in about 15 new genes required for ER to
Golgi transport have been identified. Segregation analysis of one of these
mutants, designated EH874, revealed that its growth and secretion defect was
caused by mutations in two unlinked genes. Analysis of crosses of EH874 to wild
type showed that the double mutant segregants were temperature-sensitive at
38 0C, one of the single mutants was temperature-sensitive at 410C, and the other
single mutant showed no growth defect. The mutation that caused temperature-
sensitivity at 410 C was shown to be an allele of SED4 because it failed to
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complement the growth defect of sed4-A 1 at 410 C and was completely linked to
sed4-A 1 in tetrad analysis. This allele was designated sed4-1 and in all the
phenotypic tests we performed behaved the same as sed4-A 1. The other
mutation in EH874 was phenotypically silent on its own, but was needed to
confer temperature-sensitivity on sed4-1. Because SAR1 on a low copy plasmid
complemented the temperature-sensitivity of EH874, we suspected that the
second mutation might be an allele of SAR1. Linkage to SAR1 was tested by
crossing a sed4-A 1 strain in which the SAR1 locus was marked with URA3
(CKY282) to EH874. Tetrad analysis of the resulting diploids demonstrated that
the mutation that caused temperature-sensitivity was tightly linked to SAR1. The
effect of this allele, designated sarl-5, on growth and secretion is shown in
Figure 9. sari-5 alone had no growth or secretion defect whereas sari-5
combined with sed4-A 1 showed a severe growth defect and a complete block in
transport of CPY to the Golgi at 380C. The simplest explanation for these results
is that Sed4p is needed for efficient utilization of Sarl p, and that in the absence
of Sed4p the subtle defect caused by the sari-5 mutation produces a strong
secretion defect.
The sarl-5 allele was recovered from the chromosome by gap-repair of a
SAR1 plasmid. The DNA sequence of sarl-5 revealed a change from G to T at
nucleotide 533, replacing methionine 41 with isoleucine. Methionine 41 occurs in
Sarl proteins from all organisms examined so far and is located in a highly
conserved region immediately following the G1 guanine nucleotide binding
domain and preceding the putative effector binding domain (Kuge et al., 1994).
Mutations in this region have not been previously characterized in either Sarl p or
its closest homologue Arflp.
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The sed4-A 1 sarl-5 Double Mutant Accumulates ER Membranes but not
Vesicles. The finding that deletion of SED4 in a sarl-5 background causes a
temperature-sensitive ER to Golgi transport defect allowed us to examine in more
detail the step at which Sed4p functions. Mutants that block ER to Golgi
transport fall into two morphological classes: mutants defective in fusion of ER-
derived vesicles with the Golgi accumulate ER membranes and a large number
of 50 nm vesicles, whereas mutants defective in vesicle formation accumulate
only ER membranes (Kaiser and Schekman, 1990). We examined the
morphology of the sed4-A 1 sarl-5 mutant after growth at 381C for 2 h to impose
a complete block in ER to Golgi transport (see Fig. 9). Cells were fixed with
potassium permanganate to highlight membranes and were viewed by electron
microscopy. sed4-A 1 sarl-5double mutant cells accumulated excess ER
membranes, visible as extra layers of membrane throughout the cell (Fig. 10).
To determine whether sed4-A 1 sarl-5 cells also accumulated 50 nm vesicles, we
counted vesicles in random cell sections. The average number of vesicles per
pm 3 cell volume in sed4-A 1 sarl-5 cells was 7.4 ± 1.1. This value is similar to
that previously reported for other mutants defective in vesicle formation (Kaiser
and Schekman, 1990). To establish our ability to detect vesicles in this
experiment, we counted vesicles in a mutant defective in vesicle fusion (sec17-1)
that was grown at the restrictive temperature and was fixed for microscopy in
parallel. As expected, the secl7-1 mutant accumulated vesicles (19.8 ± 2.2
vesicles per gm3 cell volume). This result implies that the sed4-A 1 sarl-5 double
mutation blocks vesicle formation at the ER, and is consistent with the genetic
interactions between SED4 and vesicle formation genes and with the localization
of Sed4p to the ER membrane, but not to vesicles.
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The sarl-5 Mutation Disrupts Interaction of SAR1 with SEC16 but not
SEC12. An important test for SAR1 function is the ability to suppress mutations
in other SEC genes. SAR1 was first isolated because overexpression of SAR1
suppresses sec12 mutations (Nakano and Muramatsu, 1989). Overexpression of
SAR1 also suppresses sec16 and sec23 mutations, although the mechanistic
relationship to sec12 suppression is not known (Nakano and Muramatsu, 1989;
Oka and Nakano, 1994). To explore the nature of the sari-5 mutation, we tested
sari-5 expressed from either a low (CEN) or a high (2g) copy plasmid for the
ability to suppress different sec mutations. The sarl-5 mutation disrupted the
interaction of SAR1 with SEC16 and SEC23, since sarl-5 on either low or high
copy plasmids did not suppress sec16-2 or sec23-1 mutations (Table V). In
contrast, sari-5 suppressed the temperature-sensitivity of sec 12-4 to the same
degree as wild type SAR1 (Table V). Thus, the sari-5 allele allowed the function
of SAR1 needed to suppress sec12 mutations to be distinguished from the
function(s) needed to suppress sec 16 and sec23 mutations.
In tests of sarl-5 for synthetic lethal interactions, sarl1-5 exacerbated the
temperature-sensitivity of secl6-2, secl3-1 and sec23-1(and of sed4-A1 as
described above), but had no effect on the growth of sec12-4 (Table IV). Again,
these results indicate that SAR1 has at least two different functions. One
function involves interaction with SED4, SEC16 and SEC23 and is disrupted by
sarl-5, while the other function involves interaction with SEC12 and is not
affected by sarl-5.
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DISCUSSION
The major conclusion of this study is that SED4 encodes an important, but
not essential, component of the machinery that assembles transport vesicles at
the ER membrane. This conclusion rests on five findings. (1) Strains with a
chromosomal deletion of SED4 exhibit a two-fold reduction in the rate of transport
of the marker protein CPY from the ER to the Golgi. (2) The cytosolic domain of
Sed4p binds to the C-terminal domain of Secl6p, an ER and vesicle protein that
is required for transport vesicle budding in vivo. (3) Sed4p is located in the ER
membrane but not in vesicles, and therefore binding to Secl6p must take place
on the ER membrane. (4) Increased dosage of SED4 suppresses sec16
mutations. (5) Deletion of SED4 exacerbates mutations in genes known to
participate in vesicle budding (SEC16, SEC12, SEC13, SEC23 and SARi), but
not mutations that affect later steps in the secretory pathway. The interaction
with SAR1 is particularly striking since the sarl-5 mutation alone is
phenotypically silent, but when combined with sed4-A 1 shows a strong secretion
block.
An important clue to the mechanism of SED4 function is the binding of the
cytosolic domain of Sed4p to the C-terminal domain of Secl6p. This interaction
was detected both by two-hybrid assay and by binding experiments in cell
extracts where the two interacting domains were expressed as soluble proteins.
An internal control for the specificity of the interaction between Sed4p and
Secl 6p is provided by comparing binding of Secl 6p to the cytosolic domains of
Sed4p and Secl2p. The binding that we observe is specific to Sed4p because
the cytosolic domain of Secl2p, which must have a similar structure to the
cytosolic domain of Sed4p, does not interact with Secl 6p by either two-hybrid or
solution binding assays. Furthermore, two-hybrid tests between Sed4p and
regions of Secl6p other than the C-terminal domain gave no interaction and a
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deletion that removed 250 amino acids from the C-terminus of Secl6p disrupted
the ability to interact with Sed4p (not shown). These results show a specific
association between the cytosolic domain of Sed4p and the C-terminal domain of
Secl6p. Since both proteins are located at the ER membrane this is presumably
where they interact.
Genetic tests provide strong evidence that SED4 is important for the
proper function of SEC16. When vesicle formation is impaired by secl6
mutation, increased dosage of SED4 restores function, whereas deletion of
SED4 increases the severity of the defect. Since the activity of SEC16 varies
according to both increased and decreased dosage of SED4, and since Sed4p
binds to Secl6p, we conclude that SED4 is almost certainly needed for proper
function of SEC16 in vesicle formation. SAR1 shows genetic interactions with
SEC16that are similar to the ones observed between SED4 and SEC16.
Increased dosage of SAR1 suppresses secl6 mutations (Nakano and
Muramatsu, 1989), and secl6-2 is lethal at 270C when combined with sarl-5.
SAR1 also interacts genetically with SED4. We show that increased dosage of
SAR1 suppresses the temperature-sensitivity caused by sed4 deletion, while
combination of sarl-5 and sed4-1 causes a strong transport block. These
multiple genetic interactions argue that the functions of Secl6p, Sed4p and
Sarl p are closely linked.
How the interactions of these proteins are coupled to vesicle
morphogenesis can be inferred from what we know of their location with respect
to the forming vesicle. Three classes of proteins that participate in vesicle
budding are defined by the dissection of the membrane and cytosolic
requirements for the reconstituted budding reaction and by localization
experiments based on cell fractionation and immunofluorescence. The first class
is associated with the ER membrane, but is not incorporated into vesicles, and
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therefore probably functions in the ER membrane before completion of the
vesicle. Representatives of this class are Secl2p (Rexach and Schekman, 1991;
Barlowe et al., 1994) and Sed4p, as shown here. The second class, represented
by the COPII proteins Secl 3p/Sec3l p, Sec23p/Sec24p and Sarl p (Barlowe et
al., 1994) can be recruited from the cytosol to form a coat on the budded
vesicles. In the accompanying paper, we show that Secl6p represents a third
class of vesicle forming proteins that is tightly associated with the ER and is also
incorporated into the vesicle coat.
From these localization studies and from the genetic interactions and
binding studies we have developed a model for the function of Sed4p, Secl 6p,
Sec23p and Sarilp in the early steps of vesicle assembly (Figure 11). Because
Secl6p is on both the ER and on vesicles it may serve as a scaffold for
incorporation of soluble coat proteins into the vesicle. In the accompanying
paper we show that the COPII protein, Sec23p, binds to the C-terminal domain of
Secl16p. The genetic interactions between SEC16 and SAR1 are consistent with
Sec16p also being a binding site for Sarip. This proposed association of Sarlp
with a complex of Secl 6p and Sec23p is further supported by the observation
that Sec23p stimulates Sarlp GTPase activity (Yosihisha et al., 1993). The
function of Sed4p may be to promote the assembly or increase the stability of a
nascent vesicle coat complex that includes Secl 6p, Sec23p and Sarilp. This
would explain why deletion of SED4 exacerbates the transport defect of sarl-5,
sec 16 and sec23 mutations, and is consistent with Sed4p being a non-essential
protein
A specific function for SED4, suggested by sequence similarity to SEC12,
would be to stimulate guanine-nucleotide exchange on Sarip. The N-terminal
domain of Secl2p has been shown to have such activity (Barlowe and
Schekman, 1993), but parallel experiments using the partially purified N-terminal
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domain of Sed4p did not show Sari p-specific nucleotide exchange activity (C.
Barlowe, personal communication). Although Sed4p does not have guanine-
nucleotide exchange activity by itself, the complex between Sed4p and Secl 6p
may have this activity. To explore this possibility, we tested the soluble complex
between the N-terminal domain of Sed4p and C-terminal domain of Secl6p for
the ability to stimulate exchange of GTP for GDP by Sari p. The complex was
not active, but the truncations of Sed4p and Secl6p used to produce a soluble
complex could have disrupted the capacity to associate with Sari p. A more
direct biochemical test of the interaction of Sarlp with Secl6p and Sed4p will
depend on our ability to extract from membranes an active complex of these
proteins.
Our data, together with the homology between Sed4p and Secl2p,
suggest a role for Sed4p in the recruitment of Sari p to a vesicle formation
complex. Secl2p has been proposed to act similarly in the initial phases of
vesicle formation by recruiting Sarip to the membrane (d'Enfert et al., 1991b).
However, our tests for functional overlap between SED4 and SEC12 show that
these genes perform different functions. Increased dosage of SED4 does not
suppress secl2 mutations and increased dosage of SEC12 does not suppress
the temperature-sensitivity of sed4 deletions. Moreover, increased dosage of
SED4 suppresses sec16 mutations, but parallel tests show no effect of increased
dosage of SEC12 on sec16. The biochemical properties of the N-terminal
domains of Secl12p and Sed4p are also different: the N-terminal domain of
Sed4p binds to the C-terminal domain of Secl6p, while no binding was detected
using the corresponding domain of Secl2p.
One way to reconcile the apparently contradictory aspects of the
relationship between SED4 and SEC12 would be to postulate that SAR1
becomes engaged in vesicle formation through two functionally independent
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pathways: one mediated by SEC12 and the other mediated by SED4 and
SEC16. A genetic test of this idea would be to identify mutations in SAR1 that
affect one pathway but not the other. The sarl-5 mutation appears to have this
property as shown by tests for dosage-dependent suppression of secl2 and
sec16mutations. Increased dosage of sarl-5 does not suppress sec16-2
indicating that the mutation diminishes the effectiveness of Sarilp to function with
Secl 6p. However, increased dosage of sarl-5 does suppress sec12 mutations
as effectively as wild type SAR1, showing no negative effect of sarl-5 on the
interaction of Sarl p with Secl2p. Moreover, sarl-5 exacerbates secl6
mutations, but has no effect on secl2 mutations, further supporting the idea that
SAR1 engages in two independent processes and that sarl-5 selectively disrupts
the processes that involve SEC16. The two ways that SAR1 functions in vesicle
formation as distinguished by the sarl-5 mutation are outlined in Figure 11.
The view suggested by our work is that Secl6p and Sed4p together may
constitute a docking site needed to recruit Sarilp and coat proteins such as
Sec23p to a nascent vesicle. Models for the formation of other coated vesicles
have a similar outline. The binding of coatomer in formation of intra-Golgi
transport vesicles and of AP-1 in formation of clathrin-coated vesicles have both
been shown to depend on the action of the small GTP-binding protein, ADP-
ribosylation factor (ARF) (Donaldson et al., 1992; Helms et al., 1992; Stamnes
and Rothman, 1993; Traub et al., 1993). These same studies showed that
assembly of both types of vesicle also requires Golgi membrane factors which
presumably act as docking proteins for both ARF and coat subunits. The
putative docking proteins for the Golgi have not yet been identified. We propose
that Sed4p and Secl6p carry out this function at the ER membrane.
Knowledge of the interactions between SEC16, SED4, SARi and SEC23
offers a way to study the subunit associations in the early steps of ER vesicle
116
assembly free of the inherent biochemical complexity of the membrane. If
soluble Secl 6p can be obtained in an active form either as a recombinant protein
or by extraction from membranes, it should be possible to develop assays in
solution for the subunit assembly steps delineated here.
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Figure 1. SED4 overexpression suppresses the temperature-sensitivity of sec16-
2. Lanes 1 and 2: A secl6-2 strain (CKY50) containing vector (pRS306-2[) or
SED4 on a 2[t plasmid (pRH46). Lanes 3 and 4: A wild type strain (CKY8)
containing vector (pRS306-2g) or SED4 on a 24 plasmid (pRH46). Cells were
spotted on selective medium and incubated at the indicated temperatures for
40h.
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Figure 2. SED4 overexpression suppresses the temperature-sensitive ER to
Golgi transport defect of secl6-2. Lanes 1-5: A secl6-2 strain (CKY50) carrying
vector (pRS306-2j). Lanes 6-10: A secl6-2 strain carrying SED4 on a 2p
plasmid (pRH46). Cells were grown in selective medium at 250C, shifted to 320C
for 2h and pulse-labeled with [35S]-methionine for 5 min. The label was chased
for the times indicated. CPY was immunoprecipitated from extracts, resolved by
SDS-PAGE, and imaged on a phosphorimager.
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Figure 3. The N-terminal and transmembrane domains of SED4 are necessary
and sufficient for suppression of secl6-2. The indicated 2p plasmids were
transformed into CKY50 (secl6-2), CKY251 (sed4-A 1), CKY39 (sec12-4) and
RSY656 (SEC12/secl12A). Growth of single colonies assayed on selective
medium at 330C (secl6-2, secl2-4) or on rich medium at 410C (sed4-A1) is
shown. +++ indicates growth comparable to wild type, - indicates no growth.
Complementation/suppression of secl2-4 and secl6-2 strains was also tested at
300 and 360C with similar results. Suppression of sec12A was assayed by
sporulating heterozygous secl2A diploids carrying test plasmids, dissecting 10
to 20 tetrads and scoring Leu+ (sec12A) spores. +++ indicates that Leu+ spores
were readily obtained, - indicates that no Leu+ spores were obtained.
127
i
-c
vv
I I I I I
.2
.o g
0i a
E
E
0
0a..COI-
+ +I 
+ +
coC%- I- i .-" k krr r
.0 v v Lw N N wZ z mz
0.0.00.0.0
+ + +I 
+ + +
+ +
+ +
+ +
+ +
+ +
+ +
I I
I I
-r
m =
M r0
r• r
Figure 4. A. Immunodetection of Sed4p-HA and comparison of the protein
levels of Sed4p-HA and Secl2-Sed4p-HA fusion proteins. The SEC12-SED4
fusion construct is described in Figure 3. Wild type cells (CKY10) carrying the
indicated plasmids (pRH121, pRH120, pRH148, pRH141 and pRH46; lanes 1-5,
respectively) were grown in selective medium. Extracts of 0.2 OD600 units of
cells were resolved by SDS-PAGE on 6% gels and HA-tagged proteins were
detected by Western blotting. B. Sed4p-HA is an O-glycosylated protein.
Sed4p-HA was immunoprecipitated from extracts from either wild type (CKY10)
(lanes 1, 2 and 5) or dpm 1-6 (PRY303) (lanes 3 and 4) strains carrying SED4-HA
on a 2g plasmid (pRH120). Cells were grown in minimal medium, shifted to the
indicated temperatures for 15 min, and radiolabeled with [35S]-methionine for 15
min. Tunicamycin was added to 10 pg/ml 5 min before labeling (lane 5). HA-
tagged proteins were immunoprecipitated from extracts from 1 OD600 unit of
cells and labeled proteins were visualized by fluorography after SDS-PAGE on a
6% gel.
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Figure 5. Sed4p-HA is located in the ER. Indirect immunofluorescence of a wild
type diploid strain (CKY8 x CKY10) carrying SED4-HA on a 2l plasmid
(pRH120). Fixed cells were incubated with both anti-HA and anti-BiP antibodies.
The anti-HA antibody was visualized with rhodamine-coupled secondary antibody
(top panel), the anti-BiP antibody was visualized with FITC-coupled secondary
antibody (bottom panel).
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Figure 6. Sed4p-HA is not incorporated into ER-derived vesicles. Vesicles were
produced in vitro using ER membranes from a sed4-A 1 strain containing SED4-
HA on a low-copy plasmid (CKY295) (see Materials and Methods). The amount
of Sed4p-HA or Sec22p in the starting membranes or the vesicle-containing high
speed pellet (HSP) was determined by Western blotting and quantitated by
densitometry. The ratio of protein in the HSP to protein in the starting
membranes is expressed as % release.
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Figure 7. The N-terminal domain of Sed4p and the C-terminal domain of
Secl6p bind in extracts. The C-terminal domain of Secl6p fused to GST
(pPE122, lanes 1 and 2) or GST only (pRD56, lanes 3 and 4) were expressed in
yeast strain CKY289 together with either myc-tagged N-terminal domain of
Sed4p (pRH260, upper row) or myc-tagged N-terminal domain of Secl2p
(pRH261, lower row). Tagged proteins were detected by Western blotting after
SDS-PAGE on a 8% gel. Lanes 1 and 3: Total extracts from 0.05 OD600 units
of cells. Lanes 2 and 4: Material bound to glutathione beads from 0.4 OD600
units of cells.
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Figure 8. Deletion of SED4 slows transport of CPY from the ER to the Golgi. A.
Pulse-chase analysis of CPY in a sed4-A 1 strain (CKY251, lanes 1-6) or a wild
type strain (CKY252, lanes 7-12). Cells grown at 380C were pulse-labeled with
[35S]-methionine for 5 min. The label was chased for the times indicated. The
different forms of CPY were immunoprecipitated from extracts and visualized on
a phosphorimager after SDS-PAGE. B. Determination of kinetic parameters.
The amount of radiolabeled pl CPY and total CPY was quantitated for each time-
point using the phosphorimager software. The ratio pl CPY/total CPY gives the
half-life of pl from a linear curve-fit on a semilogarithmic plot using Cricket graph
(v. 1.0). The half-life of pl in a sed4-A 1 strain is 1.6-fold greater than wild type in
the experiment shown. Similar results were obtained in four independent
experiments.
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Figure 9. Deletion of SED4 in combination with a mutation in SAR1 causes a
temperature-sensitive growth and secretion defect. A. Wild-type (CKY291),
sed4-A 1 (CKY292), sarl-5 sed4-A 1 (CKY293) and sarl-5 (CKY294) cells were
spotted on rich medium and incubated for 40h at 240C or 380C. B. CPY
transport in the strains shown in A. Cells were grown in YPD at 300C, shifted to
380C for 2h and pulse-labeled with [35S] methionine for 5 min. The label was
chased for the times indicated and the different forms of CPY were
immunoprecipitated from extracts, resolved by SDS-PAGE, and imaged on a
phosphorimager.
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Figure 10. A sed4-A 1 sarl-5 double mutant accumulates ER membranes, but
not vesicles. Electron micrograph of sed4-A 1 sarl-5 (CKY293) grown at 25 0C
and shifted to 380C for 2h. Membranes were stained with potassium
permanganate. Arrows indicate excess ER. The bar represents 1 ltm.
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Figure 11. Proposed protein interactions early in vesicle formation. Interaction of
Sarl p with Secl 6p, Sec23p and Sed4p (1) is interrupted by sarl-5. Interaction
of Sarilp with Secl2p (2) is not affected by sarl-5. Interaction of Secl6p with
Sed4p and Sec23p is based on genetic interactions and binding studies.
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Table I. S. cerevisiae Strains
Strain Genotype Source or Reference
CKY8
CKY10
CKY93
CKY289
CKY249
CKY250
CKY251
CKY252
CKY255
CKY258
CKY291
CKY292
CKY293
CKY294
CKY295
CKY296
CKY39
CKY45
CKY50
CKY52
CKY54
CKY58
CKY62
CKY64
CKY69
CKY70
CKY78
CKY105
CKY23O
NY768
NY770
NY772
NY774
NY776
NY778
NY780
NY782
NY784
NY786
AFY72
ANY123
ANY125
RSY533
RSY53O
RSY153
CKY234
RSY656
EGY40
PRY3O3
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
MATa ura3-52 leu2-3,112
MA Ta ura3-52 leu2-3,112
MA Ta ura3-52 leu2 pep4::URA3
MATa ura3-52 leu2 his3A200 trp 1A63 lys2-801 Gal +
MATa/Mata SED4/sed4-A 1::URA3 ura3-52/ura3-52
leu2-3,112/leu2-3,112
MATa/Mata SED4/sed4-A 1 ura3-52/ura3-52
leu2-3,112/leu2-3,112
MATa sed4-A1 ura3-52 leu2-3,112
MATa ura3-52 leu2-3,112
MATa sed4-A 1::URA3 ura3-52 leu2-3,112
MA Ta sed4-A I1::URA3 ura3-52 leu2-3,112
MA Ta ura3-52 leu2-3,112
MA Ta sed4-A 1::URA3 ura3-52 leu2-3,112
MATa sed4-A1::URA3 sarl-5 ura3-52 leu2-3,112
MATa sari-5 ura3-52 leu2-3,112
MATa sed4-A 1 ura3-52 leu2-3,112 pep4::LEU2 (pRH121)
MATd sed4-A1 SAR1::URA3 ura3-52 leu2-3,112
MATa secl2-4 ura3-52 his4-619
MA Ta secl3-1 ura3-52 his4-619
MATa sec16-2 ura3-52 his4-619
MATa secl6-1 ura3-52 leu2-3,112
MATa sec17-1 ura3-52 his4-619
MATa sec18-1 ura3-52 his4-619
MATa secl9-1 ura3-52 his4-619
MATa sec20-1 ura3-52 his4-619
MATa sec21-1 ura3-52 his4-619
MA Ta sec22-3 ura3-52 his4-619
MA Ta sec23-1 ura3-52 leu2-3,112
MATa sec16-3 ura3-52 leu2-3,112
MATa sec16-4 ura3-52 leu2-3,112 ade2 ade3 sec13-1
(pCEN-ADE3-SEC13)
MA Ta sec 1-1 ura3-52 leu2-3,112
MATa sec2-41 ura3-52 leu2-3,112
MA Ta sec3-52 ura3-52 leu2-3,112
MA Ta sec4-8 ura3-52 leu2-3,112
MATa sec5-24 ura3-52 leu2-3,112
MA Ta sec6-4 ura3-52 leu2-3,112
MATa sec8-9 ura3-52 leu2-3,112
MA Ta sec9-4 ura3-52 leu2-3,112
MA Ta seclO-2 ura3-52 leu2-3,112
MATa sec15-1 ura3-52 leu2-3,112
MA Ta sec7-1 ura3-1 his3-11 trp -1
MATa bet1-1 ura3-52 his4-619
MA Ta bet2-1 ura3-52 his4-619
MATa sec61-2 ura3-52 leu2-3,112 ade2 pep4-3
MA Ta sec62 ura3-52 leu2-3,112
MATa sec63-1 ura3-52 leu2-3,112
MATa secl6::TRP1 lys2-801 ade2-101 trpl-A63
his3-.200 ura3-52 leu2-42 (pPE5)
MATa/Mata SEC12/sec12A::LEU2 ura3-1/ura3-1
leu2-3/leu2-3 trp1-1/trp1-1 ade2-1/ade2-1
his3-11/his3-11 can 1-100/can 1-100
MATa ura3-52 leu2 his3 trp l
MATa dpm 1::LEU2 leu2-3,112 lys2-801 trplA I ura3-52
(pdpml-6)
Golemis and Brent, 1992
Orlean, 1990
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
P. Novick (Yale University)
R. Schekman (U.C. Berkeley)
S. Ferro-Novick (Yale University)
S. Ferro-Novick (Yale University)
R. Schekman (U.C. Berkeley)
R. Schekman (U.C. Berkeley)
R. Schekman (U.C. Berkeley)
Espenshade et al., 1995
d'Enfert et al., 1991a
Table II. Plasmids
Source or Reference
pRS306
pRS316
pRS313
pRS315
pRS306-21
pRS305-211
pRH46
pRH 107
pPE87
pRH120
pRH121
pRH47
pRH54
pRH78
pRH128
pRH62
pRH141
pRH148
pRH50
pRH213
pPE5
pPE8
pKR1
pCK1313
YCP1142
pRH259
pRH262
pRH279
pRH280
pEG202
pJG4-5
pSH18-34
pPE58
pPE59
pPE74
pRH151
pRH 152
pRH260
pRH261
pRD56
pPE122
integrating vector marked with URA3
centromere vector marked with URA3
centromere vector marked with HIS3
centromere vector marked with LEU2
2g. vector marked with URA3 (pRS306 derivative)
2g vector marked with LEU2 (pRS305 derivative)
SED4 in pRS306-211
SED4 in pRS316
SED4 in pRS305-21
SED4-HA in pRS306-2pg
SED4-HA in pRS316
SED4 (1-841) in pRS306-211
SED4 (1-369) in pRS306-211
SED4 (1-343) in pRS306-211
SED4 (1-294/331-1061) in pRS 306 -2g
SEC 12 (1-374) fused to SED4 (368-1065) in pRS306-2p.
SEC12 (1-374) fused to SED4-HA (368-1065) in pRS306-2A
SEC12 (1-374) fused to SED4-HA (368-1065) in pRS316
SEC12 in pRS306-2j
SEC12 in pRS316
SEC16 in YCp50O
SEC16 in pRS315
SEC13 in pRS316
SEC13 in YEp352
SEC23 in YCp50
SARI in pRS316
sarl-5 in pRS316
sarl-5 in pRS306-211
SAR1 in pRS306-2pg
lexA DNA binding domain in a 2g. vector marked with HIS3
acidic activation domain in a 2p. vector marked with TRP1I
lacz gene under control of 8 lexA DNA binding sites in a
2g vector marked with URA3
SEC16 (1645-2194) in pEG202
SEC16 (1-824) in pEG202
SEC16 (447-1737) in pEG202
SED4 (1-347) in pJG4-5
SEC12(1-354) in pJG4-5
GAL 10 promoted SED4-MYC(1-347) in pRS313
GAL 10 promoted SEC12-MYC (1-354) in pRS313
GAL 1 promoted GSTin pRS316
GAL 1 promoted GST-SEC16 (1638-2194) in pRS316
Note: The numbers in parenthesis indicate the amino acid numbers of the preceeding gene's product
Plasmid Description
Sikorski and Hieter, 1989
Sikorski and Hieter, 1989
Sikorski and Hieter, 1989
Sikorski and Hieter, 1989
Miller and Fink, unpublished
Miller and Fink, unpublished
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Espenshade et al., 1995
Espenshade et al., 1995
Roberg and Kaiser, unpublished
Pryer et al., 1993
Hicke and Schekman,1989
This study
This study
This study
This study
Gyuris et al., 1993
Gyuris et al., 1993
Gyuris et al., 1993
Espenshade et al., 1995
Espenshade et al., 1995
Espenshade et al., 1995
This study
This study
This study
This study
R. Deshaies
This study
Plas id
Table IIl. The N-terminal Domain of Sed4p and the C-terminal Domain
of Secl6p Interact in the Two-Hybrid Assay
lexA DNA-binding
domain
Activation domain
8-Gal (units)
SEC16C
SEC16N
SEC16CEN
no fusion
SED4N
681.6 ± 77.2
18.6 ± 0.9
18.2 ± 2.0
100.3 ± 4.5 146.3 ± 65.4
SEC12N
21.6 0.3
15.7 ± 2.8
17.2 ± 0.0
no fusion
18.9 ± 0.1
16.1 ± 2.1
22.5 ± 1.1
74.1 ± 7.2
Interactions were assayed for two independent transformants as
described in Materials and Methods. The values given are means ± SD.
Plasmids used were pPE58 (SEC16C), pPE59 (SEC16N), pPE74
(SEC16CEN), pRH151 (SED4N) and pRH152 (SEC12N).
Table IV. Deletion of SED4 Exacerbates the Growth Defect of
Mutants Defective in Vesicle Formation
Genotype Incubation Temperature
280 300 330
A.Vesicle formation:
sec 12-4 +++ + -
secl12-4 sed4-A1::URA3 + - -
sec13-1 +++ ++ -
sec13-1 sed4-A 1::URA3 + + -
sec16-2 +++ + -
sec 16-2 sed4-A1::URA3 + - -
sec23-1 +++ - -
sec23-1 sed4-A ::URA3 - - -
B. Vesicle fusion:
sec17-1 +++ +++ ±
sec17-1 sed4-A1::URA3 +++ +++ -
sec18-1 + - -
sec18-1 sed4-A1::URA3 + - -
Growth of single colonies on YPD after 24 to 48h. +++ is
growth comparable to wild-type, - is no growth.
Table V. Genetic Interactions of sari-5 with Vesicle
Formation Mutants
Incubation Temperature
240 270 300 330 380
+
+sari-5
(pSARi)
(psaril-5)
sec 13-1
sec13-1 sari-5
sec 16-2
seci6-2 sari-5
sec16-2 (pSARi)
seci6-2 (psaril-5)
sec23-1
sec23-1 sari-5
sec23-1 (pSARi)
sec23-1 (psari-5)
+++ +
+++
+++
Genotype
sec 12-4
sec 12-4
sec 12-4
sec 12-4
pSARi is pRH259 or pRH280. psarl-5 is pRH262 or
pRH279. Growth of single colonies on YPD after 24 to 48h.
+++ is growth comparable to wild-type, - is no growth.
Chapter 4
Isslp: a Sec24p Homolog that Binds Secl6p and Sec23p, and
Facilitates Docking of Endoplasmic Reticulum Derived Vesicles
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PREFACE
This chapter represents primarily my own work. Alison Frand isolated the
sec24-1 mutant and performed some of the genetic crosses presented in Table
III.
151
ABSTRACT
Secretory proteins are transported from the endoplasmic reticulum (ER) to
the Golgi apparatus in membrane-bounded vesicles that are surrounded by a
proteinaceous coat, termed COPII. Sec24p is one of six proteins that are
required for formation of COPII coated vesicles, and that are themselves
components of the COPII coat. Sec24p associates with two additional COPII
coat components, Sec23p and Secl6p, and a Sec23p/Sec24p/Secl6p complex
has been suggested to be an important intermediate during COPII coat
assembly. We identified a Sec24p homolog, Issip, in a screen for proteins that
bind to the central domain of Secl6p. Issip, like Sec24p, binds to Secl6p and to
Sec23p, as demonstrated by two-hybrid and coprecipitation assays. Issilp can
functionally substitute for Sec24p, since overexpression of ISS1 rescues the
growth and secretion defect of a temperature-sensitive sec24 mutant. However,
genetic interactions of ISS1 suggest, that Issilp acts to facilitate docking, rather
than formation, of COPII coated vesicles. iss1 deletion exacerbates mutations
defective in vesicle docking, but not those that affect formation of ER-derived
vesicles. Furthermore, ISS1 overexpression suppresses mutations in the vesicle
docking gene SEC22.
A temperature-sensitive sec24 mutant exacerbates mutants defective in
vesicle formation at the ER, consistent with the known role of Sec24p in this
process. In contrast to other mutants in COPII coat components, however, a
sec24 mutant also exacerbates mutants defective vesicle docking. We suggest
that Sec24p, in addition to its function in vesicle formation, facilitates docking of
ER-derived vesicles.
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INTRODUCTION
COPII coated vesicles transport secretory proteins from the endoplasmic
reticulum (ER) to the Golgi apparatus in both yeast and mammalian cells
(Barlowe et al., 1994, Schekman and Orci, 1996). Genetic and biochemical
studies in yeast identified six proteins that are required for the assembly of COPII
coated vesicles and are themselves components of the COPII coat (Novick et al.,
1981; Barlowe et al., 1994; Espemshade et al., 1995). Five of these proteins -
two heteromeric protein complexes, Sec23p/Sec24p and Secl 3p/Sec3l p, and
the small GTP-binding protein Sarl p - are present in the cytosol and are
recruited to the ER membrane during vesicle formation in vitro (Salama et al.,
1993; Barlowe et al., 1994). A sixth protein, Secl 6p, is tightly associated with ER
membranes and has been suggested to act as a scaffold onto which cytosolic
COPII coat components assemble (Espenshade et al., 1995; Gimeno et al., in
press). Assembly of the COPII coat is thought to be regulated by the small GTP-
binding protein Sarlp. In its GTP-bound form, Sarlp promotes COPII coat
formation, while GTP hydrolysis on Sarl p is required for coat disassembly
(Barlowe et al., 1994; Oka and Nakano, 1994).
Formation of COPII coated vesicles is coupled to sorting of cargo proteins.
One class of cargo proteins are integral ER membrane proteins that are required
for vesicle docking, such as Sec22p, Boslp and Betlp (Rexach et al., 1994;
Barlowe et al., 1994). Sec22p and Boslp form a docking complex with proteins
at the acceptor membrane; formation of this complex is required for vesicle fusion
to proceed (Rothman, 1994). A small GTP-binding protein, Yptlp, activates
Sec22p and Bosl p, and is required for formation of the docking complex (Lian et
al., 1994; Soogard et al., 1994). Since vesicles formed in vitro in the presence of
a non-hydrolyzable GTP analog are blocked in docking prior to the requirement
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for Yptl p, it is thought that COPII coat disassembly precedes Sec22p/Bos1 p
activation and vesicle docking (Oka and Nakano, 1994).
The function of the COPII coat component Sec24p is still largely unclear.
Sec24p is a 105 kD protein that is present in the cytosol in a 300-400 kD complex
with Sec23p. Both Sec23p and Sec24p are required for vesicle formation in vitro
(Hicke et al., 1992), and a sec23 mutant has a vesicle formation defect in vivo
(Kaiser and Schekman, 1990). Furthermore, both Sec23p and Sec24p bind to
Secl 6p, and it has been suggested that a Sec23p/Sec24p/Secl 6p complex is an
intermediate in COPII vesicle formation (Gimeno et al., in press). Although
Sec23p has GAP activity with respect to Sarl p, Sec24p does not modulate this
activity of Sec23p (Yoshihisa et al., 1993).
We identified a Sec24p homolog, Issip, in a two-hybrid screen for proteins
that interact with the central domain of Secl 6p. Issilp is similar to Sec24p in
sequence, protein-protein interactions and some genetic interactions, suggesting
that Issip functions in a manner similar to Sec24p. Surprisingly, we found that
ISS1 and SEC24, but not other COPII coat component genes, have genetic
interactions indicative of a role in vesicle docking. We suggest that Sec24p and
its homolog, Issilp, function to ensure efficient docking of ER-derived transport
vesicles.
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MATERIALS AND METHODS
Strains, Media and General Techniques. Yeast media were prepared and
yeast genetic and molecular biological techniques were performed using
standard methods (Kaiser et al., 1994) All experiments on plasmid-bearing
strains were performed on at least two independent transformants. DNA
manipulations were carried out using standard methods (Sambrook et al., 1989).
DNA sequencing was performed using the Sequenase kit (USB, Cleveland, OH).
For PCR, Vent polymerase was used (New England Biolabs, Beverly, MA).
Western blotting was performed as described (Gimeno et al., 1995) using the
following antibodies: anti-invertase (1/1,000), anti-CPY (1/1,000), anti-Sec23p
(1/500; kindly provided by L. Hicke) and HRP-coupled sheep anti rabbit Ig
(1/10,000; Amersham Corp., Arlington Heights, IL). DNA sequence comparisons
were performed using the BestFit program (Genetics Computer Group).
Isolation and Two-Hybrid Analysis of ISS1. ISS1 was isolated in a two-hyrid
screen for proteins that bind to the central domain of Secl6p. The screen was
performed using EGY48 carrying the plasmid pSH18-34 as an indicator strain
(Golemis et al., 1994). In this strain, positive interactions can be detected as
growth on medium lacking leucine - reflecting expression of a LEU2 reporter
gene in EGY48 - and by measuring the expression of 3-galactosidase from the
reporter plasmid pSH18-34. A plasmid containing the central domain of Secl6p
(amino acids 447-1235) fused to the lexA DNA binding domain (pPE62) was
used as a bait (Gimeno et al., in press), and a S. cerevisiae genomic library fused
to an acidic activation domain in the vector pJG4-5 was used as a fish (Watt et
al., 1995). -2 x 105 transformants were replica-plated onto SC medium lacking
leucine and supplemented with 2% galactose. Colonies able to grow were tested
for expression of f3-galactosidase by patching on SC medium (pH 7.0) lacking the
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appropriate amino acids and supplemented with 2% galactose and 40 mg/I X-gal.
Library plasmids were recovered from Leu+, blue colonies. Two sets of
plasmids, representing two distinct genes were isolated. These genes were
named ISS1 and ISS2 (Interacting with Sec sixteen 1 and 2). DNA sequencing
of the fusion junction and comparison to the database showed that the library
clone of ISS1 (pRH231) contained amino acids 597-875 of Issi p fused to the
acidic activation domain.
Two full-length clones of ISS1 (pRH194 and pRH195) were isolated from a
library of yeast genomic DNA in pCT3 (Thompson et al., 1993) by hybridization
using the 1 kb EcoRI fragment of pRH231 as a probe. A subclone containing the
entire ISS1 reading frame flanked by 2.5 kb and 2 kb genomic DNA at the 5' and
3' end (pRH200), was made by cutting pRH194 with Xbal and ligating to itself.
To express ISS1 on a multicopy vector, the 8 kb BamHI-Clal fragment of pRH195
was cloned into pRS306-2p1, creating pRH210. pRH210 was then cut with Sacl
and ligated to itself, creating pRH310. pRH310 contains the entire ISS1 reading
frame flanked by 2.5 kb and 1 kb genomic DNA.
The protein-protein interactions of Issilp were tested in vivo using the two-
hybrid system. Plasmids were constructed as follows: To make a fusion of the
entire ISS1 sequence to the lexA DNA-binding domain (pRH266), the N-terminus
of ISS1 was amplified by PCR and ligated into pCD43, a pRS316 derivative. The
C-terminus of ISS1 was then added by inserting the 2.8 kb BgAIl fragment of
pRH200 into the resulting construct, creating pRH256. pRH266 was made by
inserting the 3 kb BamHII-Notl fragment of pRH256 into pEG202. The N-terminal
ISS1 fusion to lexA (pRH319) contains the 1.9 kb EcoRI fragment of pRH266
ligated into pEG202. The fusion of the C-terminal region of ISS1 to lexA
(pRH249) was made by inserting the 1.2 kb EcoRI fragment of pRH321 into
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pEG202-AAT, a derivative of pEG202 that has a different reading frame in the
polylinker.
All interactions were assayed in EGY40 carrying the indicator plasmid
pSH18-34. To measure interactions between Issilp and Secl6p, indicator cells
were grown to exponential phase in selective medium containing 2% glucose. To
measure interactions between Sec23p and Secl 6p or Issl p, cells were grown to
exponential phase in selective medium containing 2% raffinose, then galactose
was added to 2% and growth was continued for an additional 3 h. 10-
galactosidase activity assays were performed as described (Kaiser et al., 1994).
Units of P-galactosidase are expressed as: [OD420 x vol. of assay] / [0.0045 x
protein concentration in extract x vol. of extract assayed x time].
Coprecipitation of GST-fusion Proteins from Yeast Extracts. ISS1 (aal-875;
pRH303) was fused to GST by inserting the 3 kb BamHI-Xhol fragment of
pRH266 into pPE128, a derivative of pRD56 that has a different reading frame in
the polylinker. To produce a soluble and detectable central domain of Secl6p
(pRH317), invertase was fused to amino acids 565-1235 of Secl6p, and the
fusion protein was expressed from the GAL 1 promoter. To facilitate detection of
Sec23p, SEC23 was expressed from the GAL 1 promoter (pPE123).
Coprecipitation experiments were performed in CKY473 as described
(Gimeno et al., in press).
Construction of an issi Deletion Allele. A chromosomal deletion iss1-A1::TRP
that replaced amino acids 116-622 of ISS1 with the TRP1 marker was made
using a one-step gene disruption technique (Rothstein, 1991). The disruption
plasmid (pRH247) was constructed as follows. A Spel fragment of pRH200 was
cloned into pRS306 creating pRH217. After deleting the EcoRI site from the
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polylinker, the 1.5 kb BgAI-EcoRI fragment of pRH217 was replaced with a 1 kb
fragment containing the TRP1 marker, creating pRH247.
A trpl diploid, CKY19, was transformed with the 2.3 kb Spel fragment of
pRH347, yielding CKY498. Tetrad analysis of CKY498 gave 2:2 segregation of
TRP1. Integration of TRP1 at the ISS1 locus was confirmed by Southern blotting
(ECL kit, Amersham).
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RESULTS
Issilp is Homologous to Sec24p.
To identify proteins that bind to the central domain of Secl6p (amino acids
447-1235), we screened a library of S. cerevisiae genomic DNA fused to an
acidic activation domain for plasmids that confer interaction with the central
domain of Secl6p fused to the lexA DNA binding domain. Positive interactions
bring together the lexA DNA binding domain and the acidic activation domain to
drive transcription of LEU2 and lacZ reporter genes, and were detected by their
ability to confer growth on medium lacking leucine and blue color on medium
containing X-GAL. Two sets of plasmids interacted strongly with the central
domain of Secl6p; the corresponding genes were named ISS1 and ISS2
(Interacting with Sec Sixteen 1 and 2). DNA sequencing and database
comparison showed that ISS1 encodes a 99 kD protein with strong similarity to
the COPII coat component Sec24p (Fig. 1 A), while ISS2 encodes a novel
protein. ISS2 will be described elsewhere.
The protein sequence of Issl p is 62% identical to Sec24p (Fig. 1 A). This
sequence similarity extends throughout the length of the protein, and defines two
variable regions in the N-terminal part of the proteins, a glutamine-rich domain
(amino acids 17-143 in Sec24p, 17-67 in Issip) and a charged domain (amino
acids 362-372 in Sec24p, 295-327 in Issi p). We noticed that both Iss1p and
Sec24p contain a putative Zn-binding motif (CX2C-CX2C) near their N-terminal
domains (Fig. 1 A, bold amino acids; Fig. 1B). Similar Zn-binding motifs have
been found in several proteins that direct secretory pathway function, such as a
GTPase activating protein for ARF1 (ARF-GAP), and in two genes required for
transport of proteins to the vacuole, Vpsl lp and Vps18p; these Zn-binding
motifs are important for the function of at least ARF-GAP and Vpsl8p (Robinson
et al., 1991, Cukierman et al., 1995). Interestingly, Vpsl p and Vpsl8p, two
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proteins that are likely to function at a common step in the secretory pathway,
share sequence homology in the region of the Zn-binding motif (Robinson et al.,
1991). Database searches with the putative Zn-binding domain of Sec24p
showed that Sec23p contains a homologous Zn-binding motif in its N-terminal
domain (Fig. 1 B), suggesting that Sec24p and Sec23p belong to a group of
proteins that are functionally related and share a homologous Zn-binding motif. It
will be interesting to determine whether the Zn-binding motif is important for the
function of Sec23p and/or Sec24p, and if so, what effects it has on the protein-
protein interactions of Sec23p and Sec24p. Our database search also identified
a novel protein, YHRO98c, that shares homology with Sec24p in the Zn-binding
domain (Fig. 1 B), but also shows weak sequence similarity with Sec24p
throughout the length of the protein (21%). YHRO98c is likely a more distant
Sec24p homolog.
Issl p Binds to the Central Domain of Secl 6p and to Sec23p.
The strong sequence similarity between Issi p and Sec24p suggested that
Issip, like Sec24p, may bind Sec23p and the central domain of Secl6p. Indeed,
full-length Issip interacted with both the central domain of Secl6p (amino acids
565-1235) and with Sec23p in the two-hybrid assay (Fig. 2 A). We had
previously demonstrated that Sec23p and Secl 6p bind to distinct domains on
Sec24p: the central domain of Secl6p binds to both the N-terminal and the C-
terminal domain of Sec24p, while Sec23p binds to the N-terminal domain of
Sec24p only (Gimeno et al., in press). To determine whether Issip interacted
with Secl 6p and Sec23p in a similar manner, we constructed fusions
corresponding to the N-terminal and C-terminal portions of Issilp. The C-terminal
domain of Issip interacted with the central domain of Secl6p only, while the N-
terminal domain of Issilp interacted only with Sec23p (Fig. 2 A). Since the
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interaction between the N-terminal Issi p fusion and Sec23p is weak, it is
possible that this fusion protein is partially inactive, possibly explaining the lack of
an interaction between the Issl N-terminus and the central domain of Secl6p.
However, it is clear that Issilp, like Sec24p, has distinct binding sites for Sec23p
and the central domain of Secl6p.
We also used the two-hybrid system to examine the part of Secl6p with
which the C-terminus of Issip interacts. The C-terminus of Issip (amino acids
622-875) fused to an acidic activation domain was tested for interactions with
three Secl 6p fragments fused to the lexA DNA-binding domain (Fig. 1B). Like
the C-terminal domain of Sec24p (Gimeno et al., in press), the C-terminal domain
of Issl p interacted only with the central domain of Secl 6p (Fig. 1 B). Thus, Issi p
is also similar to Sec24p in its interaction with Secl 6p.
To confirm the interactions between Issl p and Sec23p/Secl 6p, we tested
the ability of these proteins to associate in yeast extracts. Issi p was fused to
glutathione-S-transferase (GST) and expressed in yeast from the GAL 1
promoter. The central domain of Secl6p (amino acids 565-1235) fused to
invertase or full-length Sec23p were similarly expressed from the GAL1
promoter. GST-fusion and associated proteins were purified by affinity to
glutathione beads from extracts prepared from yeast strains coexpressing either
GST-Issl p or GST alone and either the Secl 6p-invertase fusion protein or
Sec23p. GST-Isslp associated with both the central domain of Secl6p (Fig. 3,
top panel, lanes 1 and 2) and with Sec23p (Fig. 3, bottom panel, lanes 1 and 2).
No binding was detected for a control that used GST only (Fig. 3, lanes 3 and 4).
These results confirm that Issilp, like Sec24p, can form a complex with Sec23p
and with the central domain of Secl6p.
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Deletion of issl Exacerbates Vesicle Docking Mutants.
Since Issilp is similar to Sec24p in both sequence and protein-protein
interactions, we were interested in whether Issilp functions in ER to Golgi
transport. A null allele of ISS1 (issl-A1::TRP1) was constructed by replacing
amino acids 166-622 with the TRP1 marker (see Materials and Methods).
Strains deleted for issI grew as well as wild-type strains at temperatures
between 250 and 380C, and had no obvious secretion defects (data not shown).
In particular, issl-A1::TRP1 strains did not accumulate intermediate forms of
CPY or invertase as judged by Western Blotting, and showed wild-type kinetics of
CPY maturation in pulse-chase experiments at 300C (data not shown).
Furthermore, issl deletion strains did not secrete resident ER proteins, such as
Kar2p, or the soluble vacuolar protein CPY, suggesting that Issip is not required
for retrograde transport from the Golgi apparatus to the ER.
To determine whether Issi p functions in the secretory pathway and, if so,
at which step, we examined synthetic lethal interactions between iss1-A1::TRP1
and a panel of secretion mutants (Table III). Synthetic lethal interactions have
been used extensively to define the step in the secretory pathway where a gene
product acts, and so far have only been observed between genes that affect the
same stap of the secretory pathway (Salminen and Novick, 1987; Newman et al.,
1987; Rothblatt et al., 1989; Kaiser and Schekman, 1990; Gimeno et al., 1995).
Surprisingly, issl-A1::TRP1 did not affect mutants defective in vesicle formation
(sec12-4, secl3-1, sec16-2, sec23-1) or vesicle fusion (sec17-1, sec18-1), but
showed strong synthetic lethal interactions with mutants defective in docking of
ER-derived vesicles (sec22-3, beti-1; Table ll). These data argue that Issip
does not function during formation of vesicles at the ER, but is required for
efficient docking of ER-derived vesicles with the Golgi apparatus.
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Overexpression of ISS1 Suppresses Mutations in the Vesicle Docking Gene
SEC22.
We also examined the effects of ISS1 overexpression on temperature-
sensitive mutants in a panel of secretion genes. ISS1 on a low or high copy
plasmid was transformed into the sec and bet mutants listed in Table I and tested
for growth at 30, 33, 36 and 380C. ISS1 overexpression suppressed the growth
defect of both sec22 alleles tested (Fig. 4 and data not shown), but had no effect
on the growth of any of the other mutants, with the exception of sec24-1 (see
below). The ability of ISS1 overexpression to suppress sec22 is consistent with
its genetic interactions with vesicle docking mutants, and strongly argues for a
role for Issi p in vesicle docking.
Overexpression of ISS1 Suppresses a Temperature-sensitive sec24 Mutant.
Since Issi p is similar to Sec24p in both sequence and protein-protein
interactions, we examine whether Issilp could substitute for Sec24p during ER to
Golgi transport. A temperature-sensitive allele of SEC24, sec24-1, was isolated
from a collection of random Ts mutants by screening for mutants that accumulate
the ER froms of invertase and carboxypeptidase Y (CPY) at the non-permissive
temperature (E. Chitouras and C. Kaiser, unpublished; Gimeno et al., in press).
The sec24-1 mutant is unable to grow at temperatures above 270C and
accumulates the ER (pl) form of the secretory marker protein CPY at
temperatures of 300C or higher (Fig. 5 A and B). Expression of ISS1 from a high
copy (2g) plasmid allowed growth of sec24-1 at temperatures up to 360C (Fig. 5
A), and considerably decreased the amount of pl CPY accumulated at 300C (Fig.
5 B, lanes 4-6). These data indicate that Issl p can indeed functionally substitute
for Sec24p.
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A Temperature-sensitive sec24 Mutant Exacerbates Vesicle Docking
Mutants.
The genetic interactions of ISS1 with vesicle docking genes prompted us
to examine the synthetic lethal interactions of sec24-1 in more detail. Since
Sec24p is required for COPII vesicle formation in vitro (Hicke et al., 1992), we
expected to find strong synthetic lethal interactions between sec24 mutants and
other vesicle formation mutants (sec12-4, secl3-1, sec16-2, sec23-1). This was
indeed the case (Table III). In addition, however, we found strong synthetic lethal
interactions between sec24-1 and mutants defective in vesicle docking (sec22-3,
bet1-1) and mutants defective in vesicle fusion (secl7-1, sec18-1) (Table III).
Interactions with docking or fusion mutants were not observed for sec12, sec13,
secl6 or sec23 mutants (Kaiser and Schekman, 1990), suggesting that Sec24p
performs a unique role among vesicle formation genes. We propose that
Sec24p, like Issi p, participates in docking of ER-derived vesicles with the Golgi
apparatus.
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DISCUSSION
In this paper, we describe a Sec24p homolog, Issilp, that is similar to
Sec24p in many respects: First, Issilp has a high degree of sequence identity
with Sec24p. Second, Issilp physically interacts with two Sec24p binding
proteins, Sec23p and Secl6p, and these interactions likely occur through similar
domains of Issilp. Finally, Issi p has functional overlap with Sec24p, as
evidenced by the observation that mutants in both genes show synthetic lethal
interactions with vesicle docking mutants, and by the ability of ISS1 to suppress a
sec24 mutant.
Given these similarities between Issilp and Sec24p, it was surprising that
Issilp did not share the genetic interactions of a sec24 mutant with mutants
defective in vesicle formation, suggesting that the function of Issip is not required
during vesicle formation. The functional differences between Issilp and Sec24p
may be due to subtle differences in the strength of the interactions with Sec23p
and Secl6p, or they may reflect as yet unidentified properties, such as binding to
an additional protein. However, since ISS1 overexpression suppresses a sec24
mutant that is at least partly defective in vesicle formation, it is likely that Issi p
can function during vesicle formation upon overexpression. It will be interesting
to determine whether Issi p can functionally substitute for Sec24p in the in vitro
vesicle formation assay, and whether Issl p is incorporated into vesicles like
Sec24p.
Perhaps the most striking finding in this paper is that Issilp and its
homolog, the COPII coat component Sec24p, are important for docking of ER-
derived vesicles with the Golgi apparatus. Evidence for this function comes from
two observations. First, loss of function mutants in iss 1 and sec24 exacerbate
the growth defect of mutants defective in vesicle docking. Second,
overexpression of ISS1 suppresses the vesicle docking mutant sec22. The
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genetic interactions of sec24 mutants with vesicle docking mutants were
particularly surprising, since none of the other mutants in COPII components
shows interactions with vesicle docking mutants (Kaiser and Schekman, 1990).
Three mechanisms can be imagined by which Sec24p and Issilp could
affect vesicle docking. First, Sec24p and Issilp may be required for loading of
docking factors, such as Sec22p, Bosi p and, possibly, Bet1 p, into vesicles
during vesicle formation. Components of clathrin and coatomer coated vesicles
have been identified that load cargo proteins into vesicles by binding to their
cytosolic domains (Ohno et al., 1995; Cosson and Letourneur, 1994). It is
conceivable that Sec24p and Issilp similarly direct incorporation of docking
factors into COPII coated vesicles by binding to their cytosolic domains. So far,
attempts to coprecipitate Sec22p with either Sec24p or Issilp have been
unsuccessful (R. E. Gimeno, unpublished). A second possibility is that Sec24p
and Issilp participate in the formation of retrograde transport vesicles that recycle
integral membrane docking factors to the ER. If formation of these vesicles is
blocked, Sec22p and other docking factors will be depleted from the ER,
ultimately causing a defect in vesicle docking. Interestingly, mutants in coatomer
components that block recycling (sec21, sec26, sec27) have multiple genetic
interactions with docking mutants similar to issl and sec24 mutants (Newman
and Ferro-Novick, 1987; Duden et al., 1994). If Issilp and Sec24p indeed
participate in retrograde transport, it would be expected that mutants in these
proteins cause missorting of recycled cargo proteins. So far, however, we have
been unable to detect a sorting defect in issl mutants. In particular, deletion of
issl does not cause missorting of Kar2p, an ER protein that undergoes recycling,
and does not affect the recycling of a KKXX-containing fusion protein (our
unpublished data). Finally, a role for Sec24p and Issilp in vesicle docking could
reflect a requirement for these proteins in disassembly of the COPII coat,
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possibly stimulating GTP hydrolysis on Sarip. This possibility is particularly
intriguing, since both Sec24p and Issi p bind to Sec23p, a protein that activates
GTP hydrolysis by Sarilp. While Sec24p by itself does not affect the GAP activity
of Sec23p, proteins that bind to Sec24p, such as Secl 6p, may modulate its
ability to increase the GAP activity of Sec23p. More detailed biochemical studies
will be required to determine the effects of Sec24p and Issip on cargo protein
loading and on the assembly and dissassembly of the COPII coat.
One other COPII coat component, Sarilp, has previously been implicated
in vesicle docking. GTP hydrolysis on Sarilp is required for disassembly of the
COPII coat after vesicle formation in vitro (Barlowe et al., 1994), and is also
necessary for docking and fusion of ER-derived vesicles with the Golgi apparatus
(Oka and Nakano, 1994). It might be expected that mutants in Sarlp that are
locked predominantly in the GTP-bound form have genetic interactions similar to
sec24 mutants. Although mutants in other COPII coat components, such as
sec 12, sec 13, sec 16, sec23 and sec31, do not show genetic interactions
indicative of a role in vesicle docking (Kaiser and Schekman, 1990; Frand and
Kaiser, unpublished), we cannot exclude the possibility that some of these
proteins function during vesicle docking; isolation of new alleles may be required
to reveal this additional function for COPII proteins in vivo.
The role of the COPII coat components in processes other than vesicle
formation is still only poorly understood. The isolation of a homolog of a COPII
coat component that is required for vesicle docking, but not vesicle formation,
may provide an important tool to analyze the role of coat components in vesicle
docking, and may shed light on the role of Sec24p in vesicle docking and fusion.
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Figure 1. (A) Comparison of the protein sequences of Issilp and Sec24p. Lines
indicate identical amino acids, dots indicate similar amino acids. Overall amino
acid identity is 62%. The putative Zn-binding motif is printed in bold. Amino acid
positions are indicated by the numbers to the right of each protein.
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Figure 1. (B) Comparison of the putative Zn-binding motif of Sec24p, Issi p,
Lstlp and Sec23p. Amino acids that are identical in three of the four sequences
are printed in bold; conserved cysteines are underlined. Amino acid positions are
indicated by the numbers to the left of each sequence. The overall percent
identity for the sequences shown is indicated to the right.
174
CC)
0
0
2: 0
CL
0
z
.-J
0I
U-
Z<C
crI0I
0licacCU
LL
a.0r
z
0
LI
UI
a)
0
0o w
co It C
Figure 2. Two-hybrid interactions between Secl 6p, Sec23p and Issi p. The
extent of each of the gene fragments of ISS1 and SEC16 are indicated by gene
diagrams and by the amino acids numbers included in each construct given in
brackets. Each interaction was evaluated by 13-galactosidase assays of two to
four independent transformants for which the mean activity is given (the standard
deviation was less than 20%).
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Figure 3. Affinity isolation of complexes between Issi p, Secl6p and Sec23p
from yeast extracts. Issi p fused to GST (lanes 1 and 2) or GST only (lanes 3
and 4) were coexpressed with either the central domain of Secl 6p fused to
invertase (pRH317, upper panel) or Sec23p (pPE123, lower panel). GST-fusion
and associated proteins were purified by affinity to glutathione-agarose. Proteins
were detected by Western blotting after SDS-PAGE on a 6% gel. T = total, B =
bound. Lanes 1 and 3:100,000 x g supernatant from 0.044 OD600 U of cells.
Lanes 2 and 4: material bound to beads from 0.73 OD600 U of cells.
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Figure 4. ISS1 overexpression suppresses the temperature-sensitivity of sec22-
3. A sec22-3 strain (CKY70) containing vector (pRS306-21) or ISS1 on a 24
plasmid (pRH310), and a wild-type strain (CKY8) containing vector (pRS306-2g)
were streaked for single colonies on selective medium and incubated at 300C for
40 h.
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Figure 5. ISS1 overexpression suppresses the temperature-sensitive growth and
secretion defect of sec24-1. (A) A sec24-1 strain (CKY496) containing vector
(pRS306-24, lane 1), ISS1 on a CEN or 21a plasmid (pRH200 and pRH310, lanes
2 and 3) or SEC24 on a CEN plasmid (pAF70, lane 4). Cells were spotted on
selective medium and incubated at the indicated temperatures for 40 h. (B) A
sec24-1 strain (CKY496) containing vector (pRS306-2p, lanes 1, 4, 7), ISS1 on a
2g plasmid (pRH310, lanes 2, 5, 8) or SEC24 on a CEN plasmid (pAF70, lanes 3,
6, 9) was grown in selective medium at 250C and shifted to the indicated
temperature for 1 h. Extracts of 0.2 OD600 U of cells were resolved by SDS-
PAGE on an 8% gel and CPY was detected by Western blotting.
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Table I. S. cerevisiae Strains
Strain Genotype Source or Reference
MA Ta ura3-52 leu2-3
MA Ta/MA Ta ura3-52/ura3-52 leu2-A1/leu2-A1
his3-A200/his3-A200 lys2-801/lys2/801 ade2-101/ade2-101
trp 1-A63/trp 1-A63
MATa ura3-52 leu2-3,112 Gal+
MATa sec24-1 ura3-52 leu2-3,112
MA Ta/MA Ta iss 1 -A 1::TRP1/ISS1 ura3-52/ura3-52
leu2-A 1/leu2-A I his3-A200/his3-A200 lys2-801/lys2/801
ade2-101/ade2-101 trp 1-A63/trp 1-A63
MA Ta issl-A 1::TRP1 ura3-52 leu2-A 1 his3-4200 lys2-801
ade2-101 trpl-A63
MATa issl-A1::TRP1 ura3-52 leu2-A I his3-A200 lys2-801
ade2-101 trp1-A63
MATa secl2-4 ura3-52 his4-619
MATa sec12-4 ura3-52
MATa secl3-1 ura3-52 his4-619
MATa sec 16-2 ura3-52
MATa sec17-1 ura3-52 his4-619
MATa secl8-1 ura3-52 his4-619
MATa sec18-1 ura3-52 his4-619
MATa sec22-3 ura3-52 his4-619
MATa sec22-3 ura3-52
MATa sec22-1 ura3
MA Ta sec23-1 ura3-52 leu2-3,112
MA Ta beti-1 ura3-52
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
This study
This study
This study
This study
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
Kaiser Lab Collection
CKY8
CKY19
CKY473
CKY496
CKY498
CKY499
CKY500
CKY39
CKY40
CKY46
CKY51
CKY55
CKY58
CKY59
CKY70
CKY71
CKY72
CKY78
CKY85
--~-
Table II. Plasmids
Plasmid Description Source or Reference
centromere vector marked with LEU2
centromere vector marked with URA3
2g vector marked with URA3
centromere vector marked with URA3
ISSi in pCT3
ISSI in pRS306-2p
SEC24 in pCT3
lexA DNA binding domain in a 2g vector marked with HIS3
lexA DNA binding domain in a 2g vector marked with HIS3
acidic activation domain in a 2g vector marked with TRP1
GAL4 activation domain in a CEN vector marked with LEU2
lacz gene under control of 8 lexA DNA binding sites in a
2g vector marked with URA3
ISS1 (1-875) in pEG202
ISS1 (1-622) in pEG202
ISS1 (622-875) in pEG202
SEC23in pGILDA
SEC16 (1645-2194) in pEG202
SEC16 (1-824) in pEG202
SEC16 (447-1235) in pEG202
SEC23 in pJG4-5
SEC16 (565-1235) in pGAD-GH
SEC24 (622-875) in pJG4-5
GALl promoted GSTin pRS316
GALl promoted GST-ISS1 (1-875) in pRS316
GAL 1 promoted SEC16 (565-1235)-SUC2 in pRS315
GAL1 promoted SEC23 in pRS315
Sikorski and Hieter, 1989
Sikorski and Hieter, 1989
Gimeno et al., 1995
Thompson et al., 1993
This study
This study
Gimeno et al., in press
Gyuris et al., 1993
Shaywitz and Kaiser, unpublished
Gyuris et al., 1993
Hannon et al., 1993
Gyuris et al., 1993
This study
This study
This study
Gimeno et al., in press
Espenshade et al., 1995
Espenshade et al., 1995
Gimeno et al., in press
Espenshade et al., 1995
Gimeno et al., in press
This study
Espenshade et al., 1995
This study
Gimeno et al., in press
Gimeno et al., in press
Note: The numbers in parenthesis indicate the amino acid numbers of the preceding gene's product
pRS315
pRS316
pRS306-2g
pCT3
pRH200
pRH310
pAF70
pEG202
pGILDA
pJG4-5
pGAD-GH
pSH18-34
pRH266
pRH319
pRH249
pDS79
pPE58
pPE59
pPE62
pPE81
pPE 167
pRH343
pRD56
pRH303
pRH317
pPE1_23
Table Ill. Genetic Interactions of issl and sec24 Mutants
Genotype Incubation Temperature
280 300 330
sec24-1 ++ - -
sec24-1 iss1-A1::TRP1 ++ - -
A. Vesicle docking:
sec22-3 + + + -
sec22-3 issl-A1::TRP1 double mutants not viable at 250C
sec22-3 sec24-1 double mutants not viable at 250C
betl-1 +++ +++ +++
bet1-1 issl-A 1::TRP1 +++ - -
betl-1 sec24-1 double mutants not viable at 250C
B. Vesicle fusion:
sec17-1 +++ ++ +
sec17-1 issl-A1i::TRP1 +++ ++ +
secl7-1 sec24-1 - - -
sec18-1 +++ - -
secl8-1 issl-AI::TRP1 +++ - -
sec18-1 sec24-1 double mutants not viable at 250C
C. Vesicle formation:
sec12-4
sec12-4 iss l-A1::TRP1
secl2-4 sec24-1
sec13-1
secl3-1 iss1-A1::TRP1
sec 13-1 sec24-1
sec16-2
sec 16-2 iss 1 -A1::TRP 1
sec16-2 sec24-1
sec23-1
sec23-1 issl-A1 ::TRP1
sec23-1 sec24-1
double mutants not viable at 2500+++ - -+++ "4 - -
++ + -
++ + -
double mutants not viable at 250C
dueun - -
++4 -- -
double mutants not viable at 250C
doubl + -m --
++-+4 -- --
double mutants not viable at 25°C
Growth of single colonies on YPD after 24 to 48h. +++, growth
comparable to wild-type; -, no growth.
Chapter 5
Prospectus
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This thesis focuses on the function of the COPII coat component Secl6p.
Chapter 2 demonstrates that Secl 6p interacts independently with two soluble
COPII coat components, Sec23p and Sec24p. The ability of Secl 6p to bind to
soluble COPII coat components suggests that Secl6p may act as a scaffold for
the assembly of cytosolic coat components. Chapter 3 describes Sed4p, an
integral ER membrane component that has properties expected of a regulator of
COPII coat assembly. Interestingly, Sed4p, like Sec23p, interacts with the C-
terminal domain of Secl6p. Since Sed4p, Sec23p and Secl6p have strong
genetic and/or biochemical interactions with Sarlp, a protein that is thought to
initiate COPII vesicle formation, we proposed that initiation of vesicle formation
occurs at the C-terminal domain of Secl6p (Chapter 2). Our model for COPII
vesicle formation suggests that Sarl p primes Secl 6p for binding of Sec23p;
Sec23p binding then allows assembly of Sec24p, which in turn recruits Secl3p
and Sec31 p.
This model for COPII coat assembly can be tested using tools developed
in the course of this thesis. In particular, it would be expected that binding of
Sec23p/Sec24p and Secl 3p/Sec31 p to Secl 6p is regulated by Sarl p. Using
pure Sec23p and Secl 6p as described in Chapter 2, bacterially expressed Sarl p
(Barlowe et al., 1993) and bacterially expressed Sed4p N-terminus (R. E.
Gimeno, unpublished), the effect of Sarilp on binding of Sed4p and Sec23p to
Secl6p can now be examined in vitro. Preliminary experiments suggest that
Sed4p and Sec23p bind to a similar site on Secl6p, as binding of Sed4p and
Sec23p is mutually exclusive (P. Espenshade, personal communication). This
finding is consistent with our proposal that Sed4p binds to Secl6p at the ER
membrane prior to or during vesicle formation, while binding of Sec23p to
Secl 6p represents the first step in assembly of the COPII coat. It will be
interesting to examine whether Sarlp can modulate the ratio of Sec23p to Sed4p
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bound to Secl6p. In chapter 3 we suggest that Secl2p and Sed4p perform
distinct functions. Secl2p does not associate with the C-terminal domain of
Secl 6p in coprecipitation experiments, and genetic tests show that Secl 2p and
Sed4p are functionally distinct. Using bacterially expressed Secl2p N-terminus
(P. Espenshade, unpublished), it will now be possible to examine whether
Secl2p is indeed unable to bind to the C-terminus of Secl6p in vitro. It will also
be important to test whether Secl 2p affects binding of Sec23p to Secl 6p.
The two-hybrid system has proven to be useful for identifying proteins that
bind to Secl6p. Conventional biochemical approaches to this problem were
difficult since Secl6p is a large, easily degraded molecule that is solubilized only
by treatment with agents that disrupt protein-protein interactions (0.5 M NaCI or
pH 11). Using a two-hybrid screen similar to the one described in chapter 4, D.
Shaywitz recently identified a third COPII coat component, Sec31p, as a Secl6p
binding molecule (D. Shaywitz, unpublished). Interestingly, Sec31 p binds to the
central domain of Secl6p at a site close to the Sec24p binding site and interacts
with Sec24p in both the two-hybrid assay and by coimmunoprecipitation (D.
Shaywitz and R. E. Gimeno, unpublished data). Thus, Sec24p could recruit the
Secl 3p/Sec31 p complex to the membrane both by binding directly to this
complex and by facilitating its binding to Secl6p. Once purified Sec31p is
available, it will be possible to test whether Sarl p or Sec23p facilitate the
interaction between Sec24p and Sec31 p and whether Sec24p facilitates the
binding of Sec31 p to Secl 6p.
The COPII coat in vivo is likely not a stable complex, but goes through
rounds of assembly and disassembly on the membrane. By identifying Secl6p
as a scaffold on which this assembly could occur, and by developing assays in
solution that allow the analysis of protein-protein interactions on Secl 6p, it may
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now be possible to reconstitute the subunit interaction steps that occur during
COPII coat assembly in vitro.
Chapter 4 describes a new Secl6p binding protein, the Sec24p homolog
Issl p. Surprisingly, both Sec24p and Issilp appear to function in docking of
COPII coated vesicles. As described in the discussion of Chapter 4, this function
of Sec24p and Issilp could reflect a role for Sec24p/lssl p in loading of docking
components into the vesicle or a requirement for these proteins during steps
preceding vesicle docking, such as uncoating. Both possibilities represent a
novel function for COPII coat components and can be easily explored further. In
particular, the importance of Issip in loading docking factors could be examined
in vitro by determining the ability of membranes and cytosol from an issi deletion
strain to incorporate the docking factor Sec22p or a soluble cargo protein, such
as radiolabeled ca-factor, into vesicles. Furthermore, since the stability of the
COPII coat has been tied to GTP-hydrolysis in Sarip (Oka and Nakano, 1994), it
would be interesting to examine the effects of Sec24p and Issi p on the GAP
activity of Sec23p in the presence or absence of Secl6p.
An important question in COPII coat formation is how cargo proteins are
incorporated into vesicles. Appendix I describes a protein, Issl 3p/Hkrl p, that
was identified based on its interaction with the C-terminal domain of Secl6p in
the two-hybrid assay. Issl3p appears to be an integral membrane cargo protein;
it is tempting to speculate that the association between Secl 6p and Issl 3p plays
a role in transport of Issl3p from the ER to the Golgi apparatus. It will be
important to verify the interaction of Issl 3p/Hkrl p with the C-terminal domain of
Secl6p in vitro. If the cytosolic domain of Issl3p indeed binds to Secl6p, the
effects of Iss 13p on the protein-protein interactions described above can then be
examined.
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The finding that a putative cargo protein, Issl3p, as well as several other
membrane proteins (Issl 1 p, Issl 2p, Issl 4p, Issl 5p, Issl 8p) interact with Secl 6p
in the two-hybrid assay suggests that Secl 6p may have a general role in loading
cargo proteins into COPII coated vesicles. Secl 6p could bind directly to the
cytosolic domains of integral membrane cargo proteins; soluble cargo proteins
could be loaded into vesicles by binding to Secl6p of an integral membrane
sorting receptor that binds to soluble cargo proteins. It will be interesting to
examine whether Secl6p binds to the cytosolic domain of other known cargo
proteins, such as Sec22p and Emp24p/Bst2p.
It is worth noting that Issl p - Issl 8p interact with both the C-terminal
domain of Secl6p and with Sec23p in the two-hybrid assay, suggesting that
cargo loading into COPII vesicles may involve a trimeric Sec23p/Secl 6p/cargo
protein complex. Interestingly, initiation of vesicle formation may also occur at
the C-terminus of Secl6p and involves Sec23p (see above). Thus, cargo protein
loading may be tightly coupled to initiation of COPII vesicle formation by
facilitating the recruitment of cytosolic COPII coat components to Secl6p.
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Appendix I
Identification of Proteins that Interact with Secl6p Using the
Two-Hybrid System
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PREFACE
This appendix summarizes the results of two-hybrid screens for proteins that
interact with the central or the C-terminal domain of Secl6p.
MATERIALS AND METHODS
Plasmids Constructions. Plasmids are summarized in Table I. To make
pRH108, a fragment encoding amino acids 1-347 of SED4 was amplified by PCR
as described (Gimeno et al., 1995), and ligated into EcoRI-Xhol cut pEG202.
pRH157 is the BamHl-Sacl fragment of a GAL promoted SEC13 construct
(Shaywitz et al., 1995) ligated into BamHI-Xhol cut pEG202X, a derivative of
pEG202, in which the reading frame of the polylinker is changed. pRH221-229
are library plasmids recovered from the screen.
Two-Hybrid Screen for Proteins that Interact with Secl6p. Two-hybrid
screens were performed as described (Chapter 4; Golemis et al., 1994).
Plasmids containing either the central (amino acids 447-1235; pPE62) or the C-
terminal (amino acids 1645-2194; pPE58) domain of Secl6p fused to the lexA
DNA binding domain were used as a bait, and a S. cerevisiae genomic library
fused to an acidic activation domain was used as a fish (Watt et al., 1995).
Briefly, ~2 x 105 transformants were screened for Leu+ 3-Gal+ colonies;
plasmids were recovered from positive colonies and analyzed by restriction
digestion and DNA sequencing.
Two-Hybrid Test for Protein-Protein Interactions. Protein-protein interactions
were tested in the two-hybrid system using either a transformation (Golemis et
al., 1994) or a mating assay (Finley and Brent, 1994). In the transformation
assay, fish and bait constructs were cotransformed into EGY48 carrying the
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indicator plasmid pSH18-34 (Golemis et al., 1994), and lacZexpression was
tested by patching 4 to 8 transformants on SC medium (pH 7.0) lacking the
appropriate amino acids and supplemented with 2% galactose and 40 mg/I X-gal.
In the mating assay, fish constructs were transformed into EGY48 and bait
constructs and the indicator plasmid pSH18-34 were transformed into RFY206
(Finley and Brent, 1994). Bait and fish constructs were then brought together by
mating, and lacZ expression was tested by patching two diploids derived from
two independent transformants on X-gal medium as above.
RESULTS AND DISCUSSION
Issip and Iss2p Interact with the Central Domain of Secl6p.
We have previously shown that the central domain of Sec16p (amino acids 447-
1235) interacts with the COPII coat component Sec24p (see chapter 2). To
identify additional proteins that bind to this domain of Sec16p, we performed a
two-hybrid screen using a library of Saccharomyces cerevisiae genomic DNA.
Two proteins, Issip and Iss2p (Interacting with Sec sixteen 1 and 2), interacted
strongly with the central domain of Sec16p. The properties of Issip and Iss2p
are summarized in Table II, and Isslp is described in detail in Chapter 4. Iss2p is
a novel, hydrophilic protein that is closely related to an uncharacterized yeast
protein, YGL107c (Fig. 1), but has no homology to any other proteins in the
database.
We tested the protein-protein interactions of the Iss2p fragment recovered
in the screen using the two-hybrid system (Fig. 2). As expected, Iss2p interacted
strongly with the central domain of Secl 6p. Interestingly, Iss2p also showed
strong interactions with Issl p and Sec24p, two proteins that bind to the central
domain of Secl6p (Gimeno et al., in press, and chapter 4). Iss2p interacted with
both the N-terminal and the C-terminal domain of either Sec24p or Issip,
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suggesting that Sec24p and Issip have at least two distinct binding sites for
Iss2p. Iss2p did not interact with several protein that have previously been
shown to be active in the two-hybrid assay, including the C-terminal domain of
Secl6p, the N-terminal domain of Sed4p, or full-length Sec23p or Secl3p (Fig.
2). The finding that Iss2p interacts with only a small number of bait proteins
strongly argues that the observed interactions for Iss2p are specific.
The two-hybrid data suggest that Iss2p may form a ternary complex with
the COPII coat components Secl 6p and Sec24p. Thus, Iss2p is an excellent
candidate for a novel COPII coat associated protein. Iss2p could be part of the
COPII coat, or it could interact with COPII coat components either before coat
formation or after coat disassembly. It will be important to confirm the observed
two-hybrid interactions of Iss2p in vitro. Furthermore, it will be interesting to
determine whether deletion of iss2 - either by itself or in combination with its
homolog, YGL107c - affects transport from the ER to the Golgi apparatus and, if
so, which step during transport is affected, and whether Iss2p localizes to ER-
derived vesicles.
Issl Ip - Issl 8p Interact with the C-terminal Domain of Secl 6p. The C-
terminal domain of Secl6p binds to the COPII coat component Sec23p and to
the cytosolic domain of an integral ER membrane protein, Sed4p (Gimeno et al.,
1995; Gimeno et al., in press). To identify additional proteins that bind to the C-
terminal domain of Secl6p, we performed a two-hybrid screen using the library
described above. Eight proteins, Iss 1lp-18p, were identified. The properties of
these proteins are summarized in Table III and Fig. 3.
Two of the eight proteins, Issl6p and Issl7p, are predicted to be soluble
proteins. Both Issl6p and Issl7p are novel proteins with no homology to other
proteins in the database. Issl7p was previously isolated as a high copy
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suppressor of temperature-sensitive mutations in the coatomer component arfl1
(SFS2, Kahn, R. A., personal communication; Kahn et al., 1995), and is not
essential for viability (C. A. Carter, personal communication). The genetic
interaction of ISS17with ARF1 suggests that Issl7p is indeed involved in the
secretory pathway, although its exact role remains unclear. As discussed below,
Issl6p interacts with Secl3p in the two-hybrid assay (Fig. 4).
The remaining six proteins identified as interacting with the C-terminal
domain of Secl6p are predicted to be integral membrane proteins (Fig. 3). We
were surprised to recover several fusion proteins that contained one or more
membrane-spanning domains, since a two-hybrid signal is generally thought to
require soluble bait and fish proteins that have been transported into the nucleus.
Possibly, fusion proteins, once inserted in the ER membrane, can be
translocated to the inner membrane of the nuclear envelope and then interact
with the soluble bait protein in the nucleus. Alternatively, the presence of the
acidic activation domain may disrupt insertion of some fusion proteins into the
membrane, resulting in a soluble fish protein.
One of the six integral membrane proteins, Issl 3p, has been previously
identified as Hkrl p, a protein that confers resistance to HM-1 killer toxin when
overexpressed (Kasahara et al., 1994). Issl3p is predicted to encode a type I
integral membrane protein; the C-terminal, cytosolic domain of Issl3p consists of
294 amino acids and contains a calcium-binding consensus sequence (EF hand
motif; Kasahara et al., 1994). Given the location of Secl6p on the cytosolic face
of the membrane, it is expected that Secl6p interacts with the C-terminal,
cytosolic domain of Issl 3p. While cells carrying a deletion of the entire ISS13
reading frame are inviable (Kasahara et al., 1994), cells carrying an allele of
ISS13 that is truncated just before the transmembrane domain show reduced 13-
1,3,-glucan synthase activity, an abnormal cell wall composition, and
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abnormalities in budding pattern (Yabe et al., 1996). This argues that the
transmembrane and/or cytosolic domains of Issl3p, are required for proper cell
function. Issl3p is localized to the plasma membrane (Yabe et al., 1996); thus,
any interaction between Issl3p and Secl6p is likely to occur during transit of
Issl3p through the ER.
Two integral membrane proteins, Issl4p and Issl8p, show significant
homology to proteins in the database. Issl4p has strong similarity to P-type
ATPases. Interestingly, Issl4p has a C-terminal ER retention sequence
(KXKXX), suggesting that Issl4p may function in the ER. Issl8p has strong
similarity to the yeast protein Sgel p, that confers resistance to crystal violet when
overexpressed (Ehrenhofer-Murray et al., 1994). Since Issl8p also has weaker
similarity to a number of bacterial antibiotic resistance proteins, Issl8p is likely to
be a membrane transport protein.
We used the two-hybrid system to test whether the Iss 1 p-18p fragments
recovered in the screen interacted with proteins other than the C-terminal domain
of Secl6p (Fig. 4). Interestingly, all of the fragments interacted with Sec23p, but
none interacted with the N-terminal domain of Sed4p (Fig. 4). Furthermore, none
of the fragments interacted with the central or the N-terminal domain of Secl 6p,
and only one fragment, Issl6p, interacted with Secl3p (Fig. 4). Importantly, the
N-terminal domain of Sed4p used in this assay is active since it can interact with
a C-terminal fragment of Secl6p (data not shown). These data suggest that
Iss 11 p-18p bind specifically to the C-terminal domain of Secl6p and to Sec23p.
Since Iss11 lp-18p interact with both the C-terminal domain of Secl6p and
with Sec23p, but not with Sed4p, we propose that Iss 11 p-18p interact with
Secl6p during or after vesicle formation. Issl6p and Issl7p could be
components of the COPII coat that regulate vesicle formation or affect the
function of the vesicle after vesicle formation is complete. An intriguing possibility
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for membrane-spanning Iss proteins is that these proteins are cargo proteins that
interact with Secl 6p during cargo sorting into vesicles. This hypothesis is
consistent with the localization of Issl3p at the plasma membrane, and the
finding that a large number of diverse proteins can bind to the C-terminal domain
of Secl 6p. Secl 6p, perhaps in conjunction with Sec23p, may function as a
cargo receptor during vesicle formation at the ER. Clearly, more work is needed
to understand the role of Secl6p and its interactions with Iss proteins.
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Figure 1. Comparison of the protein sequences of Iss2p and YGL107c. Solid
lines indicate identical amino acids, dotted lines indicate similar amino acids.
Overall amino acid identity is 47%. Amino acid positions are indicated by the
numbers to the right of each protein. Sequence comparison was performed
using the BestFit program (Genetics Computer Group).
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Iss2p
Figure 2. Two-hybrid interactions of Iss2p. The amino acid numbers included in
each construct are given in brackets. The portion of Iss2p used is indicated by
the arrow on the diagram. Constructs marked with an asterisk were tested in the
mating assay, unmarked constructs were tested in the transformation assay. 4-8
transformants (transformation assay) or 2 independent diploids (mating assay)
were patched on medium containing X-gal and their color was evaluated after 24
to 48 h. +++, dark blue; -, white.
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Activation Domain fused to
ISS2 no fusion
LexA-DNA Binding (329-731)
Domain Fused to 3Domain Fused to -galactosidase activity
(Blue color on X-GAL plates)
SEC16CEN +++
(447-1235)
SEC16C - -
(1645-2194)
SED4N - -
(1-347)
SEC13* - -
(1-297)
SEC23 - -
(1-768)
SEC24 +++
(1-926)
SEC24N +++
(1-666)
SEC24C +++ -
(666-926)
ISS1 +++ -
(1-875)
ISSIN + -(1-622)
ISSic +++
(622-875)
r I- Starting Point of Clone Identified in ScreenIss2p I
Figure 3. Schematic representation of Issl 1 p - Issl 8p. The starting points of the
clones identified in the screen are indicated by an arrow. Transmembrane
domains are indicated by shaded boxes. Transmembrane domains were
predicted using the TMpred program (Hofmann and Stoffel, 1993;
http://ulrec3.unil.ch/software/TMPRED_form.htm I)
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Issl2p
Issl3p
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Issl8p I
I Transmembrane Domain
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Figure 4. Two-hybrid interactions of Issl 1 p-lssl8p. The amino acid numbers
included in each construct are given in brackets. Constructs marked with an
asterisk were tested in the mating assay, unmarked constructs were tested in the
transformation assay. 4-8 transformants (transformation assay) or 2 independent
diploids (mating assay) were patched on medium containing X-gal and their color
was evaluated after 24 to 48 h. +++, dark blue; -, white.
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Table I. Plasmids
Plasmid Description Source or Reference
lexA DNA binding domain in a 2g vector marked with HIS3
lexA DNA binding domain in a 2g vector marked with HIS3
acidic activation domain in a 2g vector marked with TRP1
lacz gene under control of 8 lexA DNA binding sites in a
2g vector marked with URA3
ISS2 (329-731) in pJG4-5
/SS11(127-292) in pJG4-5
ISS12 (281-656) in pJG4-5
ISS13 (1263-1802) in pJG4-5
ISS14 (160-1472) in pJG4-5
ISS15 (200-725) in pJG4-5
ISS16 (85-500) in pJG4-5
ISS17(298-586) in pJG4-5
ISS18 (94-768) in pJG4-5
SED4 (1-347) in pEG202
SEC13 in pEG202
SEC23 in pGILDA
ISS1 (1-875) in pEG202
ISS1 (1-622) in pEG202
ISS1 (622-875) in pEG202
SEC24 (34-926) in pEG202
SEC24 (1-666) in pEG202
SEC24 (666-926) in pEG202
SEC16 (1645-2194) in pEG202
SEC16 (1-824) in pEG202
SEC16 (447-1235) in pEG202
Golemis et al., 1994
Shaywitz and Kaiser, unpublished
Golemis et al., 1994
Golemis et al., 1994
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Gimeno et al., in press
Chapter 4
Chapter 4
Chapter 4
Gimeno et al., in press
Gimeno et al., in press
Gimeno et al., in press
Espenshade et al., 1995
Espenshade et al., 1995
Gimeno et al., in press
Note: The numbers in parenthesis indicate the amino acid numbers of the preceding gene's product
pEG202
pGILDA
pJG4-5
pSH 18-34
pRH229
pRH221
pRH222
pRH223
pRH224
pRH225
pRH226
pRH227
pRH228
pRH 108
pRH 157
pDS79
pRH266
pRH319
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pRH347
pPE58
pPE59
pPE62
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PREFACE
Appendix II represents primarily Peter Espenshade's work. My main contribution
is the development of the two-hybrid system to assay interactions of Secl 6p with
Sec23p (Table III).
Appendix II has been published in its entirety in the Journal of Cell Biology as:
Espenshade, P., Gimeno, R. E., Holzmacher, E., Teung, P., and C. A. Kaiser.
(1995). Yeast SEC16 gene encode a multidomain vesicle coat protein that
interacts with Sec23p. J. Cell Biol. 131:311-324.
ABSTRACT
Temperature-sensitive mutations in the SEC16 gene of Saccharomyces
cerevisiae block budding of transport vesicles from the ER. SEC16 was cloned
by complementation of the secl6-1 mutation and encodes a 240 kD protein
located in the insoluble, particulate component of cell lysates. Secl 6p is
released from this particulate fraction by high salt, but not by nonionic detergents
or urea. Some Secl6p is localized to the ER by immunofluorescence
microscopy. Membrane-associated Secl6p is incorporated into transport
vesicles derived from the ER that are formed in an in vitro vesicle budding
reaction. Secl 6p binds to Sec23p, a COPII vesicle coat protein, as shown by the
two-hybrid interaction assay and affinity studies in cell extracts. These findings
indicate that Secl6p associates with Sec23p as part of the transport vesicle coat
structure.
Genetic analysis of SEC16 identifies three functionally distinguishable
domains. One domain is defined by the five temperature-sensitive mutations that
are clustered in the middle of SEC16. Each of these mutations can be
complemented by the central domain of SEC16 expressed alone. The
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stoichiometry of Secl 6p is critical for secretory function since overexpression of
Secl6p causes a lethal secretion defect. This lethal function maps to the N-
terminus of the protein, defining a second functional domain. A separate function
for the C-terminal domain of Secl6p is shown by its ability to bind Sec23p.
Together, these results suggest that Secl6p engages in multiple protein-protein
interactions both on the ER membrane and as part of the coat of a completed
vesicle.
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